
<html lang="en"     class="pb-page"  data-request-id="a45fceb1-663c-4472-9a8e-640481190641"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-8;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b01663;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Small-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery" /></meta><meta name="dc.Creator" content="Xibao  Tian" /></meta><meta name="dc.Creator" content="Jiali  Gao" /></meta><meta name="dc.Creator" content="Meishuo  Liu" /></meta><meta name="dc.Creator" content="Yuqin  Lei" /></meta><meta name="dc.Creator" content="Fangjun  Wang" /></meta><meta name="dc.Creator" content="Jin  Chen" /></meta><meta name="dc.Creator" content="Peng  Chu" /></meta><meta name="dc.Creator" content="Jiujiao  Gao" /></meta><meta name="dc.Creator" content="Feida  Long" /></meta><meta name="dc.Creator" content="Minzhi  Liang" /></meta><meta name="dc.Creator" content="Xiangyu  Long" /></meta><meta name="dc.Creator" content="Huiying  Chu" /></meta><meta name="dc.Creator" content="Cuixia  Liu" /></meta><meta name="dc.Creator" content="Xueliang  Li" /></meta><meta name="dc.Creator" content="Qingxiang  Sun" /></meta><meta name="dc.Creator" content="Guohui  Li" /></meta><meta name="dc.Creator" content="Yongliang  Yang" /></meta><meta name="dc.Description" content="Exportin-1 (also named as CRM1) plays a prominent role in autoimmune disorders and has emerged as a potential therapeutic target for colitis. Here we report on the rational structure-based discover..." /></meta><meta name="Description" content="Exportin-1 (also named as CRM1) plays a prominent role in autoimmune disorders and has emerged as a potential therapeutic target for colitis. Here we report on the rational structure-based discover..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 30, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01663" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01663" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01663" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01663" /></link>
        
    
    

<title>Small-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01663" /></meta><meta property="og:title" content="Small-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0012.jpeg" /></meta><meta property="og:description" content="Exportin-1 (also named as CRM1) plays a prominent role in autoimmune disorders and has emerged as a potential therapeutic target for colitis. Here we report on the rational structure-based discovery of a small-molecule antagonist of exportin-1, LFS-829, with low-range nanomolar activities. The co-crystallographic structure, surface plasmon resonance binding assay, and cell-based phenotypic nuclear export functional assay validated that exportin-1 is a key target of LFS-829. Moreover, we demonstrated that the C528S mutation or the knockdown on exportin-1 can abolish the cellular activities of LFS-829. Strikingly, oral administration of LFS-829 can significantly reverse the pathological features of colitis model mice. We revealed that LFS-829 can attenuate dual NF-κB signaling and the Nrf2 cytoprotection pathway via targeting exportin-1 in colitis mice. Moreover, LFS-829 has a very low risk of cardiotoxicity and acute toxicity. Therefore, LFS-829 holds great promise for the treatment of colitis and may warrant translation for use in clinical trials." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Exportin-1 (also named as CRM1) plays a prominent role in autoimmune disorders and has emerged as a potential therapeutic target for colitis. Here we report on the rational structure-based discovery of a small-molecule antagonist of exportin-1, LFS-829, with low-range nanomolar activities. The co-crystallographic structure, surface plasmon resonance binding assay, and cell-based phenotypic nuclear export functional assay validated that exportin-1 is a key target of LFS-829. Moreover, we demonstrated that the C528S mutation or the knockdown on exportin-1 can abolish the cellular activities of LFS-829. Strikingly, oral administration of LFS-829 can significantly reverse the pathological features of colitis model mice. We revealed that LFS-829 can attenuate dual NF-κB signaling and the Nrf2 cytoprotection pathway via targeting exportin-1 in colitis mice. Moreover, LFS-829 has a very low risk of cardiotoxicity and acute toxicity. Therefore, LFS-829 holds great promise for the treatment of colitis and may warrant translation for use in clinical trials." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0012.jpeg" /></meta><meta name="twitter:title" content="Small-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01663"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01663">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01663&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01663&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01663&amp;href=/doi/10.1021/acs.jmedchem.9b01663" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3881-3895</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01621" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01501" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xibao Tian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xibao Tian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xibao++Tian">Xibao Tian</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiali Gao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiali Gao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiali++Gao">Jiali Gao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Meishuo Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Meishuo Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Meishuo++Liu">Meishuo Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuqin Lei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuqin Lei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuqin++Lei">Yuqin Lei</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fangjun Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fangjun Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Separation Sciences for Analytical Chemistry, National Chromatographic R&A Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS), Dalian, Liaoning 116023, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fangjun++Wang">Fangjun Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8118-7019" title="Orcid link">http://orcid.org/0000-0002-8118-7019</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jin Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jin Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">CAS Key Laboratory of Separation Sciences for Analytical Chemistry, National Chromatographic R&A Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS), Dalian, Liaoning 116023, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jin++Chen">Jin Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peng Chu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peng Chu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peng++Chu">Peng Chu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiujiao Gao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiujiao Gao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiujiao++Gao">Jiujiao Gao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Feida Long</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Feida Long</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Feida++Long">Feida Long</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Minzhi Liang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Minzhi Liang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Minzhi++Liang">Minzhi Liang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiangyu Long</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiangyu Long</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiangyu++Long">Xiangyu Long</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Huiying Chu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Huiying Chu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Molecular Modeling and Design, State key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Huiying++Chu">Huiying Chu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cuixia Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cuixia Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cuixia++Liu">Cuixia Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xueliang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xueliang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xueliang++Li">Xueliang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qingxiang Sun</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qingxiang Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#aedfc7c0c9d6c7cfc0c980dddbc0eeddcddb80cbcadb80cdc0"><span class="__cf_email__" data-cfemail="4d3c24232a35242c232a633e38230d3e2e3863282938632e23">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qingxiang++Sun">Qingxiang Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guohui Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guohui Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Molecular Modeling and Design, State key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3b5c5357527b5f52584b155a58155855"><span class="__cf_email__" data-cfemail="25424d494c65414c46550b44460b464b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guohui++Li">Guohui Li</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8223-705X" title="Orcid link">http://orcid.org/0000-0001-8223-705X</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Yongliang Yang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yongliang Yang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratoy of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#6104170413031308060915585821070e190c00080d4f020e0c"><span class="__cf_email__" data-cfemail="761300130414041f111e024f4f3610190e1b171f1a5815191b">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yongliang++Yang">Yongliang Yang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0449-0599" title="Orcid link">http://orcid.org/0000-0003-0449-0599</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01663&amp;href=/doi/10.1021%2Facs.jmedchem.9b01663" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3881–3895</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 30, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 October 2019</li><li><span class="item_label"><b>Published</b> online</span>30 March 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 April 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01663" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01663</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3881%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXibao%2BTian%252C%2BJiali%2BGao%252C%2BMeishuo%2BLiu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D8%26contentID%3Dacs.jmedchem.9b01663%26title%3DSmall-Molecule%2BAntagonist%2BTargeting%2BExportin-1%2Bvia%2BRational%2BStructure-Based%2BDiscovery%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3895%26publicationDate%3DApril%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01663"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1539</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01663" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small-Molecule Antagonist Targeting Exportin-1 via Rational Structure-Based Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xibao&quot;,&quot;last_name&quot;:&quot;Tian&quot;},{&quot;first_name&quot;:&quot;Jiali&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Meishuo&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yuqin&quot;,&quot;last_name&quot;:&quot;Lei&quot;},{&quot;first_name&quot;:&quot;Fangjun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Peng&quot;,&quot;last_name&quot;:&quot;Chu&quot;},{&quot;first_name&quot;:&quot;Jiujiao&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Feida&quot;,&quot;last_name&quot;:&quot;Long&quot;},{&quot;first_name&quot;:&quot;Minzhi&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Xiangyu&quot;,&quot;last_name&quot;:&quot;Long&quot;},{&quot;first_name&quot;:&quot;Huiying&quot;,&quot;last_name&quot;:&quot;Chu&quot;},{&quot;first_name&quot;:&quot;Cuixia&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Xueliang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Qingxiang&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Guohui&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yongliang&quot;,&quot;last_name&quot;:&quot;Yang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;3881-3895&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01663&quot;},&quot;abstract&quot;:&quot;Exportin-1 (also named as CRM1) plays a prominent role in autoimmune disorders and has emerged as a potential therapeutic target for colitis. Here we report on the rational structure-based discovery of a small-molecule antagonist of exportin-1, LFS-829, with low-range nanomolar activities. The co-crystallographic structure, surface plasmon resonance binding assay, and cell-based phenotypic nuclear export functional assay validated that exportin-1 is a key target of LFS-829. Moreover, we demonstrated that the C528S mutation or the knockdown on exportin-1 can abolish the cellular activities of LFS-829. Strikingly, oral administration of LFS-829 can significantly reverse the pathological features of colitis model mice. We revealed that LFS-829 can attenuate dual NF-κB signaling and the Nrf2 cytoprotection pathway via targeting exportin-1 in colitis mice. Moreover, LFS-829 has a very low risk of cardiotoxicity and acute toxicity. Therefore, LFS-829 holds great promise for the treatment of colitis and may warrant &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01663&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01663" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01663&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01663" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01663&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01663" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01663&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01663&amp;href=/doi/10.1021/acs.jmedchem.9b01663" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01663" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01663" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (14 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01663%26sid%3Dliteratum%253Aachs%26pmid%3D32223194%26genre%3Darticle%26aulast%3DTian%26date%3D2020%26atitle%3DSmall-Molecule%2BAntagonist%2BTargeting%2BExportin-1%2Bvia%2BRational%2BStructure-Based%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D8%26spage%3D3881%26epage%3D3895%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/8" title="Go to Volume 63, Issue 8"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/jmcmar.2020.63.issue-8/20200423/jmcmar.2020.63.issue-8.largecover.jpg" alt="Go to Volume 63, Issue 8"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Exportin-1 (also named as CRM1) plays a prominent role in autoimmune disorders and has emerged as a potential therapeutic target for colitis. Here we report on the rational structure-based discovery of a small-molecule antagonist of exportin-1, LFS-829, with low-range nanomolar activities. The co-crystallographic structure, surface plasmon resonance binding assay, and cell-based phenotypic nuclear export functional assay validated that exportin-1 is a key target of LFS-829. Moreover, we demonstrated that the C528S mutation or the knockdown on exportin-1 can abolish the cellular activities of LFS-829. Strikingly, oral administration of LFS-829 can significantly reverse the pathological features of colitis model mice. We revealed that LFS-829 can attenuate dual NF-κB signaling and the Nrf2 cytoprotection pathway via targeting exportin-1 in colitis mice. Moreover, LFS-829 has a very low risk of cardiotoxicity and acute toxicity. Therefore, LFS-829 holds great promise for the treatment of colitis and may warrant translation for use in clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The incidence of inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), has been increasing very rapidly during the past decade worldwide, affecting more than two million individuals in North America, more than three million individuals in Asia, and around two million individuals in Europe.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The chronic inflammatory disorders of colitis also harbor a huge risk of colorectal cancer development.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Unfortunately, to date, there is no known cure for colitis, and available first-line treatment options are aimed toward controlling symptoms for mild patients.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Therefore, new therapeutic strategies are urgently needed to combat colitis.</div><div class="NLM_p">Exportin-1 (also named as CRM1) is responsible for the nuclear export of critical transcription factors and tumor suppressor proteins.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8">(4−8)</a> There is a considerable amount of evidence implicating that the dysregulation of CRM1 contributes to the pathogenesis of a panel of human cancer and autoimmune disorders. In particular, prior reports demonstrated that CRM1 is highly upregulated in the intestinal epithelial cells (IEC) of both CD patients and model animals.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Therefore, CRM1 has emerged as a viable target for developing new therapeutics against colitis. Previously, we found that sulforaphene, the major active chemical component from the seeds of <i>Raphanus sativus</i>, can alleviate colitis in model mice and protect the epithelial barrier by covalently targeting a conserved cysteine residue in the NES (nuclear export signal) binding cleft of CRM1.<a onclick="showRef(event, 'ref5 ref10'); return false;" href="javascript:void(0);" class="ref ref5 ref10">(5,10)</a></div><div class="NLM_p last">Herein, we reported the rational structure-based discovery and extensive evaluation of the synthetic analogue of sulforaphene, LFS-829, in colitis model mice. Importantly, the co-crystallographic structure, cell-based phenotypic nuclear export functional assay, and SPR (surface plasmon resonance) binding assay firmly establish that CRM1 is a major cellular target of LFS-829. Furthermore, oral treatment of LFS-829 can reverse the pathological development of colitis in model mice. Our proteomics analysis study also showed that LFS-829 can reverse the disease-affected signatures in colitis mice. Remarkably, LFS-829 exhibits excellent safety profiles and pharmacological properties compatible with treating colitis. Our results not only provide the mechanistic insights to explain the activities of LFS-829 in reversing colitis but also open new avenues of developing novel pharmacological treatment of colitis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> CRM1 Is Significantly Upregulated in the IEC of Colitis Patients</h3><div class="NLM_p last">To investigate the intestinal expression of CRM1 in colitis patients, we performed an analysis of the endoscopic mucosal biopsy tissues from the inflamed and noninflamed areas of UC patients and normal individuals. We employed Western blot experiments and confirmed that CRM1 was significantly overexpressed in the intestinal epithelial cells (IEC) of colitis patients as compared with normal controls (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figure S1</a>). Hence, our results indicated that CRM1 is closely associated with the progression and pathogenesis of colitis.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure-Based Discovery of Small-Molecule Antagonist LFS-829</h3><div class="NLM_p">In our prior work, we identified that sulforaphene (LFS-01) is a natural antagonist of CRM1, and the isocyanate group of LFS-01 can trap the cysteine residue in the nuclear export signal (NES) binding cleft of CRM1 via a covalent bond.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> We revealed that oral administration of LFS-01 can reverse colitis in model mice.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Herein we wanted to develop a potent antagonist based on the scaffold of LFS-01 and evaluate its efficacy in the colitis model. First, to increase the noncovalent interactions with the NES binding groove of CRM1, we installed a phenyl ring next to the sulfoxide moiety in the parent structure of LFS-01, which leads to compound LFS-06 that inhibits nuclear export with an IC<sub>50</sub> value of 1.5 μM, 3-fold better than that of LFS-01 determined by the cell-based phenotypic nuclear export functional assay as previously described.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> We next sought to optimize the scaffold of LFS-06 with better potency and drug-like properties for colitis. To this end, we generated a virtual combinatorial library based on the phenyl ring of LFS-06. In total, 45 substitution moieties were used in the generation of a virtual library consisting of 2025 analogue molecules with disubstituted groups on the phenyl ring (see Data set_S1). Furthermore, we used the ADME/T module as well as the drug-likeness module implemented in the DiscoveryStudio suite to filter out the top 100 analogue molecules from the combinatorial library with acceptable ADME/T and drug-like properties. Subsequently, we employed covalent docking to predict the binding of the analogue molecules with the nuclear export signal (NES) cleft of CRM1. Lastly, we selected LFS-829 from the top 15 analogue molecules to prepare on the basis of binding energy, drug-like properties, ADME/T properties, solubility, and easy synthesis (see <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, also see Data set_S1).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Discovery Scheme of Small-Molecule Antagonist LFS-829</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Crystallographic Structure of LFS-829 Bound with CRM1</h3><div class="NLM_p">To establish the precise mode of actions of LFS-829, we determined its cocrystal structure complexed with humanized yeast (<i>Saccharomyces cerevisiae</i>) CRM1 protein, yeast RanBP1, and human RanGTP at 2.60 Å resolution (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZPU">5ZPU</a>; <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>; <a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figures S2 and S3</a>). The cocrystal structure clearly shows that LFS-829 forms a covalent bond with the sulfur atom of Cys<sup>539</sup> located in the NES binding cleft of CRM1, similar to that of the existing CRM1 inhibitor KPT-330.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The ditrifluoromethyl-phenyl moiety fits well into a subpocket in the NES binding cleft of CRM1 formed by Ile555, Met556, Thr575, Val576, Lys579, and Leu580 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B,E). Importantly, the two trifluoromethyl substituent groups form strong hydrogen bonding with Leu536, Lys548, Lys579, and Leu580 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C,E). Moreover, the phenyl ring of LFS-829 enjoys hydrophobic contacts with Phe583 and Phe572 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>E). This cocrystal structure provides a solid structural basis for the specific and covalent binding of LFS-829 with Cys<sup>539</sup> in the NES binding cleft of CRM1. Additionally, our mass spectroscopic analysis and pull-down assay experiments also showed that LFS-829 is a potent and covalent CRM1 inhibitor (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figure S4</a>). In particular, we showed by the pull-down assay that LFS-829 binds to both human CRM1 and humanized yeast CRM1 strongly by inhibiting the binding of GST-NES<sup>MVM</sup> to the NES binding groove (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D). In addition, C528S mutation on CRM1 completely abolished LFS-829’s binding, suggesting that the covalent bond formation is essential for its function (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figure S4</a>, C528 in human CRM1 is equivalent to C539 in yeast CRM1).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystallographic structure of compound LFS-829 bound to CRM1. (A) Co-crystallographic structure of compound LFS-829 (green) complexed with CRM1 (cyan) at 2.60 Å resolution (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZPU">5ZPU</a>). (B) A covalent bond between Cys539 and LFS-829 was detected. (C) Electrostatic potential surface display of LFS-829 bound in the nuclear export signal (NES) cleft of CRM1. (D) SDS-PAGE analysis of the GST-NES<sup>MVM</sup> pull-down assay of various CRM1 in the presence or absence of 50 μM compound LFS-829. (E) Schematic representation shows the interaction of LFS-829 with the NES binding cleft of CRM1 (the red dash line indicates the hydrogen bonding, and the dark dash line indicates the hydrophobic pocket).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> CRM1 Is a Major Cellular Target of LFS-829</h3><div class="NLM_p">In addition to the cocrystal structure, we revealed that CRM1 is a major target of LFS-829 through a series of experiments. First, the incubation of the CRM1 protein with LFS-829 caused an increase in molecular weight of 373 Da as determined by LC–MS/MS via the LTQ Orbitrap method, corresponding to the covalent addition of the LFS-829 moiety (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figure S4</a>). We demonstrated that the activities toward HCT-15 cells by LFS-829 was significantly abrogated when CRM1 was knocked down by siCRM1, implicating that CRM1 is the main target responsible for the cellular activities of LFS-829 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). Next, we tried to evaluate the binding specificity of LFS-829 with CRM1 as compared to other possible protein targets with reactive cysteine in the binding pocket. Here, we chose IkB<sub>α</sub> and Keap1 as two control probes to investigate because both of them are reactive for covalent inhibitors and thereby frequently used for testing selectivity. Our SPR (surface plasmon resonance, Biacore T200) results revealed that LFS-829 binds strongly with CRM1 (<i>K</i><sub>d</sub> ∼ 26.95 nM, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A) as compared to KPT-330 (<i>K</i><sub>d</sub> ∼18.74 nM). In contrast, LFS-829 does not bind with either two control probes IkB<sub>α</sub> or Keap1 in SPR binding assay experiments.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CRM1 is a major cellular target of LFS-829. (A) The SPR (surface plasmon resonance) binding assay between LFS-829 and CRM1 performed on Biacore T200 with KPT-300 as a positive control (LFS-829, <i>K</i><sub>d</sub> = 26.95 nM; KPT-330, <i>K</i><sub>d</sub> = 18.74 nM). (B) The cellular activities of LFS-829 on siCRM1-HCT-15 and the wild-type HCT-15 cell line with different concentrations of treatment for 24 h. (C) The time course of CRM1-LFS829 complex degradation determined by a cell-based phenotypic nuclear export functional assay. The localization of NES-GFP per hour was monitored by confocal microscopy after cells (293T cell line) were washed with PBS to remove the compounds. Only after two hours, NES-GFP in cells incubated with LFS-829 was almost completely translocated to the cytoplasm, indicating its reverse binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Importantly, we investigated the time course of CRM1-LFS829 complex degradation by the cell-based phenotypic nuclear export functional assay (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Here, KPT-330 was used as a control compound because prior studies have shown that KPT-330 is a reversible CRM1 inhibitor. Briefly, NES-GFP was quickly accumulated in the nucleus upon the treatment of KPT-330 or LFS-829. Subsequently, cells (293T cell line) were washed with PBS to remove the KPT-330 or LFS-829, and we monitored the localization of NES-GFP per hour by confocal microscopy. Only after two hours, NES-GFP in cells incubated with LFS-829 was almost completely translocated to the cytoplasm, whereas, in cells incubated with KPT-330, NES-GFP was still localized in the nucleus of the cells. This result implicates that LFS-829 binds with CRM1 in a more reversible fashion as compared to that of KPT-330, indicating that LFS-829 may exert a lower toxicity profile. Moreover, we used the GSH/GSSG detection assay kit to show that the GSH/GSSG ratio keeps constant upon the treatment of LFS-829, and therefore, we ruled out the possibility that LFS-829 is a general redox modulator (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figure S7</a>). Collectively, our results revealed that CRM1 is a major cellular target of LFS-829, and it appears that LFS-829 is a reversible inhibitor of CRM1.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> LFS-829 Exhibits Superior Efficacy than First-Line Therapy in a Colitis Model</h3><div class="NLM_p">Next, we assessed the therapeutic efficacy of LFS-829 in DSS (dextran sodium sulfate)-induced colitis mice as compared to 5-ASA (5-aminosalicylicacid), the first-line therapy for colitis patients.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> Oral treatment of LFS-829 significantly attenuated the severity of DSS-induced colitis in model mice (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The dosage of 30 mg/kg that we used in the murine colitis model was translated from the clinical dosage of 5-ASA for humans. Remarkably, LFS-829 treatment can reduce body weight loss (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), reverse colon shortening (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F), decreased diarrhea (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C), and improve colonic histology (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). On the other hand, mice subjected to 7 days of administration of DSS supplemented in drinking water developed acute colitis characterized by bloody diarrhea, ulcerations, and infiltrations with granulocytes and showed severe weight loss resulting in a mortality of 20% (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). Furthermore, we observed extensive destruction of the colon mucosal layer and severe colonic damage in the untreated mice group characterized by ulceration, epithelial cell loss, reduction of the density of the tubular glands, and disseminated fibrosis. In contrast, the LFS-829-treated group showed a preserved mucosal architecture, reduced swelling, inflammation and ulceration, and more complete re-epithelialization (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Noteworthy, oral treatment of 5-ASA failed to prevent DSS-induced colitis at the same dose. Importantly, we demonstrated that LFS-829 can attenuate colitis in a dose-dependent fashion, and a 3 mg/kg dose of LFS-829 could lead to increased severity of colitis. These data provide strong evidence that LFS-829 oral treatment can reverse the course of DSS-induced acute colitis.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Oral administration of LFS-829 significantly ameliorates DSS-induced colitis mice as compared to 5-ASA. Oral treatment of LFS-829 was assessed by the following. (A) Survival rate. (B) Body weight. (C) Diarrhea. (D) The colon after sacrifice for each group. (E) H&E-stained results for the sections of the mouse colon. (F) The colon length determined for each group after sacrifice. (G) The DAI score for each group. (H) The histopathological score for the H&E-stained sections. Statistical analysis of the quantitative multiple group comparisons was performed using the one-way analysis of variance (ANOVA) followed by Tukeyʼs test, * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Comparison of LFS-829 with Clinical Candidate Compound APD334</h3><div class="NLM_p">APD334 (also known as etrasimod) is the next-generation small-molecule modulator of sphingosine-1-phosphate (S1P) currently in the evaluation of Phase 3 clinical trials for the treatment of ulcerative colitis (UC).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Of note, APD334 achieves rather positive results in clinical remission for colitis patients (2 mg per day for patients, which can be translated into 10 mg/kg dosage in a colitis murine model). Therefore, we wanted to compare the therapeutic potential of LFS-829 with APD334 in a colitis model. In brief, the group of mice treated with LFS-829 after DSS administration recovered more body weight and achieved a better disease activity index score (DAI score) as compared to the APD334 treatment group under the same dose (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A,B). Moreover, animals treated with LFS-829 exhibited much less incidence of diarrhea over the course of treatment as compared with the APD334 treatment group (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). In addition, oral treatment of LFS-829 to colitis model mice significantly restored colon length as compared to the APD334 treatment group (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D,E). Note that we observed a much better recovery of swelling, inflammation, and ulceration in the LFS-829 treatment group as compared to the APD334 treatment group within 1 week. This is consistent with the results that LFS-829 treatment can reduce more proinflammatory cytokines levels in the serum of colon tissues as compared to the APD334 treatment group as measured by the ELISA assay (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). We found that LFS-829 treatment clearly restored the damaged colon mucosal layer in the DSS group, as observed by the histopathological staining analysis (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E). Together, our results indicate that LFS-829 treatment promotes better efficacy and mucosal healing in colitis model mice than APD334 in a one-week dosing schedule. However, we wanted to remind the reader that our results do not infer that APD334 is not efficacious for colitis. Our results only implicate that LFS-829 can exert its biological effects against colitis in a relatively short period of dosing time as compared to APD334. More studies may be warranted to compare the two compounds in a long period of dosing time for colitis treatment.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. LFS-829 exerts superior efficacy than APD334 in colitis mice in a one-week dosing schedule. (A) The change of body weight during the course of treatment by LFS-829 and APD334. (B) The DAI score during the course of treatment by LFS-829 and APD334. (C) Colon length among different treatment groups. (D) The percentage of diarrhea during the course of treatment. (E) The colon after sacrifice for the LFS-829 treatment group and APD334 treatment group. From left to right: control group, DSS model group, APD334 treatment group (10 mg/kg), and LFS-829 treatment group (10 mg/kg). (F) H&E staining of the colon section for different animal groups. (G) Immunohistochemical analysis for Occuludin expression in the intestinal epithelial layer for different animal groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Proteomics Analysis of the Expression of Disease Signatures</h3><div class="NLM_p">To dissect the molecular pathways underlying the pathogenesis of colitis, we assessed the gene expression signatures determined by RNA-seq techniques in both UC patients and the DSS animal model derived from previous literatures.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Of 92 IBD-associated genes, functional enrichment analysis revealed that gene signatures involved in host defense, inflammatory response, NF-κB signaling, immune response, and gastrointestinal disease are mostly dysregulated in both UC patients and the DSS-induced animal model (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, Data set_S2). Next, we employed a proteomics technique to detect the global protein expression change in the intestinal epithelial cells (IEC) of the DSS animal model group and LFS-829 treatment group, respectively. Comparative inspection of the protein expression in the DSS model group and LFS-829 treatment group revealed the expected antithetical expression patterns between the two groups (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Interestingly, functional enrichment analysis implicated that protein signatures involved in the epithelial barrier, wound healing, immune response, inflammatory response, host defense, gastrointestinal disease, and NF-κB signaling were reciprocally expressed between the LFS-829 treatment group and the colitis model group. These results implicated that LFS-829 treatment can restore the disturbed disease signature patterns in colitis model mice.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proteomics analysis of protein signatures between the DSS-induced animal group and LFS-829-treated group. Comparison of the LFS-829 treatment group signature (right) to the DSS-induced animal group protein signature profile (left) determined by proteomics techniques, showing a generally anticorrelated pattern, with genes at the top- and bottommost ends of the expression pattern, showing generally oppositional expression patterns. Protein signatures that are upregulated are shown in green. Protein signatures that are downregulated are shown in red. An adjusted [Adj] <i>p</i>-value ≤ 0.05 was considered significant. The pathways and functional groups significantly enriched (enrichment <i>P</i> < 0.05) in the top and bottom 25% of genes are shown on the right-hand side.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> LFS-829 Attenuates Both NF-κB Signaling and the Nrf2 Cytoprotection Pathway in a Colitis Model</h3><div class="NLM_p">Previous work has suggested that NF-κB signaling and host defense pathways play predominant roles in the pathogenesis of colitis. In accordance, our proteomics results also revealed that gene signatures involved in host defense and NF-κB signaling were dysregulated in the DSS model group. Therefore, we wanted to investigate the biological effects of LFS-829 toward NF-κB signaling and host defense pathways in the colitis model. First, we observed a significant accumulation of IkB<sub>α</sub> and Nrf2 in the nucleus by confocal microscopy upon treatment with LFS-829 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Consequently, the accumulated IkB<sub>α</sub> in the nucleus can bind to NF-κB and inhibit its transcriptional activities. Analogously, the accumulated Nrf2 in the nucleus can induce the cellular defense pathway. Next, as assessed by Western blots, we found a significant upregulation of p65 levels in the intestinal epithelial cells obtained from the DSS-treated group as compared to the control group (see <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). This constitutive activity of NF-κB p65 was accompanied by the increased production of a few proinflammatory cytokines including Cox-2, TNF-α, IL-6, IL-1β, and IL-23 as measured by the ELISA assay (see <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D). Remarkably, when colitis mice were treated with LFS-829, a significant reduction of NF-κB p65 as well as the proinflammatory cytokines mentioned above were observed (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A,D). Accordingly, we found that oral treatment of LFS-829 can abrogate the clinical signs of established intestinal inflammation in colitis mice. Moreover, LFS-829-treated colitis mice no longer had diarrhea and started to gain weight (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. LFS-829 treatment causes nuclear accumulation of IkB<sub>α</sub> and Nrf2 observed by confocal microscopy. (A) Nuclear retention of IkB<sub>α</sub> upon treatment with LFS-829. (B) Nuclear retention of Nrf2 upon treatment with LFS-829. (C, D) Quantification of the nuclear IkB<sub>α</sub> and Nrf2 ratio by fluorescence intensity per cell.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. LFS-829 treatment attenuates downstream targets of the NF-κB signaling and Nrf2 cytoprotection pathway. (A) LFS-829 treatment downregulates the expression of p65 and Cox-2. (B) LFS-829 treatment attenuates the expression of HO-1 and NQO1. (C) LFS-829 treatment regulates the expression of MRP8 and MRP14. (D) ELISA detection of cytokine production after treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the other hand, prior reports have shown that a few important antioxidants and anti-inflammatory enzymes regulated by the Nrf2 cellular defense pathway play protective roles in the pathogenesis of colitis.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> As mentioned before, the nuclear retention of Nrf2 by LFS-829 treatment may activate the cytoprotection pathway in the colon of colitis mice. Hence, we evaluated the expression levels of several antioxidant and phase II detoxifying enzymes among different animal groups. As expected, we found that the DSS-induced colitis group was associated with increased expression of Nrf2-regulated enzymes such as NQO1 and reduced expression of Nrf2 and phase II detoxifying enzyme HO-1 as compared to the control group (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). In contrast, in LFS-829 treatment group, we found a significant reduction of expression levels of NQO1 and an increase of expression levels of Nrf2 and HO-1 as compared to the DSS model group (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Of note, the overexpression of MRP8 (S100A8) and MRP14 (S100A9), which is called as the calprotectin complex, has been regarded as a very valuable biomarker for monitoring the colonic inflammatory conditions in colitis patients.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Interestingly, we observed that the upregulation of MRP8 (S100A8) and MRP14 (S100A9) in the DSS model group as compared to the control group was restored upon the treatment of LFS-829 as measured by Western blot (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C). The tight junction protein, occludin, is crucial to the integration of the intestinal epithelial barrier and, therefore, often used as a critical pathological marker for colitis patients. Our immunohistochemical analysis results revealed that occludin expression was significantly reduced in colitis mice (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F). Conversely, LS-829 treatment restored the dysregulation of occludin, which suggested that LFS-829 protects the epithelial barrier during intestinal damage of colitis. Taken together, our results implicate that LFS-829 can reverse the pathogenetic course of colitis by regulating both NF-κB signaling and the Nrf2 cellular defense pathway.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Encapsulation of LFS-829 in Nanoparticles</h3><div class="NLM_p">IBD is a chronic relapsing disease, and patients may require a rather long-term medication. Therefore, an oral colon-specific drug delivery system can enhance the drug efficacy and reduce adverse effects for patients.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In our prior work, we have prepared a water-soluble nanoparticle encapsulated form of sulforaphene by α-cyclodextrin.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Analogously, to enhance the oral bioavailability, stability, solubility, and other therapeutic properties of LFS-829, we prepared a nanoparticle encapsulated form of LFS-829 by α-cyclodextrin as previously described (named as CD-LFS-829 or Cyclone-829, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Molecular modeling and scanning electron microscopy (SEM) demonstrate that LFS-829 can be well stabilized in the cavity of α-CD (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A,B). In brief, we examined the therapeutic potential of CD-LFS-829 in the DSS-induced colitis rodent model. Notably, oral treatment of CD-LFS-829 (30 mg/kg/day) significantly restored the colon length and histological score as compared to the untreated DSS group (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C–E). Taken together, our study provides a demo encapsulation system for the potential use of LFS-829 in the clinical treatment of colitis.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Oral administration of the encapsulated form of LFS-829 (α-cyclodextrin-LFS-829, also named as CD-LFS-829) ameliorate DSS-induced colitis in model mice. (A) Modeling structure of LFS-829 encapsulated in α-cyclodextrin as a host–guest complex. (B) The scanning electron microscopy (SEM) data for the water-soluble formulation of CD-LFS-829. (C) Survival rate of different animal groups. (D) Percentage of diarrhea among different animal groups. (E) Histopathological score for the H&E-stained sections.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Permeability and Stability Properties of LFS-829</h3><div class="NLM_p">The parallel artificial membrane permeability assay (PAMPA) study and the Caco-2 cell permeability study determined that the permeability index of LFS-829 was high with approved drugs as the control (SIM 2–3), suggesting that LFS-829 may achieve good bioavailability in humans. Moreover, we employed an artificial gastric juice stability assay and artificial intestinal juice stability assay to determine the stabilities of LFS-829 in an alimentary system, critical properties for IBD new drug. LFS-829 is rather stable in both artificial gastric juice (half-life ∼24 h) and artificial intestinal juice (half-life ∼8 h), suggesting a pharmacokinetic profile compatible with once-daily dosing (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A,B).</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Evaluation of acute toxicity, gastrointestinal tract stability, and cardiotoxicity of compound LFS-829. (A) Stability test of LFS-829 in artificial gastric juice (omeprazole is an FDA-approved drug for GI disorders and routinely used as a control in the pharmacokinetic study). (B) Stability test of LFS-829 in artificial intestinal juice (chlorambucil is an FDA-approved chemotherapy for chronic leukemia and routinely used as a control in the pharmacokinetic study). (C) H&E-stained results for the sections of the mouse colon in the vehicle-treated group and LFS-829-treated group. (D) The concentration dependence curve of the LFS-829 blockade of hERG currents and the inhibition constant IC<sub>50</sub> of LFS-829 is above 30 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Assessment of the Acute Toxicity Profile of LFS-829</h3><div class="NLM_p last">To determine the suitability of LFS-829 in clinical practice, we assessed the acute toxic effects of LFS-829 in mice. Ten C57BL6 mice were exposed to oral administration of LFS-829 at an increasing dose of 300 mg/kg to 600 mg/kg over the course of 1 day, whereas another ten mice were exposed to vehicle only (50% ethanol, <i>n</i> = 10). The LFS-829-treated animals did not show lethargy, weight loss, or other physical indications of sickness. The mice were sacrificed after the 14 day washout period to assess delayed toxicity. The colon, spleen, and other tissues were examined, and no toxic effects or tissue damage (either macroscopic or microscopic) were observed (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figure S10</a>).</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Evaluation of the Cardiotoxicity Profile of LFS-829</h3><div class="NLM_p last">Cardiotoxicity is a crucial factor and major safety concern for preclinical or clinical evaluation of pharmacological therapeutics for the treatment of chronic relapsing diseases such as IBD.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Therefore, it is necessary to evaluate the potential cardiotoxicity for LFS-829. To this end, we used an hERG potassium channel patch-clamp assay to test whether LFS-829 would cause QT interval prolongation as a result of hERG potassium channel inhibition. LFS-829 did not inhibit hERG even at a high concentration, suggesting a very low risk for cardiotoxicity (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>D, <a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figure S11, Table S3</a>). These studies clearly established the excellent safety profiles of LFS-829 for its potential use in the clinical treatment of colitis.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52852" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52852" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There are unmet medical needs for disease-modifying therapies for IBD with excellent response rates and safety profiles due to the relative inefficacy of the current maintenance therapies. It is rather challenging to develop therapeutics for colitis because the pathogenesis of colitis is extremely complicated and remains elusive. For instance, two recent clinical trials with IL-23 antibodies, Secukinumab<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and Brodalumab,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> showed no efficacy or even higher rates of adverse events for colitis patients. Moreover, in the past decades, no therapeutics have been introduced in clinical practice for the treatment of colitis. Of note, a few small-molecule compounds for colitis are currently under clinical development including JAK inhibitors and the sphingosine-1-phosphate receptor 1 (S1P1) modulator such as Etrasimod (also named as APD334).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">In light of this, here, we designed a rational structure-based strategy to discover a potent small-molecule antagonist for exportin-1 based on the scaffold of sulforaphene with a distinct mode of action. Our previous work has found that sulforaphene, a natural antagonist of CRM1, exhibits therapeutic effects toward colitis. To improve the potency, we first introduced a hydrophobic phenyl ring next to the sulfoxide moiety in the parent structure of LFS-01. Next, through the screening of a virtual combinatorial library, we identified LFS-829 with the replacement of two trifluoromethyl groups at the R3 and R5 position, resulting in a potency nearly 30-fold higher than that of the parent compound as determined by a cell-based phenotypic nuclear export functional assay. Our strategy has the advantages of considering affinity, ADME/T properties, and other properties. LFS-829 is amenable to large-scale synthesis and has a low cost of chemicals, which may be advantageous as a therapy for colitis.</div><div class="NLM_p">We revealed that LFS-829 can inhibit CRM1 in the low nanomolar range (∼26.95 nM) through an SPR binding assay. We revealed that the cellular activities by LFS-829 were significantly diminished when CRM1 was suppressed by siCRM1, implicating that CRM1 is a main cellular target of LFS-829. The study of the time course of CRM1-LFS829 complex degradation suggests that LFS-829 is a more reversible inhibitor as compared to KPT-330. This indicates that LFS-829 may exert a lower toxicity profile, which is advantageous because colitis patients typically require very long-term medication. Strikingly, our study showed that LFS-829 was very efficacious in a mouse model of colitis and exhibited superior therapeutic potential than first-line therapy 5-ASA as well as APD334, a promising candidate, compounds under clinical trials for colitis. Importantly, our study provides the co-crystallographic structure of LFS-829 bound to CRM1, which also firmly establishes the working mechanism of LFS-829. Therefore, our study may provide insights to guide functional elucidation of the mechanism of action for LFS-829 and may open new avenues for future drug development based on similar chemical scaffolds.</div><div class="NLM_p">It has been well recognized that colitis is a complex and heterogeneous disease with several molecular pathways contributing to the disease pathophysiology. Therefore, the next-generation therapeutics for colitis may allow the simultaneous modulation of multiple disease-causing cytokines or pathways. Our study, for the first time, demonstrated that a small-molecule antagonist of exportin-1 can reverse the pathogenesis of colitis by regulating both NF-κB signaling and the Nrf2 cellular defense pathway (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The activation of NF-κB signaling plays a dominant role in the inflamed gut of colitis patients. In particular, it has been found that the upregulation of NF-κB (p65 or p50) is significant in the macrophages and epithelial cells isolated from the inflamed gut specimens of IBD patients.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Moreover, there has been mounting evidence suggesting that NF-κB signaling in the gut epithelium plays as a critical regulator of epithelial integrity and intestinal immune homeostasis and thereby is closely associated with the pathogenesis of colitis.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> We revealed that LFS-829 treatment can lead to significant nuclear accumulation of IkB<sub>α</sub>, which consequently strongly suppresses NF-κB signaling and its downstream targets. In particular, we found that the exposure of colitis mice with LFS-829 leads to the suppression of a few critical downstream targets of NF-κB signaling including Cox-2, IL-6, TNF-α, IL-1β, and IL-23, all of which are hallmarks in the pathogenesis of colitis. On the other hand, Nrf2 plays a fundamental role in the cellular defense pathway against inflammation and intestinal integrity through the regulation of proinflammatory cytokines and the induction of Phase II detoxifying enzymes. Of note, Nrf2 deficient mice were more susceptible to DSS-induced colitis.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Our data clearly show that LFS-829 treatment can lead to the nuclear retention of Nrf2 and enable the activation of the Nrf2 cellular defense pathway. Particularly, we found that the LFS-829 administration restored the dysregulation of detoxifying enzymes HO-1 and NQO1 in the colon tissues of colitis mice, both of which are essential for the cytoprotective effects during inflammation and the maintenance of mucosal homeostasis in the gastrointestinal tract of colitis patients. Moreover, one of the current focuses in colitis research attends to a group of immunogenic endogenous damage-associated molecular patterns (DAMPs).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The calprotectin, also named as the S100A8/S100A9 complex, belongs to DAMPs and has been recognized to play a key role in the etiology of colitis during colon tissue damage. Moreover, the complex S100A8/S100A9 proteins are present at high levels in the serum of patients, and therefore, S100A8/S100A9 has been established as sensitive and specific biomarkers for colitis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Notably, we observed that S100A8/S100A9 was upregulated in colitis mice, and the expression level of S100A8/S100A9 was reduced upon the administration of LFS-829, indicating that LFS-829 reverses the pathogenesis of colitis. Collectively, we concluded that LFS-829 exerted its therapeutic effects toward colitis through dual targeting of the NF-κB signaling and Nrf2 cellular defense pathway. Moreover, it has been documented that there exists functional crosstalk between NF-κB signaling and the Nrf2/ARE pathway.<a onclick="showRef(event, 'ref17 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref17 ref29 ref30">(17,29,30)</a> Therefore, we argued that the dual attenuation of both NF-κB signaling and the Nrf2 cytoprotection pathway by LFS-829 might have synergistic effects to prevent inflammation and restore intestinal homeostasis (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. LFS-829 Attenuates Dual NF-κB Signaling and Nrf2 Cytoprotection Pathway</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pathological characteristics of colitis determine that the onset of the disease may translate into long-standing disease activity and thereby require very long-term medication. Hence, the safety profile of a candidate compound for treating colitis is of utmost importance. Noteworthy, our results suggest that LFS-829 has a rather low risk of both cytotoxicity and cardiotoxicity. Furthermore, we evaluated the acute toxicity of LFS-829 in animals, and our results suggest that LFS-829 barely shows any acute toxicity at a dose of 600 mg/kg. Moreover, we showed that LFS-829 is quite stable in artificial gastric juice and intestinal juice with an excellent permeability index. Hence, LFS-829 may hold great potential as colitis therapy with a good safety profile. Finally, there is an increasing risk for colitis patients to develop colon cancer. Our results implicated that LFS-829 also exerts excellent biological effects toward colon cancer cells. Therefore, we argue that LFS-829 may have protective effects in colitis as well as its malignant transition to colon cancer. This may be beneficial for treating colitis patients in the severe stage and is warranted for further investigation.</div><div class="NLM_p last">In summary, we report the rational structure-based discovery and extensive evaluation of a potent antagonist of CRM1 toward the treatment of colitis. We demonstrated that oral treatment of LFS-829 holds great promise as an effective remedy for colitis, acting through dual attenuation of NF-κB signaling and the Nrf2 cellular defense pathway. Our data suggest that LFS-829 is a promising new candidate compound and is expected to feature prominently in the future of colitis treatment.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> The Purity of the Compound</h3><div class="NLM_p last">Compound LFS-829 was confirmed by <sup>1</sup>H NMR, LC–MS, and HPLC with 99% purity (≥95% purity, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Supporting Information</a>). The organic synthesis was conducted following standard procedures (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Supporting Information</a>). All of the chemicals and solvents were purchased from Sigma.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Human Biopsy Samples</h3><div class="NLM_p last">The biopsy samples of actively inflamed and noninflamed intestinal regions were collected from patients with colitis indicated by clinical pathology (UC, <i>n</i> = 5). The control biopsy specimens were obtained from normal areas of healthy subjects (<i>n</i> = 5). All patients and healthy subjects were approved by the Digestive System Department of the First Affiliated Hospital of Nanjing Medical University. The intestinal samples were immediately fixed in formalin and embedded in paraffin until use for future immunohistochemistry analysis. All of the written informed consents were obtained before sample collection. The study was approved by the Institutional Review Board of Nanjing Medical University.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Co-crystallographic Structure</h3><div class="NLM_p last">After purification of the CRM1-Ran-RanBP1 complex by the Superdex 200 increase gel filtration column,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> protein complexes were concentrated to 6 mg/mL and mixed at a 1:1 ratio with crystallization solution containing 18% PEG3350, 200 mM ammonium nitrate, 1 mM LFS-829, 100 mM Bis·Tris, pH 6.6. Next, 12% (v/v) glycerol was supplemented with crystallization conditions as the cryo-protectant. X-ray diffraction data were collected at the Shanghai Synchrotron Radiation Facility (SSRF) beamline BL17U1 and BL19U1. Coordinates of yCRM1-hRan-yRanBP1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HAT">4HAT</a>) were used as the search model and refined with a rigid body briefly then restrained refinement using the program Refmac5. The data collection and refinement statistics are provided in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Table S1</a>. The coordinates are deposited to PDB with accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZPU">5ZPU</a>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> LC–MS/MS via LTQ Orbitrap</h3><div class="NLM_p last">CRM1 protein was incubated with 20-fold excess (molar ratio) of compound LFS-829, which was then removed by ultrafiltration (Millipore). Subsequently, CRM1 protein was cleaved by trypsin with an enzyme-to-protein ratio of 1:60 (w/w) in 150 mM Tris-HCl (pH 8.5) at 37 °C for 6 h. The samples were then analyzed using an LTQ Orbitrap Velos (Thermo Scientific, San Jose, CA, USA) coupled with an Accela 600 HPLC system (Thermo Scientific). The samples were automatically loaded onto the trap column (3 cm × 200 μm i.d.) packed with C18 AQ beads (5 μm 120 Å) followed with binary gradient separation using an analytical column (15 cm × 75 μm i.d.) packed with C18 AQ beads (5 μm, 120 Å). The MS full scans were acquired in positive ion mode from <i>m</i>/<i>z</i> 350 to 1850 with a mass resolution of 60 000 at <i>m</i>/<i>z</i> 400, and the MS/MS scans were acquired in LTQ positive ion linear trap mode. All MS and MS/MS spectra were acquired in the data-dependent analysis mode. Peptides with a Mascot score >20 were retained for the analyses.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> DSS-Induced Colitis, LFS-829, 5-ASA, and APD334 Oral Administration</h3><div class="NLM_p last">To induce acute colitis, 6–8 weeks old male C57BL/6J mice were given drinking water containing 3.0% (w/v) DSS (MP Biomedicals) ad libitum for 7 days and distilled water for one additional day before sacrifice. Mice were observed for weight and signs of diseases. The disease activity index (DAI) was scored based on a nonblinded fashion. LFS-829 or 5-ASA (Energy Chemical) were first dissolved in ethanol (70%) and then diluted in saline water. The solutions were administrated to DSS-drinking mice with a gastric tube by a dose of 30 mg/kg body weight.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Treatment of the Animals</h3><div class="NLM_p last">In the therapeutic treatment protocol, 30 mg/kg body weight of LFS-829 was administered to mice with a gastric tube starting from day 0 (DSS administration) and on every following day. The 5-ASA treatment group and the APD334 treatment group followed the same protocol. Control mice were given vehicle solution, phosphate-buffered saline (PBS) with a cosolvent such as ethanol or DMSO, and subjected to the same protocols and schedules as described for LFS-829. In all animals, body weight and diarrhea severity were monitored each day. Thirteen days after disease induction, the mice were killed, and the intestine was collected and evaluated for colon length and microscopic damage. In addition, proximal, medial, and distal portions of the colon were fixed in 10% phosphate-buffered formalin, and paraffin-embedded sections were stained with H&E. The degree of histological damage and intestinal inflammation was graded in a blinded fashion by a panel-approved pathologist.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Histopathological Analysis, Macroscopic Damage, and Microscopic Damage Assessment</h3><div class="NLM_p last">After the animals were sacrificed, the colon was extracted, cleaned, and weighed. The colonic tissue samples were preserved in buffered formalin, embedded in paraffin, cut into 5 μm sections, and stained with hematoxylin and eosin (H&E) for histopathological analysis. The macroscopic damage score (MDS) was assessed in a blinded fashion by examination of excised colons, and the disease activity index (DAI) of mice was evaluated as previously described.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The colonic tissue was homogenized in a Greenburger buffer supplemented with protease inhibitors (complete Mini EDTA free, Roche). After sonication for 10 s, the suspension was centrifuged at 8000<i>g</i> for 20 min at 4 °C. The supernatant was used to quantify the myeloperoxidease (MPO) activity and the levels of cytokines using commercial ELISA kits (USCN, USA) following the manufacturer’s protocol.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cell-Based Phenotypic Nuclear Export Functional Assay</h3><div class="NLM_p last">293T cells were seeded onto 96-well, black, clear-bottom plates at a density of 3000–5000 cells/well in 100 μL of complete media. After incubation at 37 °C and 5% CO<sub>2</sub> for 24 h, cells were treated with CRM1 inhibitors for 2 h. Small-molecule compounds were serially diluted 1:2 starting from 1 μM in RPMI 1640 medium supplemented with 10% FBS. Following the indicated treatments, cells were fixed for 20 min with 4% paraformaldehyde in PBS. Next, cell membranes were permeabilized by 0.3% Triton X-100 in PBS for 20 min. After blocking with 5% bovine serum albumin (BSA) in PBS for 1 h at 37 °C, cells were treated with IkB<sub>α</sub> antibodies in blocking buffer for 24 h at 4 °C. Antimouse Alexa 594 were used as secondary antibodies. Cell nuclei were stained with DAPI for 20 min. After washing, photomicrographic images were recorded with a confocal laser scanning microscope, Fluoview FV10i. For cell counts, at least 200 cells exhibiting nuclear, nuclear and cytoplasmic, or cytoplasmic staining were counted from three separate images. Percentages of N (nuclear), N/C (nuclear/cytoplasmic), and C (cytoplasmic) cells were calculated, and standard deviations were determined (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">Figure S7</a>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> SPR Binding Assay</h3><div class="NLM_p last">Studies of binding kinetics were performed on a Biacore T200 (GE Healthcare). His-tagged CRM1, IkB<sub>α</sub>, and Keap1 proteins were immobilized in 0.5 mM NiCl<sub>2</sub> on a Biacore Series S NTA chip. LFS-829 and control compound KPT-330 (10 μM) were tested in immobilization buffer supplemented with 5% (v/v) DMSO, with a flow rate of 30 μL/min, a contact time of 60 s, and a dissociation time of 300 s. A solvent correction curve from 4.5–5.8% (v/v) DMSO was included. The analysis was performed using the Biacore Evaluation software, version 3.0, using a kinetic fit and a 1:1 binding model. Representative curves were exported and replotted in GraphPad Prism.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> ELISA Assay</h3><div class="NLM_p last">The peripheral blood of the animals from different experimental groups (the control group, DSS group, LFS-829-treated group, and APD334-treated group) was collected, centrifuged at 1500<i>g</i> for 15 min at 4 °C, and incubated overnight to obtain serum. The concentrations of serum cytokines were assayed by the ELISA kit (Elabscience, USA) according to the manufacturer’s instructions.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Western Blot</h3><div class="NLM_p last">The total protein was extracted from colon tissues of animals. Equal amounts of proteins were fractioned with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by electrophoretic transfer of proteins onto nitrocellulose membranes. The blots were probed with antibodies against Cox-2, IL-6, TNF-α, IL-1β, IL-23, etc. and followed by incubation with secondary antibodies conjugated with horseradish peroxidase (HRP, USCN, USA). The immune complexes were detected with a Western Bright ECL Western Blotting HRP Substrate kit and analyzed with image lab software (Bio-Rad, USA).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Functional Analysis of IBD Disease Signatures</h3><div class="NLM_p last">Functional analysis of the up- and downregulated protein signatures determined by proteomics techniques (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, heatmap analysis) was performed through the use of IPA (Ingenuity Systems, trial version). The functional analysis was able to identify the biological functions/pathways and/or diseases that were most relevant/significant to the data set. Signatures in the top and bottom 25% of rank change versus normal in both the DSS model group and LFS829 treatment group that were associated with biological functions and/or diseases in the Ingenuity Knowledge Base were considered for the analysis.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Evaluation of Compound Cardiotoxicity</h3><div class="NLM_p last">Briefly, the cell line HEK293 stably expressing the hERG K+ channel was used in the study. Cells were grown in essential medium-α (MEM; Gibco) supplemented with 10% (v/v) heat-inactivated fetal calf serum, 1% (v/v) penicillin/streptomycin/glutamine solution (Gibco), and 1 mg/mL G418. Compound LFS-829 for testing was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 mM and diluted in extracellular saline to the desired concentration. The whole-cell configuration of the patch-clamp technique was used for the current recording. The results obtained from at least three cells were pooled and fitted to estimate the mean values of IC<sub>50</sub>.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Statistics</h3><div class="NLM_p last">All data were evaluated as mean ± SEM. Statistical analysis of the quantitative multiple group comparisons was performed using the one-way analysis of variance (ANOVA) followed by Tukeyʼs test, whereas pairwise comparisons were performed using the <i>t</i> test by GraphPad Prism 5 (Graph Pad Software, La Jolla, CA, USA). Results were considered to be statistically significant with <i>p</i> < 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="NOTES-d7e1081-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01663" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01663?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01663</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Organic synthesis; the expression of CRM1 in intestinal tissues of UC patients; co-crystallographic structure; mass spectrometric analysis; MS data analysis; cell-based phenotypic assay; pull-down assay; GSH/GSSG ratio detection assay; si-RNA knockdown efficiency; acute toxicity; cardiotoxicity; PK/liver microsome stability; putative metabolic products; permeability properties; <sup>1</sup>H and <sup>13</sup>C NMR spectra; evaluation of different linkers; SPR results of control proteins (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf">jm9b01663_si_001.pdf (1.34 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_002.csv">jm9b01663_si_002.csv (0.21 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01663" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34283" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34283" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingxiang Sun</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#abdac2c5ccd3c2cac5cc85d8dec5ebd8c8de85cecfde85c8c5"><span class="__cf_email__" data-cfemail="53223a3d342b3a323d347d20263d132030267d3637267d303d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guohui Li</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Modeling and Design, State key Laboratory of Molecular
Reaction Dynamics, Dalian Institute of Chemical
Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8223-705X" title="Orcid link">http://orcid.org/0000-0001-8223-705X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#16717e7a7f56727f7566387775387578"><span class="__cf_email__" data-cfemail="0b6c6367624b6f62687b256a68256865">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongliang Yang</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0449-0599" title="Orcid link">http://orcid.org/0000-0003-0449-0599</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bbdecddec9d9c9d2dcd3cf8282fbddd4c3d6dad2d795d8d4d6"><span class="__cf_email__" data-cfemail="583d2e3d2a3a2a313f302c6161183e372035393134763b3735">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xibao Tian</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiali Gao</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meishuo Liu</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuqin Lei</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fangjun Wang</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Separation Sciences for Analytical Chemistry, National
Chromatographic R&A Center, Dalian Institute
of Chemical Physics, Chinese Academy of Sciences (CAS), Dalian, Liaoning 116023, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8118-7019" title="Orcid link">http://orcid.org/0000-0002-8118-7019</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jin Chen</span> - <span class="hlFld-Affiliation affiliation">CAS
Key Laboratory of Separation Sciences for Analytical Chemistry, National
Chromatographic R&A Center, Dalian Institute
of Chemical Physics, Chinese Academy of Sciences (CAS), Dalian, Liaoning 116023, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peng Chu</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiujiao Gao</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feida Long</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minzhi Liang</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiangyu Long</span> - <span class="hlFld-Affiliation affiliation">Laboratoy
of Innovative Drug Discovery, School of Bioengineering, Dalian University of Technology, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huiying Chu</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Molecular Modeling and Design, State key Laboratory of Molecular
Reaction Dynamics, Dalian Institute of Chemical
Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cuixia Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Gastroenterology, The First Affiliated
Hospital of Nanjing Medical University, Nanjing 210029, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xueliang Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Gastroenterology, The First Affiliated
Hospital of Nanjing Medical University, Nanjing 210029, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>X. Tian, J. Gao, M. Liu, Y. Lei, and F. Wang contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Dr. Y. Yang’s laboratory was supported by the National Natural Science Foundation in China (81874301) and the Fundamental Research Funds for Central University (DLUT15QY43). Dr. G. Li was supported by the Innovative Support Program for Talents in Dalian (2017RD07) and the National Natural Science Foundation in China (21933010 and 21625302). Compound LFS-829 was prepared and provided by the DrivingForce Therapeutics; Y.Y. is thankful for the helpful discussion with Prof. Chu Wang at Peking University on the target engagement study and for the kind help of Dr. Mei Su from Nanjing Huawei Pharmaceutical.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, G. G.</span></span> <span> </span><span class="NLM_article-title">The global burden of IBD: from 2015 to 2025</span>. <i>Nat. Rev. Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1038/nrgastro.2015.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnrgastro.2015.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=26323879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BC287nvFaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=720-727&author=G.+G.+Kaplan&title=The+global+burden+of+IBD%3A+from+2015+to+2025&doi=10.1038%2Fnrgastro.2015.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of IBD: from 2015 to 2025</span></div><div class="casAuthors">Kaplan Gilaad G</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">720-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD, with substantial costs for health care.  These estimates do not factor in the 'real' price of IBD, which can impede career aspirations, instil social stigma and impair quality of life in patients.  The majority of patients are diagnosed early in life and the incidence continues to rise; therefore, the effect of IBD on health-care systems will rise exponentially.  Moreover, IBD has emerged in newly industrialized countries in Asia, South America and Middle East and has evolved into a global disease with rising prevalence in every continent.  Understanding the worldwide epidemiological patterns of IBD will prepare us to manage the burden of IBD over time.  The goal of this article is to establish the current epidemiology of IBD in the Western world, contrast it with the increase in IBD in newly industrialized countries and forecast the global effects of IBD in 2025.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI7MsrdaYm5d1QT_1O5WBYfW6udTcc2eZVjHc4UdF5wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287nvFaktQ%253D%253D&md5=ef578ea867a812e30ecbdcfa52af387c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2015.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2015.150%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DG.%2BG.%26atitle%3DThe%2520global%2520burden%2520of%2520IBD%253A%2520from%25202015%2520to%25202025%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2015%26volume%3D12%26spage%3D720%26epage%3D727%26doi%3D10.1038%2Fnrgastro.2015.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ananthakrishnan, A. N.</span></span> <span> </span><span class="NLM_article-title">Epidemiology and risk factors for IBD</span>. <i>Nat. Rev. Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1038/nrgastro.2015.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnrgastro.2015.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=25732745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BC2Mngt12ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=205-217&author=A.+N.+Ananthakrishnan&title=Epidemiology+and+risk+factors+for+IBD&doi=10.1038%2Fnrgastro.2015.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology and risk factors for IBD</span></div><div class="casAuthors">Ananthakrishnan Ashwin N</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">205-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">IBD, comprising Crohn's disease and ulcerative colitis, is a chronic immunologically mediated disease at the intersection of complex interactions between genetics, environment and gut microbiota.  Established high-prevalence populations of IBD in North America and Europe experienced the steepest increase in incidence towards the second half of the twentieth century.  Furthermore, populations previously considered 'low risk' (such as in Japan and India) are witnessing an increase in incidence.  Potentially relevant environmental influences span the spectrum of life from mode of childbirth and early-life exposures (including breastfeeding and antibiotic exposure in infancy) to exposures later on in adulthood (including smoking, major life stressors, diet and lifestyle).  Data support an association between smoking and Crohn's disease whereas smoking cessation, but not current smoking, is associated with an increased risk of ulcerative colitis.  Dietary fibre (particularly fruits and vegetables), saturated fats, depression and impaired sleep, and low vitamin D levels have all been associated with incident IBD.  Interventional studies assessing the effects of modifying these risk factors on natural history and patient outcomes are an important unmet need.  In this Review, the changing epidemiology of IBD, mechanisms behind various environmental associations and interventional studies to modify risk factors and disease course are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7OoVPI85pqz0O18WR3iAofW6udTcc2eZVjHc4UdF5wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mngt12ntg%253D%253D&md5=ecea9830e7648db864916c2471a37ace</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2015.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2015.34%26sid%3Dliteratum%253Aachs%26aulast%3DAnanthakrishnan%26aufirst%3DA.%2BN.%26atitle%3DEpidemiology%2520and%2520risk%2520factors%2520for%2520IBD%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2015%26volume%3D12%26spage%3D205%26epage%3D217%26doi%3D10.1038%2Fnrgastro.2015.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenoy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roedder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarwal, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasricha, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butte, A. J.</span></span> <span> </span><span class="NLM_article-title">Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">96ra76</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3002648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1126%2Fscitranslmed.3002648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=21849664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOisL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=96ra76&author=J.+T.+Dudleyauthor=M.+Sirotaauthor=M.+Shenoyauthor=R.+K.+Paiauthor=S.+Roedderauthor=A.+P.+Chiangauthor=A.+A.+Morganauthor=M.+M.+Sarwalauthor=P.+J.+Pasrichaauthor=A.+J.+Butte&title=Computational+repositioning+of+the+anticonvulsant+topiramate+for+inflammatory+bowel+disease&doi=10.1126%2Fscitranslmed.3002648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease</span></div><div class="casAuthors">Dudley, Joel T.; Sirota, Marina; Shenoy, Mohan; Pai, Reetesh K.; Roedder, Silke; Chiang, Annie P.; Morgan, Alex A.; Sarwal, Minnie M.; Pasricha, Pankaj Jay; Butte, Atul J.</div><div class="citationInfo"><span class="NLM_cas:title">Science Translational Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">96</span>),
    <span class="NLM_cas:pages">96ra76</span>CODEN:
                <span class="NLM_cas:coden">STMCBQ</span>;
        ISSN:<span class="NLM_cas:issn">1946-6242</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract for which there are few safe and effective therapeutic options for long-term treatment and disease maintenance.  Here, we applied a computational approach to discover new drug therapies for IBD in silico, using publicly available mol. data reporting gene expression in IBD samples and 164 small-mol. drug compds.  Among the top compds. predicted to be therapeutic for IBD by our approach were prednisolone, a corticosteroid used to treat IBD, and topiramate, an anticonvulsant drug not previously described to have efficacy for IBD or any related disorders of inflammation or the gastrointestinal tract.  Using a trinitrobenzenesulfonic acid (TNBS)-induced rodent model of IBD, we exptl. validated our topiramate prediction in vivo.  Oral administration of topiramate significantly reduced gross pathol. signs and microscopic damage in primary affected colon tissue in the TNBS-induced rodent model of IBD.  These findings suggest that topiramate might serve as a therapeutic option for IBD in humans and support the use of public mol. data and computational approaches to discover new therapeutic options for disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmF-DmOnq3dLVg90H21EOLACvtfcHk0lgkVMM2xqW2EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOisL3J&md5=42dd418de306427e93735180e40288a9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002648%26sid%3Dliteratum%253Aachs%26aulast%3DDudley%26aufirst%3DJ.%2BT.%26aulast%3DSirota%26aufirst%3DM.%26aulast%3DShenoy%26aufirst%3DM.%26aulast%3DPai%26aufirst%3DR.%2BK.%26aulast%3DRoedder%26aufirst%3DS.%26aulast%3DChiang%26aufirst%3DA.%2BP.%26aulast%3DMorgan%26aufirst%3DA.%2BA.%26aulast%3DSarwal%26aufirst%3DM.%2BM.%26aulast%3DPasricha%26aufirst%3DP.%2BJ.%26aulast%3DButte%26aufirst%3DA.%2BJ.%26atitle%3DComputational%2520repositioning%2520of%2520the%2520anticonvulsant%2520topiramate%2520for%2520inflammatory%2520bowel%2520disease%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D96ra76%26doi%3D10.1126%2Fscitranslmed.3002648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Targeting the nuclear transport machinery by rational drug design</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2318</span>– <span class="NLM_lpage">2325</span>, <span class="refDoi"> DOI: 10.2174/1381612811319120018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.2174%2F1381612811319120018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23082981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVKqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2318-2325&author=L.+Maoauthor=Y.+Yang&title=Targeting+the+nuclear+transport+machinery+by+rational+drug+design&doi=10.2174%2F1381612811319120018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the nuclear transport machinery by rational drug design</span></div><div class="casAuthors">Mao, Lei; Yang, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2318-2325</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  CRM1 (also referred as exportin1 or Xpo1) is a key member of the importin β superfamily of nuclear transport receptors.  Its potential as therapeutic target has attracted significant attention in recent years.  CRM1 controls the transport of a no. of growth regulatory proteins and tumor suppressor proteins including p53, p21, FOXO, PI3K/AKT, Wnt/β-catenin, AP-1 and NF-kB etc.  The overexpression of CRM1 has been found to correlate with a variety of neoplastic conditions such as pancreatic and liver cancer.  In addn., CRM1 could mediate the transport of viral proteins such as Rev, an essential factor protein for HIV replication.  Moreover, CRM1 has been implicated in key steps of mitosis during cell cycles.  Over the past years, the in-depth biol. studies have rendered CRM1 as a promising clin. target.  The interference of CRM1-mediated transport machinery could lead to the effective treatment of a variety of human disease related to cell proliferation.  The aim of this paper is to summarize the research progress of CRM1 inhibitors in the late 30 years.  More importantly, we want to provide new insights for the CRM1 drug design from the perspective of mol. simulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3z4u5peS1EbVg90H21EOLACvtfcHk0li72XUeyiUh0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVKqtbY%253D&md5=03afff8f1fea66b329e0b7b6cb931d44</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F1381612811319120018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612811319120018%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DTargeting%2520the%2520nuclear%2520transport%2520machinery%2520by%2520rational%2520drug%2520design%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D2318%26epage%3D2325%26doi%3D10.2174%2F1381612811319120018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2017.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1016%2Fj.cbi.2017.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=29247643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWmu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2018&pages=11-23&author=H.+Wangauthor=F.+Wangauthor=S.+Wuauthor=Z.+Liuauthor=T.+Liauthor=L.+Maoauthor=J.+Zhangauthor=C.+Liauthor=C.+Liuauthor=Y.+Yang&title=Traditional+herbal+medicine-derived+sulforaphene+promotes+mitophagic+cell+death+in+lymphoma+cells+through+CRM1-mediated+p62%2FSQSTM1+accumulation+and+AMPK+activation&doi=10.1016%2Fj.cbi.2017.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation</span></div><div class="casAuthors">Wang, Haina; Wang, Fuqiang; Wu, Sijin; Liu, Zhiheng; Li, Tingting; Mao, Lei; Zhang, Jie; Li, Cheng; Liu, Caigang; Yang, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-23</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Sulforaphene (LFS-01) is the major chem. constituent of Raphanus sativus, a medicinal herb used for over a thousand years in traditional Chinese medicine.  Here we identified that LFS-01 can selectively eradicate lymphoma cells while sparing normal lymphocytes by triggering concomitant mitophagy and apoptosis.  We demonstrated that LFS-01 can retain Nrf2 in the nucleus by covalently modulating CRM1 and consequently upregulate p62/SQSTM1, an essential structural component of the autophagosomes during mitophagic process.  We found that LFS-01 treatment also stimulated AMPK and thereby inhibited the mTOR pathway.  On the contrary, we revealed that AMPK inhibition can severely impair the LFS-01-mediated mitophagy.  Transcriptomic studies confirmed that 15 autophagy-assocd. genes such as p62/SQSTM1, VCP and BCL2 were differentially expressed after LFS-01 treatment.  Furthermore, protein interactome network anal. revealed that the events of apoptosis and the assembly of autophagy vacuole were significant upon LFS-01 exposure.  Lastly, we found that LFS-01 exhibited strong efficacy in xenograft mouse model yet with the lack of apparent toxicity to animals.  We concluded that LFS-01 triggered mitophagic cell death via CRM1-mediated p62 overexpression and AMPK activation.  Our findings provide new insights into the mechanism of action for LFS-01 and highlight its potential applications in treating major human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk3O6Yv3HUKbVg90H21EOLACvtfcHk0li72XUeyiUh0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWmu7bP&md5=2838e0a8f41c316557d28aa2963a4319</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2017.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2017.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DTraditional%2520herbal%2520medicine-derived%2520sulforaphene%2520promotes%2520mitophagic%2520cell%2520death%2520in%2520lymphoma%2520cells%2520through%2520CRM1-mediated%2520p62%252FSQSTM1%2520accumulation%2520and%2520AMPK%2520activation%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2018%26volume%3D281%26spage%3D11%26epage%3D23%26doi%3D10.1016%2Fj.cbi.2017.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1111%2Fcbdd.12905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=27863053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVOqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=655-662&author=S.+Wuauthor=K.+Zhangauthor=H.+Qinauthor=M.+Niuauthor=W.+Zhaoauthor=M.+Yeauthor=H.+Zouauthor=Y.+Yang&title=Caffeic+acid+phenethyl+ester+%28CAPE%29+revisited%3A+Covalent+modulation+of+XPO1%2FCRM1+activities+and+implication+for+its+mechanism+of+action&doi=10.1111%2Fcbdd.12905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action</span></div><div class="casAuthors">Wu, Sijin; Zhang, Keren; Qin, Hongqiang; Niu, Mingshan; Zhao, Weijie; Ye, Mingliang; Zou, Hanfa; Yang, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">655-662</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Caffeic acid phenethyl ester (CAPE) is the bioactive constituent of propolis from honeybee hives and is well known for its anti-inflammatory, anticarcinogenic, antioxidant, and immunomodulatory properties.  Here, we revisited the cellular mechanism underlying the diverse biol. effects of CAPE.  We demonstrated that exportin 1 (XPO1/CRM1), a major nuclear export receptor, is a cellular target of CAPE.  Through nuclear export functional assay, we obsd. a clear shift of XPO1 cargo proteins from a cytoplasmic localization to the nucleus when treated with CAPE.  In particular, we showed that CAPE could specifically target the non-catalytic and conserved Cys-528 residue of XPO1 through the means of mass spectrometric anal.  In addn., we demonstrated that the mutation of Cys-528 in XPO1 could rescue the nuclear export defects caused by CAPE.  Furthermore, we performed position-restraint mol. dynamics simulations to show that the Michael acceptor moiety of CAPE is the warhead to enable covalent binding with the Cys-528 residue of XPO1.  The covalent modulation of nuclear export by CAPE may explain its diverse biol. effects.  These findings may have general implications for further investigation of CAPE and its structural analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc3emljCcYzLVg90H21EOLACvtfcHk0lgiO4PHKXRcCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVOqsrg%253D&md5=ea49ace7c429483108936fbf45e505ae</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12905%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DQin%26aufirst%3DH.%26aulast%3DNiu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DCaffeic%2520acid%2520phenethyl%2520ester%2520%2528CAPE%2529%2520revisited%253A%2520Covalent%2520modulation%2520of%2520XPO1%252FCRM1%2520activities%2520and%2520implication%2520for%2520its%2520mechanism%2520of%2520action%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2017%26volume%3D89%26spage%3D655%26epage%3D662%26doi%3D10.1111%2Fcbdd.12905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice</span>. <i>Traffic</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1111/tra.12090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1111%2Ftra.12090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23829533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2lurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1042-1052&author=M.+Niuauthor=S.+Wuauthor=L.+Maoauthor=Y.+Yang&title=CRM1+is+a+cellular+target+of+curcumin%3A+new+insights+for+the+myriad+of+biological+effects+of+an+ancient+spice&doi=10.1111%2Ftra.12090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">CRM1 is a cellular target of curcumin: New insights for the myriad of biological effects of an ancient spice</span></div><div class="casAuthors">Niu, Mingshan; Wu, Sijin; Mao, Lei; Yang, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">Traffic (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1042-1052</span>CODEN:
                <span class="NLM_cas:coden">TRAFFA</span>;
        ISSN:<span class="NLM_cas:issn">1398-9219</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Curcumin is the major constituent of turmeric plant, an ancient spice widely used in Indian cuisine and traditional herbal medicine.  Recently, the potential medical use of curcumin as anti-cancer and anti-inflammatory agent has set off an upsurge in research into the mechanism for its broad biol. effects.  We showed that CRM1, an important nuclear exportin, is a cellular target of curcumin by serious exptl. and theor. investigation.  Using a nuclear export functional assay, we obsd. a clear and rapid shift of cargo proteins from a cytoplasmic localization to the nucleus when treated with curcumin or its structural analog dibenzylideneacetone (DBA).  We demonstrated that curcumin could specifically target the conserved Cys528 of CRM1 through mass spectrometric anal. and in vivo expts.  Furthermore, computational modeling has revealed that curcumin could be correctly docked into the hydrophobic pocket of CRM1 judged from shape complementarity and putative mol. interactions.  The Michael acceptor moiety on curcumin is within the appropriate distance to enable Michael reaction with Cys residue of CRM1.  More importantly, we showed that nuclear retention of FOXO1 could be obsd. in the presence of Leptomycin B (LMB) or curcumin whereas in cells expressing the CRM1-Cys528 mutant, only a cytoplasmic localization was obsd.  The inhibition of nuclear traffic by curcumin may account for its myriad of biol. effects, particularly for its therapeutic properties in cancer and inflammatory diseases.  Our findings may have important implications for further clin. investigation of curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeyZF80XFocLVg90H21EOLACvtfcHk0lgiO4PHKXRcCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2lurfK&md5=e01ce73d75ce025035005fca1de975d3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Ftra.12090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ftra.12090%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DCRM1%2520is%2520a%2520cellular%2520target%2520of%2520curcumin%253A%2520new%2520insights%2520for%2520the%2520myriad%2520of%2520biological%2520effects%2520of%2520an%2520ancient%2520spice%26jtitle%3DTraffic%26date%3D2013%26volume%3D14%26spage%3D1042%26epage%3D1052%26doi%3D10.1111%2Ftra.12090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landesman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calle, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannenbaum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnetta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reagan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senapedis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Martin, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghobrial, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schey, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1038/leu.2013.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fleu.2013.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23588715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVWktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=155-165&author=Y.+T.+Taiauthor=Y.+Landesmanauthor=C.+Acharyaauthor=Y.+Calleauthor=M.+Y.+Zhongauthor=M.+Ceaauthor=D.+Tannenbaumauthor=A.+Cagnettaauthor=M.+Reaganauthor=A.+A.+Munshiauthor=W.+Senapedisauthor=J.+R.+Saint-Martinauthor=T.+Kashyapauthor=S.+Shachamauthor=M.+Kauffmanauthor=Y.+Guauthor=L.+Wuauthor=I.+Ghobrialauthor=F.+Zhanauthor=A.+L.+Kungauthor=S.+A.+Scheyauthor=P.+Richardsonauthor=N.+C.+Munshiauthor=K.+C.+Anderson&title=CRM1+inhibition+induces+tumor+cell+cytotoxicity+and+impairs+osteoclastogenesis+in+multiple+myeloma%3A+molecular+mechanisms+and+therapeutic+implications&doi=10.1038%2Fleu.2013.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications</span></div><div class="casAuthors">Tai, Y-T.; Landesman, Y.; Acharya, C.; Calle, Y.; Zhong, M. Y.; Cea, M.; Tannenbaum, D.; Cagnetta, A.; Reagan, M.; Munshi, A. A.; Senapedis, W.; Saint-Martin, J-R.; Kashyap, T.; Shacham, S.; Kauffman, M.; Gu, Y.; Wu, L.; Ghobrial, I.; Zhan, F.; Kung, A. L.; Schey, S. A.; Richardson, P.; Munshi, N. C.; Anderson, K. C.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-165</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The key nuclear export protein CRM1/XPO1 may represent a promising novel therapeutic target in human multiple myeloma (MM).  Here we showed that chromosome region maintenance 1 (CRM1) is highly expressed in patients with MM, plasma cell leukemia cells and increased in patient cells resistant to bortezomib treatment.  CRM1 expression also correlates with increased lytic bone and shorter survival.  Importantly, CRM1 knockdown inhibits MM cell viability.  Novel, oral, irreversible selective inhibitors of nuclear export (SINEs) targeting CRM1 (KPT-185, KPT-330) induce cytotoxicity against MM cells (ED50<200 nM), alone and cocultured with bone marrow stromal cells (BMSCs) or osteoclasts (OC).  SINEs trigger nuclear accumulation of multiple CRM1 cargo tumor suppressor proteins followed by growth arrest and apoptosis in MM cells.  They further block c-myc, Mcl-1, and nuclear factor κB (NF-κB) activity.  SINEs induce proteasome-dependent CRM1 protein degrdn.; concurrently, they upregulate CRM1, p53-targeted, apoptosis-related, anti-inflammatory and stress-related gene transcripts in MM cells.  In SCID mice with diffuse human MM bone lesions, SINEs show strong anti-MM activity, inhibit MM-induced bone lysis and prolong survival.  Moreover, SINEs directly impair osteoclastogenesis and bone resorption via blockade of RANKL-induced NF-κB and NFATc1, with minimal impact on osteoblasts and BMSCs.  These results support clin. development of SINE CRM1 antagonists to improve patient outcome in MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYqp9GPUaiEbVg90H21EOLACvtfcHk0lgiO4PHKXRcCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVWktA%253D%253D&md5=aa7f3a69285c3c5157267ef781c3b472</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.115%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DY.%2BT.%26aulast%3DLandesman%26aufirst%3DY.%26aulast%3DAcharya%26aufirst%3DC.%26aulast%3DCalle%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DM.%2BY.%26aulast%3DCea%26aufirst%3DM.%26aulast%3DTannenbaum%26aufirst%3DD.%26aulast%3DCagnetta%26aufirst%3DA.%26aulast%3DReagan%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DA.%2BA.%26aulast%3DSenapedis%26aufirst%3DW.%26aulast%3DSaint-Martin%26aufirst%3DJ.%2BR.%26aulast%3DKashyap%26aufirst%3DT.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DM.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGhobrial%26aufirst%3DI.%26aulast%3DZhan%26aufirst%3DF.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DSchey%26aufirst%3DS.%2BA.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DCRM1%2520inhibition%2520induces%2520tumor%2520cell%2520cytotoxicity%2520and%2520impairs%2520osteoclastogenesis%2520in%2520multiple%2520myeloma%253A%2520molecular%2520mechanisms%2520and%2520therapeutic%2520implications%26jtitle%3DLeukemia%26date%3D2014%26volume%3D28%26spage%3D155%26epage%3D165%26doi%3D10.1038%2Fleu.2013.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span> <span> </span><span class="NLM_article-title">Chromosome region maintenance-1 (CRM1) regulates apoptosis of intestinal epithelial cells via p27kip1 in Crohn’s disease</span>. <i>Clin. Res. Hepatol. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/j.clinre.2017.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1016%2Fj.clinre.2017.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=28286054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2017&pages=445-458&author=L.+Yanauthor=L.+Wangauthor=J.+Baiauthor=X.+Miaoauthor=W.+Zengauthor=X.+Huaauthor=R.+Niauthor=D.+Zhangauthor=Q.+Tang&title=Chromosome+region+maintenance-1+%28CRM1%29+regulates+apoptosis+of+intestinal+epithelial+cells+via+p27kip1+in+Crohn%E2%80%99s+disease&doi=10.1016%2Fj.clinre.2017.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Chromosome region maintenance-1 (CRM1) regulates apoptosis of intestinal epithelial cells via p27kip1 in Crohn's disease</span></div><div class="casAuthors">Yan, Lijun; Wang, Liang; Bai, Jian'an; Miao, Xianjing; Zeng, Weiwen; Hua, Xiumei; Ni, Runzhou; Zhang, Dongmei; Tang, Qiyun</div><div class="citationInfo"><span class="NLM_cas:title">Clinics and Research in Hepatology and Gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">445-458</span>CODEN:
                <span class="NLM_cas:coden">CRHGAQ</span>;
        ISSN:<span class="NLM_cas:issn">2210-7401</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To investigate the role of chromosome region maintenance-1 (CRM1) in Crohn's disease (CD) and its potential pathol. mechanisms.The expression and distribution of CRM1 in mucosal biopsies from patients with active CD and normal controls were detected by immunohistochem. (IHC).  We established a murine model of acute colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS).  Western blot was performed to investigate the expression levels of CRM1, apoptotic markers (active caspase-3 and cleaved PARP), p27kip1 and p-p27ser10.  IHC was performed to evaluate the distribution of CRM1, and double immunofluorescence (IF) was performed to evaluate the co-localization of CRM1 and active capase-3.  Cells of the human intestinal epithelial cell line HT-29 were incubated with tumor necrosis factor-α (TNF-α) to establish an apoptotic in vitro model.  Western blot was performed to det. the expression levels of CRM1, active caspase-3, cleaved PARP and p-p27ser10.  Cytoplasmic and nuclear exts. were assessed to examine the translocation of CRM1.  The interaction between CRM1 and p27kip1 was assessed by co-immunopptn. (co-IP) assays.  Furthermore, we used small interfering RNA (siRNA) to knock down the protein expression of CRM1 in HT-29 cells and then measured the expression of active caspase-3, cleaved PARP and p-p27ser10.  Flow cytometry was used to det. the effect of CRM1 on intestinal epithelial cell (IEC) apoptosis.We obsd. up-regulation of CRM1 accompanied by elevated levels of IEC apoptotic markers (active caspase-3 and cleaved PARP) and p-p27ser10 in IECs of patients with active CD and in TNBS-induced colitis model cells.  However, the expression of p27kip1 was neg. correlated with the expression patterns of CRM1, p-p27ser10 and apoptotic biochem. markers.  Co-localization of CRM1 and active caspase-3 in IECs of the TNBS group further indicated the possible involvement of CRM1 in IEC apoptosis.  By employing TNF-α-treated HT-29 cells as an in vitro IEC apoptosis model, we found that the expression levels of CRM1 and p-p27ser10 were in accordance with active caspase-3 and cleaved PARP.  In addn., immunopptn. confirmed the phys. interaction between CRM1 and p27kip1. siRNA knockdown of CRM1 significantly inhibited the phosphorylation of p27kip1 and the expression of active caspase-3 and cleaved PARP.  In addn., flow cytometry anal. also showed that silencing CRM1 by siRNA inhibited TNF-α-induced cellular apoptosis in HT-29 cells.Up-regulated CRM1 may facilitate IEC apoptosis possibly through p27kip1 in CD, indicating an important role of CRM1 in the pathophysiol. of CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8nkcXnqCB4bVg90H21EOLACvtfcHk0lj76QzHnNNMDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kgsb8%253D&md5=55f1e936eda2b74c2415f3087d56ab71</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.clinre.2017.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinre.2017.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHua%26aufirst%3DX.%26aulast%3DNi%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DQ.%26atitle%3DChromosome%2520region%2520maintenance-1%2520%2528CRM1%2529%2520regulates%2520apoptosis%2520of%2520intestinal%2520epithelial%2520cells%2520via%2520p27kip1%2520in%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Res.%2520Hepatol.%2520Gastroenterol.%26date%3D2017%26volume%3D41%26spage%3D445%26epage%3D458%26doi%3D10.1016%2Fj.clinre.2017.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Traditional Herbal Medicine-Derived Sulforaphene LFS-01 Reverses Colitis in Mice by Selectively Altering the Gut Microbiota and Promoting Intestinal Gamma-Delta T Cells</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">959</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.3389%2Ffphar.2017.00959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=29375374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=959&author=M.+Liauthor=J.+Gaoauthor=Y.+Tangauthor=M.+Liuauthor=S.+Wuauthor=K.+Quauthor=X.+Longauthor=H.+Liauthor=M.+Liuauthor=Y.+Liuauthor=J.+Yuanauthor=L.+Maoauthor=Y.+Liuauthor=X.+Zhengauthor=E.+Wangauthor=J.+Wangauthor=Y.+Yang&title=Traditional+Herbal+Medicine-Derived+Sulforaphene+LFS-01+Reverses+Colitis+in+Mice+by+Selectively+Altering+the+Gut+Microbiota+and+Promoting+Intestinal+Gamma-Delta+T+Cells&doi=10.3389%2Ffphar.2017.00959"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00959%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DQu%26aufirst%3DK.%26aulast%3DLong%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DTraditional%2520Herbal%2520Medicine-Derived%2520Sulforaphene%2520LFS-01%2520Reverses%2520Colitis%2520in%2520Mice%2520by%2520Selectively%2520Altering%2520the%2520Gut%2520Microbiota%2520and%2520Promoting%2520Intestinal%2520Gamma-Delta%2520T%2520Cells%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D8%26spage%3D959%26doi%3D10.3389%2Ffphar.2017.00959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Etchin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezovskaya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kentsis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodig, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinsky, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebanov, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landesman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, A. T.</span></span> <span> </span><span class="NLM_article-title">Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1038/leu.2015.194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fleu.2015.194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=26202935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fls1KrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=190-199&author=J.+Etchinauthor=J.+Monteroauthor=A.+Berezovskayaauthor=B.+T.+Leauthor=A.+Kentsisauthor=A.+L.+Christieauthor=A.+S.+Conwayauthor=W.+C.+Chenauthor=C.+Reedauthor=M.+R.+Mansourauthor=C.+E.+Ngauthor=S.+Adamiaauthor=S.+J.+Rodigauthor=I.+A.+Galinskyauthor=R.+M.+Stoneauthor=B.+Klebanovauthor=Y.+Landesmanauthor=M.+Kauffmanauthor=S.+Shachamauthor=A.+L.+Kungauthor=J.+C.+Wangauthor=A.+Letaiauthor=A.+T.+Look&title=Activity+of+a+selective+inhibitor+of+nuclear+export%2C+selinexor+%28KPT-330%29%2C+against+AML-initiating+cells+engrafted+into+immunosuppressed+NSG+mice&doi=10.1038%2Fleu.2015.194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice</span></div><div class="casAuthors">Etchin J; Berezovskaya A; Le B T; Christie A L; Conway A S; Reed C; Mansour M R; Ng C E L; Look A T; Etchin J; Look A T; Montero J; Adamia S; Galinsky I A; Stone R M; Letai A; Kentsis A; Chen W C; Wang J C Y; Chen W C; Wang J C Y; Mansour M R; Rodig S J; Klebanov B; Landesman Y; Kauffman M; Shacham S; Kung A L</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Currently available combination chemotherapy for acute myeloid leukemia (AML) often fails to result in long-term remissions, emphasizing the need for novel therapeutic strategies.  We reasoned that targeted inhibition of a prominent nuclear exporter, XPO1/CRM1, could eradicate self-renewing leukemia-initiating cells (LICs) whose survival depends on timely XPO1-mediated transport of specific protein and RNA cargoes.  Using an immunosuppressed mouse model bearing primary patient-derived AML cells, we demonstrate that selinexor (KPT-330), an oral antagonist of XPO1 that is currently in clinical trials, has strong activity against primary AML cells while sparing normal stem and progenitor cells.  Importantly, limiting dilution transplantation assays showed that this cytotoxic activity is not limited to the rapidly proliferating bulk population of leukemic cells but extends to the LICs, whose inherent drug resistance and unrestricted self-renewal capacity has been implicated in the difficulty of curing AML patients with conventional chemotherapy alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfx-eGkpq8PFUIs6wFK5xJfW6udTcc2eYwjO0T51BOhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fls1KrsA%253D%253D&md5=956ccb6e88e07e314a1494c1261e9f1b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fleu.2015.194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2015.194%26sid%3Dliteratum%253Aachs%26aulast%3DEtchin%26aufirst%3DJ.%26aulast%3DMontero%26aufirst%3DJ.%26aulast%3DBerezovskaya%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DB.%2BT.%26aulast%3DKentsis%26aufirst%3DA.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DConway%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DReed%26aufirst%3DC.%26aulast%3DMansour%26aufirst%3DM.%2BR.%26aulast%3DNg%26aufirst%3DC.%2BE.%26aulast%3DAdamia%26aufirst%3DS.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DGalinsky%26aufirst%3DI.%2BA.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DKlebanov%26aufirst%3DB.%26aulast%3DLandesman%26aufirst%3DY.%26aulast%3DKauffman%26aufirst%3DM.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DWang%26aufirst%3DJ.%2BC.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DActivity%2520of%2520a%2520selective%2520inhibitor%2520of%2520nuclear%2520export%252C%2520selinexor%2520%2528KPT-330%2529%252C%2520against%2520AML-initiating%2520cells%2520engrafted%2520into%2520immunosuppressed%2520NSG%2520mice%26jtitle%3DLeukemia%26date%3D2016%26volume%3D30%26spage%3D190%26epage%3D199%26doi%3D10.1038%2Fleu.2015.194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirtz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichtner-Feigl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span> <span> </span><span class="NLM_article-title">Chemically induced mouse models of acute and chronic intestinal inflammation</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1295</span>– <span class="NLM_lpage">1309</span>, <span class="refDoi"> DOI: 10.1038/nprot.2017.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnprot.2017.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=28569761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovFCqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1295-1309&author=S.+Wirtzauthor=V.+Poppauthor=M.+Kindermannauthor=K.+Gerlachauthor=B.+Weigmannauthor=S.+Fichtner-Feiglauthor=M.+F.+Neurath&title=Chemically+induced+mouse+models+of+acute+and+chronic+intestinal+inflammation&doi=10.1038%2Fnprot.2017.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically induced mouse models of acute and chronic intestinal inflammation</span></div><div class="casAuthors">Wirtz, Stefan; Popp, Vanessa; Kindermann, Markus; Gerlach, Katharina; Weigmann, Benno; Fichtner-Feigl, Stefan; Neurath, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1295-1309</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammatory bowel diseases (IBDs) result in diarrhea and abdominal pain with further potential complications such as tissue fibrosis and stenosis.  Animal models help in understanding the immunopathogenesis of IBDs and in the design of novel therapeutic concepts.  Here we present an updated version of a protocol we published in 2007 for key models of acute and chronic forms of colitis induced by 2,4,6-trinitro-benzene sulfonic acid (TNBS), oxazolone and dextran sulfate sodium (DSS).  This protocol update describes an adaptation of the existing protocol that modifies the technique.  This protocol has been used to generate improved mouse models that better reflect the nature of IBDs in humans.  In TNBS and oxazolone colitis models, topical administration of hapten reagents results in T-cell-mediated immunity against haptenized proteins and luminal antigens.  By contrast, to generate DSS colitis models, mice orally receive DSS, causing death of epithelial cells, compromising barrier function and causing subsequent inflammation.  The anal. of the acute colitis models can be performed within 1-2 wk, whereas that of the chronic models may take 2-4 mo.  The strengths of the acute models are that they are based on the anal. of short-lasting barrier alterations, innate immune effects and flares.  The advantages of the chronic models are that they may offer better insight into adaptive immunity and complications such as neoplasia and tissue fibrosis.  The protocol requires basic skills in lab. animal research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMwK4B3_nXsbVg90H21EOLACvtfcHk0lhu-ypwDaPAJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovFCqu7o%253D&md5=f1eea8dd2b9540214ae1731453748353</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2017.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2017.044%26sid%3Dliteratum%253Aachs%26aulast%3DWirtz%26aufirst%3DS.%26aulast%3DPopp%26aufirst%3DV.%26aulast%3DKindermann%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DK.%26aulast%3DWeigmann%26aufirst%3DB.%26aulast%3DFichtner-Feigl%26aufirst%3DS.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26atitle%3DChemically%2520induced%2520mouse%2520models%2520of%2520acute%2520and%2520chronic%2520intestinal%2520inflammation%26jtitle%3DNat.%2520Protoc.%26date%3D2017%26volume%3D12%26spage%3D1295%26epage%3D1309%26doi%3D10.1038%2Fnprot.2017.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirtz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span> <span> </span><span class="NLM_article-title">Chemically induced mouse models of intestinal inflammation</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnprot.2007.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=17406617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=541-546&author=S.+Wirtzauthor=C.+Neufertauthor=B.+Weigmannauthor=M.+F.+Neurath&title=Chemically+induced+mouse+models+of+intestinal+inflammation&doi=10.1038%2Fnprot.2007.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically induced mouse models of intestinal inflammation</span></div><div class="casAuthors">Wirtz, Stefan; Neufert, Clemens; Weigmann, Benno; Neurath, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-546</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Animal models of intestinal inflammation are indispensable for our understanding of the pathogenesis of Crohn disease and ulcerative colitis, the two major forms of inflammatory bowel disease in humans.  Here, we provide protocols for establishing murine 2,4,6-trinitro benzene sulfonic acid (TNBS)-, oxazolone- and both acute and chronic dextran sodium sulfate (DSS) colitis, the most widely used chem. induced models of intestinal inflammation.  In the former two models, colitis is induced by intrarectal administration of the covalently reactive reagents TNBS/oxazolone, which are believed to induce a T-cell-mediated response against hapten-modified autologous proteins/luminal antigens.  In the DSS model, mice are subjected several days to drinking water supplemented with DSS, which seems to be directly toxic to colonic epithelial cells of the basal crypts.  The procedures for the hapten models of colitis and acute DSS colitis can be accomplished in about 2 wk but the protocol for chronic DSS colitis takes about 2 mo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-D9fB-7WMbVg90H21EOLACvtfcHk0lhu-ypwDaPAJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbnL&md5=7a3c29eaca8be756e3d866e23e151fdf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.41%26sid%3Dliteratum%253Aachs%26aulast%3DWirtz%26aufirst%3DS.%26aulast%3DNeufert%26aufirst%3DC.%26aulast%3DWeigmann%26aufirst%3DB.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26atitle%3DChemically%2520induced%2520mouse%2520models%2520of%2520intestinal%2520inflammation%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D541%26epage%3D546%26doi%3D10.1038%2Fnprot.2007.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buzard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoresen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbaoui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalban, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sage, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semple, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whelan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shamma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidarov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behan, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/ml500389m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500389m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1313-1317&author=D.+J.+Buzardauthor=S.+H.+Kimauthor=L.+Lopezauthor=A.+Kawasakiauthor=X.+Zhuauthor=J.+Moodyauthor=L.+Thoresenauthor=I.+Calderonauthor=B.+Ullmanauthor=S.+Hanauthor=J.+Lehmannauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=L.+Calvanoauthor=A.+G.+Montalbanauthor=Y.+A.+Maauthor=C.+Sageauthor=Y.+Gaoauthor=G.+Sempleauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=W.+Chenauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=R.+J.+Christopherauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=D.+Millsauthor=K.+Whelanauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=M.+Leauthor=I.+Gaidarovauthor=T.+Anthonyauthor=D.+J.+Unettauthor=A.+Blackburnauthor=J.+Rueterauthor=S.+Stirnauthor=D.+P.+Behanauthor=R.+M.+Jones&title=Discovery+of+APD334%3A+Design+of+a+Clinical+Stage+Functional+Antagonist+of+the+Sphingosine-1-phosphate-1+Receptor&doi=10.1021%2Fml500389m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor</span></div><div class="casAuthors">Buzard, Daniel J.; Kim, Sun Hee; Lopez, Luis; Kawasaki, Andrew; Zhu, Xiuwen; Moody, Jeanne; Thoresen, Lars; Calderon, Imelda; Ullman, Brett; Han, Sangdon; Lehmann, Juerg; Gharbaoui, Tawfik; Sengupta, Dipanjan; Calvano, Lorene; Montalban, Antonio Garrido; Ma, You-An; Sage, Carleton; Gao, Yinghong; Semple, Graeme; Edwards, Jeff; Barden, Jeremy; Morgan, Michael; Chen, Weichao; Usmani, Khawja; Chen, Chuan; Sadeque, Abu; Christopher, Ronald J.; Thatte, Jayant; Fu, Lixia; Solomon, Michelle; Mills, David; Whelan, Kevin; Al-Shamma, Hussien; Gatlin, Joel; Le, Minh; Gaidarov, Ibragim; Anthony, Todd; Unett, David J.; Blackburn, Anthony; Rueter, Jaimie; Stirn, Scott; Behan, Dominic P.; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1313-1317</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">APD334 I was discovered as part of the internal effort to identify potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple sclerosis (MS) and other autoimmune diseases.  I is a potent functional antagonist of S1P1 and has a favorable PK/PD profile, producing robust lymphocyte lowering at relatively low plasma concns. in several preclin. species.  This new agent was efficacious in a mouse exptl. autoimmune encephalomyelitis model of MS and a rat collagen induced arthritis model and was found to have appreciable central exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ikF-8Xd3ibVg90H21EOLACvtfcHk0lgtBbSQhMGH_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLnE&md5=1e44d556d856ea6f87883b3a535e554c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml500389m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500389m%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DUllman%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DCalvano%26aufirst%3DL.%26aulast%3DMontalban%26aufirst%3DA.%2BG.%26aulast%3DMa%26aufirst%3DY.%2BA.%26aulast%3DSage%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DD.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DAnthony%26aufirst%3DT.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DRueter%26aufirst%3DJ.%26aulast%3DStirn%26aufirst%3DS.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520APD334%253A%2520Design%2520of%2520a%2520Clinical%2520Stage%2520Functional%2520Antagonist%2520of%2520the%2520Sphingosine-1-phosphate-1%2520Receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1313%26epage%3D1317%26doi%3D10.1021%2Fml500389m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dassopoulos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cope, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brant, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayless, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, S.</span></span> <span> </span><span class="NLM_article-title">Genome-wide gene expression differences in Crohn’s disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis</span>. <i>Inflamm Bowel Dis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1002/ibd.20110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1002%2Fibd.20110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=17262812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BD2szitFCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=807-821&author=F.+Wuauthor=T.+Dassopoulosauthor=L.+Copeauthor=A.+Maitraauthor=S.+R.+Brantauthor=M.+L.+Harrisauthor=T.+M.+Baylessauthor=G.+Parmigianiauthor=S.+Chakravarti&title=Genome-wide+gene+expression+differences+in+Crohn%E2%80%99s+disease+and+ulcerative+colitis+from+endoscopic+pinch+biopsies%3A+insights+into+distinctive+pathogenesis&doi=10.1002%2Fibd.20110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis</span></div><div class="casAuthors">Wu Feng; Dassopoulos Themistocles; Cope Leslie; Maitra Anirban; Brant Steven R; Harris Mary L; Bayless Theodore M; Parmigiani Giovanni; Chakravarti Shukti</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">807-21</span>
        ISSN:<span class="NLM_cas:issn">1078-0998</span>.
    </div><div class="casAbstract">BACKGROUND:  Ulcerative colitis (UC) and Crohn's disease (CD) are inflammatory bowel diseases (IBD) with variable, overlapping clinical features and complex pathophysiologies.  METHODS:  To identify pathogenic processes underlying these disease subtypes, we used single endoscopic pinch biopsies to elucidate patterns of gene expression in active and inactive areas of UC and CD and compared these to infectious colitis and healthy control samples.  RESULTS:  Unsupervised classification of a total of 36 samples yielded promising separation between the affected IBD, unaffected IBD, non-IBD colitis, and normal control samples, suggesting each sample type had a distinctive gene expression pattern.  Genes differentially expressed in the CD samples compared to in the controls were related to IFNgamma-inducible TH1 processes (IFITM1, IFITM3, STAT1, and STAT3) and antigen presentation (TAP1, PSME2, PSMB8).  The most noticeable change in the UC samples was reduced expression of genes regulating biosynthesis, metabolism, and electrolyte transport (HNF4G, KLF5, AQP8, ATP2B1, and SLC16A).  Twenty-five percent of genes down-regulated in the UC samples were also down-regulated in the infectious colitis samples.  Unaffected biopsy samples of IBD patients also registered differences expression of genes compared to in the normal controls.  Of these differentially expressed genes, only 2 were up-regulated, PSKH1, a regulator of mRNA processing, and PPID, a suppressor of apoptosis.  CONCLUSIONS:  The study shows that the gene expression patterns of IBD, CD in particular, are quite different from those of infectious colitis, highlighting distinctive expression of genes and pathways in UC and CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReNUVw0kIPZjMsgLhIoICsfW6udTcc2eaJ7nYS8NPCJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szitFCqtg%253D%253D&md5=7623b44f78750fbf1c64f030e2a371c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fibd.20110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fibd.20110%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DDassopoulos%26aufirst%3DT.%26aulast%3DCope%26aufirst%3DL.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DBrant%26aufirst%3DS.%2BR.%26aulast%3DHarris%26aufirst%3DM.%2BL.%26aulast%3DBayless%26aufirst%3DT.%2BM.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DChakravarti%26aufirst%3DS.%26atitle%3DGenome-wide%2520gene%2520expression%2520differences%2520in%2520Crohn%25E2%2580%2599s%2520disease%2520and%2520ulcerative%2520colitis%2520from%2520endoscopic%2520pinch%2520biopsies%253A%2520insights%2520into%2520distinctive%2520pathogenesis%26jtitle%3DInflamm%2520Bowel%2520Dis%26date%3D2007%26volume%3D13%26spage%3D807%26epage%3D821%26doi%3D10.1002%2Fibd.20110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holgersen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutlu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holm, T. L.</span></span> <span> </span><span class="NLM_article-title">High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis</span>. <i>J. Crohns Colitis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1093/ecco-jcc/jjv050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1093%2Fecco-jcc%2Fjjv050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=25795566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmsFaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=492-506&author=K.+Holgersenauthor=B.+Kutluauthor=B.+Foxauthor=K.+Serikawaauthor=J.+Lordauthor=A.+K.+Hansenauthor=T.+L.+Holm&title=High-resolution+gene+expression+profiling+using+RNA+sequencing+in+patients+with+inflammatory+bowel+disease+and+in+mouse+models+of+colitis&doi=10.1093%2Fecco-jcc%2Fjjv050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis</span></div><div class="casAuthors">Holgersen Kristine; Kutlu Burak; Fox Brian; Serikawa Kyle; Lord James; Hansen Axel Kornerup; Holm Thomas Lindebo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Crohn's & colitis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">492-506</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND AIMS:  Proper interpretation of data from preclinical animal studies requires thorough knowledge of the pathophysiology of both the human disease and animal models.  In this study, the expression of inflammatory bowel disease [IBD]-associated genes was characterised in mouse models of colitis to examine the underlying molecular pathways and assess the similarity between the experimental models and human disease.  METHODS:  RNA sequencing was performed on colon biopsies from Crohn's disease [CD] patients, ulcerative colitis [UC] patients and non-IBD controls.  Genes shown to be significantly dysregulated in human IBD were used to study gene expression in colons from a piroxicam-accelerated colitis interleukin-10 knockout [PAC IL-10 k.o.], an adoptive transfer [AdTr] and a dextran sulfate sodium [DSS] colitis mouse model.  RESULTS:  Of 115 literature-defined genes linked to IBD, 92 were significantly differentially expressed in inflamed mucosa of CD and/or UC patients compared with non-IBD controls.  The most upregulated genes were shared by both diseases, including REG1A, LCN2, NOS2, CXCL1-2, and S100A9.  Of those 92 IBD-associated genes, 71 [77%] were significantly dysregulated in PAC IL-10 k.o. mice, whereas 59 [64%] were significantly dysregulated in AdTr mice compared with wild-type controls.  Some of the most upregulated genes, including S100a8-9, Nos2, and Lcn2, were shared by the colitis models and correlated with disease activity.  CONCLUSIONS:  IBD and experimental murine colitis have a high degree of similarity in the colonic transcriptional profile, probably secondary to non-specific inflammatory processes.  However, differences do exist between models, emphasising the need for careful selection and interpretation of qualified animal models in preclinical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTY-92jPa75bmgRQsDqrjW_fW6udTcc2eaBhOvvB0p-xbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmsFaktQ%253D%253D&md5=2bddec9f8e9c76b76720517aa1abc02e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fecco-jcc%2Fjjv050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fecco-jcc%252Fjjv050%26sid%3Dliteratum%253Aachs%26aulast%3DHolgersen%26aufirst%3DK.%26aulast%3DKutlu%26aufirst%3DB.%26aulast%3DFox%26aufirst%3DB.%26aulast%3DSerikawa%26aufirst%3DK.%26aulast%3DLord%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DA.%2BK.%26aulast%3DHolm%26aufirst%3DT.%2BL.%26atitle%3DHigh-resolution%2520gene%2520expression%2520profiling%2520using%2520RNA%2520sequencing%2520in%2520patients%2520with%2520inflammatory%2520bowel%2520disease%2520and%2520in%2520mouse%2520models%2520of%2520colitis%26jtitle%3DJ.%2520Crohns%2520Colitis%26date%3D2015%26volume%3D9%26spage%3D492%26epage%3D506%26doi%3D10.1093%2Fecco-jcc%2Fjjv050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khor, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1485</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2008.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1016%2Fj.bcp.2008.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=18694732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2qtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2008&pages=1485-1489&author=W.+Liauthor=T.+O.+Khorauthor=C.+Xuauthor=G.+Shenauthor=W.+S.+Jeongauthor=S.+Yuauthor=A.+N.+Kong&title=Activation+of+Nrf2-antioxidant+signaling+attenuates+NFkappaB-inflammatory+response+and+elicits+apoptosis&doi=10.1016%2Fj.bcp.2008.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis</span></div><div class="casAuthors">Li, Wenge; Khor, Tin Oo; Xu, Changjiang; Shen, Guoxiang; Jeong, Woo-Sik; Yu, Siwang; Kong, Ah-Ng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1485-1489</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress has been implicated in the etiol. of neurodegenerative disease, cancer and aging.  Indeed, accumulation of reactive oxygen and nitrogen species generated by inflammatory cells that created oxidative stress is thought to be one of the major factor by which chronic inflammation contributes to neoplastic transformation as well as many other diseases.  We have recently reported that mice lacking nuclear factor-erythroid 2-related factor 2 (Nrf2) are more susceptible to dextran sulfate sodium (DSS)-induced colitis and colorectal carcinogenesis.  Nrf2 is a basic leucine zipper redox-sensitive transcriptional factor that plays a center role in ARE (antioxidant response element)-mediated induction of phase II detoxifying and antioxidant enzymes.  We found that increased susceptibility of Nrf2 deficient mice to DSS-induced colitis and colorectal cancer was assocd. with decreased expression of antioxidant/phase II detoxifying enzymes in parallel with upregulation of pro-inflammatory cytokines/biomarkers.  These findings suggest that Nrf2 may play an important role in defense against oxidative stress possibly by activation of cellular antioxidant machinery as well as suppression of pro-inflammatory signaling pathways.  In addn., in vivo and in vitro data generated from our lab. suggest that many dietary compds. can differentially regulate Nrf2-mediated antioxidant/anti-inflammatory signaling pathways as the first line defense or induce apoptosis once the cells have been damaged.  In this review, we will summarize our thoughts on the potential cross-talks between Nrf2 and NFκB pathways.  Although the mechanisms involved in the cross-talk between these signaling pathways are still illusive, targeting Nrf2-antioxidative stress signaling is an ideal strategy to prevent or treat oxidative stress-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqacAYKm_OYALVg90H21EOLACvtfcHk0ljKFA3tlHlbtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2qtLfI&md5=c441c1224ecf7885104ffe7a8cf806d6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2008.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2008.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKhor%26aufirst%3DT.%2BO.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DJeong%26aufirst%3DW.%2BS.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DActivation%2520of%2520Nrf2-antioxidant%2520signaling%2520attenuates%2520NFkappaB-inflammatory%2520response%2520and%2520elicits%2520apoptosis%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D76%26spage%3D1485%26epage%3D1489%26doi%3D10.1016%2Fj.bcp.2008.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khor, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer</span>. <i>Cancer Prev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1158/1940-6207.CAPR-08-0028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1158%2F1940-6207.CAPR-08-0028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=19138955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVyruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=187-191&author=T.+O.+Khorauthor=M.+T.+Huangauthor=A.+Prawanauthor=Y.+Liuauthor=X.+Haoauthor=S.+Yuauthor=W.+K.+Cheungauthor=J.+Y.+Chanauthor=B.+S.+Reddyauthor=C.+S.+Yangauthor=A.+N.+Kong&title=Increased+susceptibility+of+Nrf2+knockout+mice+to+colitis-associated+colorectal+cancer&doi=10.1158%2F1940-6207.CAPR-08-0028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer</span></div><div class="casAuthors">Khor, Tin Oo; Huang, Mou-Tuan; Prawan, Auemduan; Liu, Yue; Hao, Xingpei; Yu, Siwang; Cheung, William Ka Lung; Chan, Jefferson Y.; Reddy, Bandaru S.; Yang, Chung S.; Kong, Ah-Ng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-191</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association of Cancer Research</span>)
        </div><div class="casAbstract">The nuclear factor-erythroid 2-related factor 2 (Nrf2) plays a crit. role in protecting various tissues against inflammation, which is a potential risk factor for colorectal and other cancers.  Our previously published mouse model work showed that Nrf2 helps protect against dextran sulfate sodium (DSS)-induced colitis/inflammation, and others have shown that Nrf2 helps protect against inflammation-assocd. colorectal carcinogenesis (aberrant crypt foci).  The present study extended these important earlier findings by exploring the role of Nrf2 in colitis-assocd. colorectal cancer in a mouse model involving azoxymethane/DSS-induced colorectal carcinogenesis in Nrf2 knockout mice.  Azoxymethane/DSS-treated Nrf2 knockout mice had increased incidence, multiplicity, and size of all colorectal tumors, including adenomas, vs. treated wild-type (WT) mice, and the proportion of tumors that were adenocarcinoma was much higher in knockout (80%) vs. WT (29%) mice.  Compared with WT mice, knockout mice also had increased markers of inflammation in tumor tissue (cyclooxygenase-2 and 5-lipoxygenase expressions and prostaglandin E2 and leukotriene B4 levels) and in inflamed colonic mucosa (nitrotyrosine expression), supporting the assocn. of knockout mouse tumor formation with inflammation.  The phase II detoxifying/antioxidant enzymes NAD(P)H-quinone reductase 1 and UDP-glucurosyltransferase 1A1 were elevated in the normal mucosa of WT, but not Nrf 2 knockout, mice treated with azoxymethane/DSS.  Our findings show that Nrf2 plays a crit. role in protecting against inflammation-assocd. colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl9iv4xHJX_LVg90H21EOLACvtfcHk0lgnZ1LJdVKmJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVyruro%253D&md5=8d5e102c6226f0e71bb73cad8aacf451</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-08-0028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-08-0028%26sid%3Dliteratum%253Aachs%26aulast%3DKhor%26aufirst%3DT.%2BO.%26aulast%3DHuang%26aufirst%3DM.%2BT.%26aulast%3DPrawan%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DW.%2BK.%26aulast%3DChan%26aufirst%3DJ.%2BY.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DYang%26aufirst%3DC.%2BS.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DIncreased%2520susceptibility%2520of%2520Nrf2%2520knockout%2520mice%2520to%2520colitis-associated%2520colorectal%2520cancer%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2008%26volume%3D1%26spage%3D187%26epage%3D191%26doi%3D10.1158%2F1940-6207.CAPR-08-0028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sands, B. E.</span></span> <span> </span><span class="NLM_article-title">Biomarkers of Inflammation in Inflammatory Bowel Disease</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2015.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1053%2Fj.gastro.2015.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=26166315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFygsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2015&pages=1275-1285&author=B.+E.+Sands&title=Biomarkers+of+Inflammation+in+Inflammatory+Bowel+Disease&doi=10.1053%2Fj.gastro.2015.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">biomarkers of inflammation in inflammatory bowel disease</span></div><div class="casAuthors">Sands, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1275-1285.e2</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recent observations suggest that subjective measures of disease activity in inflammatory bowel disease (IBD) are often misleading.  Objective measures of inflammation are more closely assocd. with important long-term outcomes, but often depend upon invasive and costly procedures such as ileocolonoscopy and cross-sectional imaging by computed tomog. or magnetic resonance imaging.  Noninvasive, accurate, and inexpensive measures of intestinal inflammation would allow clinicians to adopt widely the paradigm of adjusting therapies with a goal of controlling inflammation.  Blood, stool, and urine markers have all been explored as indicators of intestinal inflammation in IBD, and although none has been universally adopted, some have been well-characterized, and others hold great promise.  Serum C-reactive protein and fecal calprotectin are among the best-studied noninvasive biomarkers of inflammation in IBD, and their test characteristics have been described in the setting of differentiating IBD from irritable bowel syndrome, for grading inflammation, to describe the response to therapy, and in demonstrating recurrent inflammation after medical or surgically induced remission.  High-throughput research platforms, including gene expression arrays, metabolomics and proteomics, are also being applied to the discovery of novel biomarkers of inflammation.  It is certain that biomarkers of inflammation will attain growing importance in the clinic as we strive for more effective and cost-effective strategies to treat patients with IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKm5-GLEf6XbVg90H21EOLACvtfcHk0lgnZ1LJdVKmJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFygsr3J&md5=c83cd9c17316a67748b940ded53f4f3a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2015.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2015.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DSands%26aufirst%3DB.%2BE.%26atitle%3DBiomarkers%2520of%2520Inflammation%2520in%2520Inflammatory%2520Bowel%2520Disease%26jtitle%3DGastroenterology%26date%3D2015%26volume%3D149%26spage%3D1275%26epage%3D1285%26doi%3D10.1053%2Fj.gastro.2015.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, D.</span></span> <span> </span><span class="NLM_article-title">Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1393</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.1517/17425247.2012.730517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1517%2F17425247.2012.730517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23036075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCgsbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=1393-1407&author=B.+Xiaoauthor=D.+Merlin&title=Oral+colon-specific+therapeutic+approaches+toward+treatment+of+inflammatory+bowel+disease&doi=10.1517%2F17425247.2012.730517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease</span></div><div class="casAuthors">Xiao, Bo; Merlin, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1393-1407</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Inflammatory bowel disease (IBD) is a chronic relapsing idiopathic disease.  In clin. terms, most patients require lifelong medication assocd. with possible unpleasant adverse effects.  Oral colon-specific drug delivery systems are designed to deliver therapeutic drugs to the inflamed colon to target pathophysiol. manifestations of IBD.  The aim is to maintain the drug with proper concn. in the inflamed colon, to enhance drug residence time and to minimize drug absorption by healthy tissues.  Areas covered: This review addresses the main barriers for colon-specific drug delivery from organism, tissue and cell levels, resp.  It also summarizes novel colon-specific therapeutic strategies using microparticles and nanoparticles.  Expert opinion: Oral colon-specific drug delivery represents a possible approach toward efficient treatment of IBD.  As the environment of the gastrointestinal tract is harsh and intricate, this approach requires that drug carriers can respond to specific environmental factors of the inflamed colon, permitting stimulus-responsive release of loaded drugs to specific cells or even into specific organelles within cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB-fbULoB6WbVg90H21EOLACvtfcHk0lhxNz5sOImI7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCgsbfM&md5=f5c53683fb88ac93711ac2373c503b0a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F17425247.2012.730517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2012.730517%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DMerlin%26aufirst%3DD.%26atitle%3DOral%2520colon-specific%2520therapeutic%2520approaches%2520toward%2520treatment%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2012%26volume%3D9%26spage%3D1393%26epage%3D1407%26doi%3D10.1517%2F17425247.2012.730517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mladenka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Applova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patocka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mladenka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlickova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahodar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voprsalova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varner, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterba, M.</span></span> <span> </span><span class="NLM_article-title">Comprehensive review of cardiovascular toxicity of drugs and related agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1332</span>– <span class="NLM_lpage">1403</span>, <span class="refDoi"> DOI: 10.1002/med.21476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1002%2Fmed.21476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=29315692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1SmsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=1332-1403&author=P.+Mladenkaauthor=L.+Applovaauthor=J.+Patockaauthor=V.+M.+Costaauthor=F.+Remiaoauthor=J.+Pourovaauthor=A.+Mladenkaauthor=J.+Karlickovaauthor=L.+Jahodarauthor=M.+Voprsalovaauthor=K.+J.+Varnerauthor=M.+Sterba&title=Comprehensive+review+of+cardiovascular+toxicity+of+drugs+and+related+agents&doi=10.1002%2Fmed.21476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive review of cardiovascular toxicity of drugs and related agents</span></div><div class="casAuthors">Mladenka, Premysl; Applova, Lenka; Patocka, Jiri; Costa, Vera Marisa; Remiao, Fernando; Pourova, Jana; Mladenka, Ales; Karlickova, Jana; Jahodar, Ludek; Voprsalova, Marie; Varner, Kurt J.; Sterba, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1332-1403</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cardiovascular diseases are a leading cause of morbidity and mortality in most developed countries of the world.  Pharmaceuticals, illicit drugs, and toxins can significantly contribute to the overall cardiovascular burden and thus deserve attention.  The present article is a systematic overview of drugs that may induce distinct cardiovascular toxicity.  The compds. are classified into agents that have significant effects on the heart, blood vessels, or both.  The mechanism(s) of toxic action are discussed and treatment modalities are briefly mentioned in relevant cases.  Due to the large no. of clin. relevant compds. discussed, this article could be of interest to a broad audience including pharmacologists and toxicologists, pharmacists, physicians, and medicinal chemists.  Particular emphasis is given to clin. relevant topics including the cardiovascular toxicity of illicit sympathomimetic drugs (e.g., cocaine, amphetamines, cathinones), drugs that prolong the QT interval, antidysrhythmic drugs, digoxin and other cardioactive steroids, beta-blockers, calcium channel blockers, female hormones, nonsteroidal anti-inflammatory, and anticancer compds. encompassing anthracyclines and novel targeted therapy interfering with the HER2 or the vascular endothelial growth factor pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8r0vImKjog7Vg90H21EOLACvtfcHk0lhxNz5sOImI7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1SmsrnK&md5=f35f6341f689366c0c810b9f30c2c7ad</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmed.21476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21476%26sid%3Dliteratum%253Aachs%26aulast%3DMladenka%26aufirst%3DP.%26aulast%3DApplova%26aufirst%3DL.%26aulast%3DPatocka%26aufirst%3DJ.%26aulast%3DCosta%26aufirst%3DV.%2BM.%26aulast%3DRemiao%26aufirst%3DF.%26aulast%3DPourova%26aufirst%3DJ.%26aulast%3DMladenka%26aufirst%3DA.%26aulast%3DKarlickova%26aufirst%3DJ.%26aulast%3DJahodar%26aufirst%3DL.%26aulast%3DVoprsalova%26aufirst%3DM.%26aulast%3DVarner%26aufirst%3DK.%2BJ.%26aulast%3DSterba%26aufirst%3DM.%26atitle%3DComprehensive%2520review%2520of%2520cardiovascular%2520toxicity%2520of%2520drugs%2520and%2520related%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2018%26volume%3D38%26spage%3D1332%26epage%3D1403%26doi%3D10.1002%2Fmed.21476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hueber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sands, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewitzky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandemeulebroecke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinisch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehkamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feagan, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karczewski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karczewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellgard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolino, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tougas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travis, S. P.</span></span> <span> </span><span class="NLM_article-title">Secukinumab in Crohn’s Disease Study, G. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: unexpected results of a randomised, double-blind placebo-controlled trial</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1700</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2011-301668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1136%2Fgutjnl-2011-301668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=22595313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFOitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=1693-1700&author=W.+Hueberauthor=B.+E.+Sandsauthor=S.+Lewitzkyauthor=M.+Vandemeulebroeckeauthor=W.+Reinischauthor=P.+D.+Higginsauthor=J.+Wehkampauthor=B.+G.+Feaganauthor=M.+D.+Yaoauthor=M.+Karczewskiauthor=J.+Karczewskiauthor=N.+Pezousauthor=S.+Bekauthor=G.+Bruinauthor=B.+Mellgardauthor=C.+Bergerauthor=M.+Londeiauthor=A.+P.+Bertolinoauthor=G.+Tougasauthor=S.+P.+Travis&title=Secukinumab+in+Crohn%E2%80%99s+Disease+Study%2C+G.+Secukinumab%2C+a+human+anti-IL-17A+monoclonal+antibody%2C+for+moderate+to+severe+Crohn%E2%80%99s+disease%3A+unexpected+results+of+a+randomised%2C+double-blind+placebo-controlled+trial&doi=10.1136%2Fgutjnl-2011-301668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial</span></div><div class="casAuthors">Hueber, Wolfgang; Sands, Bruce E.; Lewitzky, Steve; Vandemeulebroecke, Marc; Reinisch, Walter; Higgins, Peter D. R.; Wehkamp, Jan; Feagan, Brian G.; Yao, Michael D.; Karczewski, Marek; Karczewski, Jacek; Pezous, Nicole; Bek, Stephan; Bruin, Gerard; Mellgard, Bjoern; Berger, Claudia; Londei, Marco; Bertolino, Arthur P.; Tougas, Gervais; Travis, Simon P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1693-1700</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective The authors tested whether the anti-interleukin (IL)-17A monoclonal antibody secukinumab was safe and effective for the treatment of active Crohn's disease.  Design In a double-blind, randomized, placebo-controlled proof-of-concept study, 59 patients with moderate to severe Crohn's disease (Crohn's Disease Activity Index (CDAI) ≥220 to ≤450) were assigned in a 2:1 ratio to 2×10 mg/kg i.v. secukinumab or placebo.  The primary end point, addressed by Bayesian statistics augmented with historical placebo information, was the probability that secukinumab reduces the CDAI by ≥50 points more than placebo at week 6.  Ancillary analyses explored assocns. of 35 candidate genetic polymorphisms and fecal calprotectin response.  Results 59 patients (39 secukinumab, 20 placebo, mean baseline CDAI 307 and 301, resp.) were recruited.  18/59 (31%) Patients discontinued prematurely (12/39 (31%) secukinumab, 6/20 (30%) placebo), 10/59 (17%) due to insufficient therapeutic effect (8/39 (21%) secukinumab, 2/20 (10%) placebo).  Fourteen serious adverse events occurred in 10 patients (seven secukinumab, three placebo); 20 infections, including four local fungal infections, were seen on secukinumab vs. -none on placebo.  Primary end point anal. estd. <0.1% probability (ΔCDAI (SD) =33.9 (19.7), 95% credible interval -4.9 to 72.9) that secukinumab reduces CDAI by ≥50 points more than placebo.  Secondary area under the curve anal. (weeks 4-10) showed a significant difference (mean ΔCDAI=49; 95% CI (2 to 96), p=0.043) in favor of placebo.  Post hoc subgroup anal. showed that unfavorable responses on secukinumab were driven by patients with elevated inflammatory markers (CRP≥10 mg/l and/or fecal calprotectin≥200 ng/mL; mean ΔCDAI=62; 95% CI (-1 to 125), p=0.054 in favor of placebo).  Absence of the minor allele of tumor necrosis factor-like ligand 1A was strongly assocd. with lack of response measured by baseline-adjusted changes in calprotectin at week 6 (p=0.00035 Bonferroni-cor.).  Conclusions. Blockade of IL-17A was ineffective and higher rates of adverse events were noted compared with placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQta3YJouL7Vg90H21EOLACvtfcHk0ljGZcOvvYl27A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFOitg%253D%253D&md5=efa8d726701168a26949ba174059db97</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2011-301668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2011-301668%26sid%3Dliteratum%253Aachs%26aulast%3DHueber%26aufirst%3DW.%26aulast%3DSands%26aufirst%3DB.%2BE.%26aulast%3DLewitzky%26aufirst%3DS.%26aulast%3DVandemeulebroecke%26aufirst%3DM.%26aulast%3DReinisch%26aufirst%3DW.%26aulast%3DHiggins%26aufirst%3DP.%2BD.%26aulast%3DWehkamp%26aufirst%3DJ.%26aulast%3DFeagan%26aufirst%3DB.%2BG.%26aulast%3DYao%26aufirst%3DM.%2BD.%26aulast%3DKarczewski%26aufirst%3DM.%26aulast%3DKarczewski%26aufirst%3DJ.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DBek%26aufirst%3DS.%26aulast%3DBruin%26aufirst%3DG.%26aulast%3DMellgard%26aufirst%3DB.%26aulast%3DBerger%26aufirst%3DC.%26aulast%3DLondei%26aufirst%3DM.%26aulast%3DBertolino%26aufirst%3DA.%2BP.%26aulast%3DTougas%26aufirst%3DG.%26aulast%3DTravis%26aufirst%3DS.%2BP.%26atitle%3DSecukinumab%2520in%2520Crohn%25E2%2580%2599s%2520Disease%2520Study%252C%2520G.%2520Secukinumab%252C%2520a%2520human%2520anti-IL-17A%2520monoclonal%2520antibody%252C%2520for%2520moderate%2520to%2520severe%2520Crohn%25E2%2580%2599s%2520disease%253A%2520unexpected%2520results%2520of%2520a%2520randomised%252C%2520double-blind%2520placebo-controlled%2520trial%26jtitle%3DGut%26date%3D2012%26volume%3D61%26spage%3D1693%26epage%3D1700%26doi%3D10.1136%2Fgutjnl-2011-301668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaffen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span> <span> </span><span class="NLM_article-title">The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1038/nri3707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnri3707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=25145755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSit7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=585-600&author=S.+L.+Gaffenauthor=R.+Jainauthor=A.+V.+Gargauthor=D.+J.+Cua&title=The+IL-23-IL-17+immune+axis%3A+from+mechanisms+to+therapeutic+testing&doi=10.1038%2Fnri3707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing</span></div><div class="casAuthors">Gaffen, Sarah L.; Jain, Renu; Garg, Abhishek V.; Cua, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">585-600</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the mol. mechanisms of T cell lineage commitment and function.  In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues.  We also discuss the emerging clin. data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsrf-chGl_n7Vg90H21EOLACvtfcHk0ljGZcOvvYl27A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSit7%252FL&md5=3b78e054323aae062527ce32ec8e05e2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnri3707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3707%26sid%3Dliteratum%253Aachs%26aulast%3DGaffen%26aufirst%3DS.%2BL.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DGarg%26aufirst%3DA.%2BV.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520IL-23-IL-17%2520immune%2520axis%253A%2520from%2520mechanisms%2520to%2520therapeutic%2520testing%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D585%26epage%3D600%26doi%3D10.1038%2Fnri3707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer zum Buschenfelde, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strober, W.</span></span> <span> </span><span class="NLM_article-title">Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">998</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1038/nm0996-998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnm0996-998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=8782457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADyaK28XlsFenurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=998-1004&author=M.+F.+Neurathauthor=S.+Petterssonauthor=K.+H.+Meyer+zum+Buschenfeldeauthor=W.+Strober&title=Local+administration+of+antisense+phosphorothioate+oligonucleotides+to+the+p65+subunit+of+NF-kappa+B+abrogates+established+experimental+colitis+in+mice&doi=10.1038%2Fnm0996-998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice</span></div><div class="casAuthors">Neurath, Markus F.; Pettersson, Sven; Meyer zum Bueschenfelde, Karl-Hermann; Strober, Warren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">998-1004</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Chronic intestinal inflammation induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS) is characterized by a transmural granulomatous colitis that mimics some characteristics of human Crohn's disease.  Here, we show that the transcription factor NF-κB p65 was strongly activated in TNBS-induced colitis and in colitis of interleukin-10-deficient mice.  Local administration of p65 antisense phosphorothioate oligonucleotides abrogated clin. and histol. signs of colitis and was more effective in treating TNBS-induced colitis than single or daily administration of glucocorticoids.  The data provide direct evidence for the central importance of p65 in chronic intestinal inflammation and suggest a potential therapeutic utility of p65 antisense oligonucleotides as a novel mol. approach for the treatment of patients with Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqJYS7uBMXJLVg90H21EOLACvtfcHk0ljw6whDcuRVNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFenurg%253D&md5=dc5699b3b9e6e4160baf0ab917ca8e37</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnm0996-998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0996-998%26sid%3Dliteratum%253Aachs%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26aulast%3DPettersson%26aufirst%3DS.%26aulast%3DMeyer%2Bzum%2BBuschenfelde%26aufirst%3DK.%2BH.%26aulast%3DStrober%26aufirst%3DW.%26atitle%3DLocal%2520administration%2520of%2520antisense%2520phosphorothioate%2520oligonucleotides%2520to%2520the%2520p65%2520subunit%2520of%2520NF-kappa%2520B%2520abrogates%2520established%2520experimental%2520colitis%2520in%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1996%26volume%3D2%26spage%3D998%26epage%3D1004%26doi%3D10.1038%2Fnm0996-998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nenci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wullaert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumucio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span> <span> </span><span class="NLM_article-title">Epithelial NEMO links innate immunity to chronic intestinal inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>446</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1038/nature05698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnature05698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=17361131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsV2iur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=557-561&author=A.+Nenciauthor=C.+Beckerauthor=A.+Wullaertauthor=R.+Gareusauthor=G.+van+Looauthor=S.+Daneseauthor=M.+Huthauthor=A.+Nikolaevauthor=C.+Neufertauthor=B.+Madisonauthor=D.+Gumucioauthor=M.+F.+Neurathauthor=M.+Pasparakis&title=Epithelial+NEMO+links+innate+immunity+to+chronic+intestinal+inflammation&doi=10.1038%2Fnature05698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial NEMO links innate immunity to chronic intestinal inflammation</span></div><div class="casAuthors">Nenci, Arianna; Becker, Christoph; Wullaert, Andy; Gareus, Ralph; van Loo, Geert; Danese, Silvio; Huth, Marion; Nikolaev, Alexei; Neufert, Clemens; Madison, Blair; Gumucio, Deborah; Neurath, Markus F.; Pasparakis, Manolis</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">7135</span>),
    <span class="NLM_cas:pages">557-561</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of intestinal immune responses seems to have a principal function in the pathogenesis of inflammatory bowel disease.  The gut epithelium is critically involved in the maintenance of intestinal immune homeostasis-acting as a phys. barrier sepg. luminal bacteria and immune cells, and also expressing antimicrobial peptides.  However, the mol. mechanisms that control this function of gut epithelial cells are poorly understood.  Here we show that the transcription factor NF-κB, a master regulator of pro-inflammatory responses, functions in gut epithelial cells to control epithelial integrity and the interaction between the mucosal immune system and gut microflora.  Intestinal epithelial-cell-specific inhibition of NF-κB through conditional ablation of NEMO (also called IκB kinase-γ (IKKγ)) or both IKK1 (IKKα) and IKK2 (IKKβ)-IKK subunits essential for NF-κB activation-spontaneously caused severe chronic intestinal inflammation in mice.  NF-κB deficiency led to apoptosis of colonic epithelial cells, impaired expression of antimicrobial peptides and translocation of bacteria into the mucosa.  Concurrently, this epithelial defect triggered a chronic inflammatory response in the colon, initially dominated by innate immune cells but later also involving T lymphocytes.  Deficiency of the gene encoding the adaptor protein MyD88 prevented the development of intestinal inflammation, demonstrating that Toll-like receptor activation by intestinal bacteria is essential for disease pathogenesis in this mouse model.  Furthermore, NEMO deficiency sensitized epithelial cells to tumor-necrosis factor (TNF)-induced apoptosis, whereas TNF receptor-1 inactivation inhibited intestinal inflammation, demonstrating that TNF receptor-1 signalling is crucial for disease induction.  These findings demonstrate that a primary NF-κB signalling defect in intestinal epithelial cells disrupts immune homeostasis in the gastrointestinal tract, causing an inflammatory-bowel-disease-like phenotype.  Our results identify NF-κB signalling in the gut epithelium as a crit. regulator of epithelial integrity and intestinal immune homeostasis, and have important implications for understanding the mechanisms controlling the pathogenesis of human inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomI2IJJWF2krVg90H21EOLACvtfcHk0ljw6whDcuRVNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsV2iur4%253D&md5=d2364862e0d4b2c08489fb56d758956a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature05698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05698%26sid%3Dliteratum%253Aachs%26aulast%3DNenci%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DWullaert%26aufirst%3DA.%26aulast%3DGareus%26aufirst%3DR.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26aulast%3DDanese%26aufirst%3DS.%26aulast%3DHuth%26aufirst%3DM.%26aulast%3DNikolaev%26aufirst%3DA.%26aulast%3DNeufert%26aufirst%3DC.%26aulast%3DMadison%26aufirst%3DB.%26aulast%3DGumucio%26aufirst%3DD.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26aulast%3DPasparakis%26aufirst%3DM.%26atitle%3DEpithelial%2520NEMO%2520links%2520innate%2520immunity%2520to%2520chronic%2520intestinal%2520inflammation%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D557%26epage%3D561%26doi%3D10.1038%2Fnature05698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbulescu, K.</span></span> <span> </span><span class="NLM_article-title">Role of NF-kappaB in immune and inflammatory responses in the gut</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">856</span>– <span class="NLM_lpage">860</span>, <span class="refDoi"> DOI: 10.1136/gut.43.6.856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1136%2Fgut.43.6.856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=9824616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADyaK1cXotVagt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=856-860&author=M.+F.+Neurathauthor=C.+Beckerauthor=K.+Barbulescu&title=Role+of+NF-kappaB+in+immune+and+inflammatory+responses+in+the+gut&doi=10.1136%2Fgut.43.6.856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Role of NF-κB in immune and inflammatory responses in the gut</span></div><div class="casAuthors">Neurath, M. F.; Becker, C.; Barbulescu, K.</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">856-860</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review with 76 refs.  NF-κB is a pleiotropic transcription factor with key functions in the intestinal immune system.  NF-κB family members control transcriptional activity of various promoters of proinflammatory cytokines, cell surface receptors, transcription factors, and adhesion mols. that are involved in intestinal inflammation.  The perpetuated activation of NF-κB in patients with active inflammatory bowel disease suggests that regulation of NF-κB activity is a very attractive target for therapeutic intervention.  Such strategies include antioxidants, proteasome inhibitors, inhibition of NF-κB by adenoviral IκBα expression vectors, and antisense DNA targeting of NF-κB.  These approaches will hopefully permit the design of new treatment strategies for chronic intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnZJU348S7orVg90H21EOLACvtfcHk0ljw6whDcuRVNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVagt7o%253D&md5=57bb48c513e76e3d93e91125fbb4bce0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1136%2Fgut.43.6.856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.43.6.856%26sid%3Dliteratum%253Aachs%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DBarbulescu%26aufirst%3DK.%26atitle%3DRole%2520of%2520NF-kappaB%2520in%2520immune%2520and%2520inflammatory%2520responses%2520in%2520the%2520gut%26jtitle%3DGut%26date%3D1998%26volume%3D43%26spage%3D856%26epage%3D860%26doi%3D10.1136%2Fgut.43.6.856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khor, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">11580</span>– <span class="NLM_lpage">11584</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-3562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1158%2F0008-5472.CAN-06-3562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=17178849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlagurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=11580-11584&author=T.+O.+Khorauthor=M.+T.+Huangauthor=K.+H.+Kwonauthor=J.+Y.+Chanauthor=B.+S.+Reddyauthor=A.+N.+Kong&title=Nrf2-deficient+mice+have+an+increased+susceptibility+to+dextran+sulfate+sodium-induced+colitis&doi=10.1158%2F0008-5472.CAN-06-3562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium-Induced Colitis</span></div><div class="casAuthors">Khor, Tin Oo; Huang, Mou-Tuan; Kwon, Ki Han; Chan, Jefferson Y.; Reddy, Bandaru S.; Kong, Ah-Ng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11580-11584</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inflammatory bowel diseases, chronic inflammatory disorders, have been strongly linked with an increased risk of the development of colorectal cancer.  Understanding the etiol. of these diseases is pivotal for the improvement of currently available strategies to fight against inflammatory bowel disease, and more importantly, to prevent colorectal cancer.  Nuclear factor-erythroid 2-related factor 2 (Nrf2) has been known to be a transcriptional factor which plays a crucial role in cytoprotection against inflammation, as well as oxidative and electrophilic stresses.  The aim of this study is to investigate the role of Nrf2 in the regulation of dextran sulfate sodium (DSS)-induced exptl. colitis in mice.  Nrf2-deficient mice were found to be more susceptible to DSS-induced colitis as shown by the increased severity of colitis following 1 wk of oral administration of 1% DSS.  The increased severity of colitis in Nrf2(-/-) mice was found to be assocd. with decreased expression of antioxidant/phase II detoxifying enzymes including heme-oxygenase-1, NAD(P)H-quinone reductase-1, UDP-glucurosyltransferase 1A1, and glutathione S-transferase Mu-1.  In addn., proinflammatory mediators/cytokines such as COX-2, inducible nitric oxide synthase, interleukin 1β, interleukin 6, and tumor necrosis factor α were significantly increased in the colonic tissues of Nrf2(-/-) mice compared with their wild-type (Nrf2+/+) counterparts.  In summary, we show for the first time that mice lacking Nrf2 are more susceptible to DSS-induced colitis.  Our data suggests that Nrf2 could play an important role in protecting intestinal integrity, through regulation of proinflammatory cytokines and induction of phase II detoxifying enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiYnmui9KH6rVg90H21EOLACvtfcHk0lgW3gihUnIA-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlagurjI&md5=b40e65af2cdb7dcc412f7eece187d875</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-3562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-3562%26sid%3Dliteratum%253Aachs%26aulast%3DKhor%26aufirst%3DT.%2BO.%26aulast%3DHuang%26aufirst%3DM.%2BT.%26aulast%3DKwon%26aufirst%3DK.%2BH.%26aulast%3DChan%26aufirst%3DJ.%2BY.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DNrf2-deficient%2520mice%2520have%2520an%2520increased%2520susceptibility%2520to%2520dextran%2520sulfate%2520sodium-induced%2520colitis%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D11580%26epage%3D11584%26doi%3D10.1158%2F0008-5472.CAN-06-3562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khateb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinoco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Yoseph, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowers, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerassy-Vainberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starosvetsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen-Orr, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tessier, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronai, Z. A.</span></span> <span> </span><span class="NLM_article-title">Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3296</span>– <span class="NLM_lpage">3311</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2018.08.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1016%2Fj.celrep.2018.08.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=30232010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGnurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=3296-3311&author=Y.+Fujitaauthor=A.+Khatebauthor=Y.+Liauthor=R.+Tinocoauthor=T.+Zhangauthor=H.+Bar-Yosephauthor=M.+A.+Tamauthor=Y.+Chowersauthor=E.+Saboauthor=S.+Gerassy-Vainbergauthor=E.+Starosvetskyauthor=B.+Jamesauthor=K.+Brownauthor=S.+S.+Shen-Orrauthor=L.+M.+Bradleyauthor=P.+A.+Tessierauthor=Z.+A.+Ronai&title=Regulation+of+S100A8+Stability+by+RNF5+in+Intestinal+Epithelial+Cells+Determines+Intestinal+Inflammation+and+Severity+of+Colitis&doi=10.1016%2Fj.celrep.2018.08.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis</span></div><div class="casAuthors">Fujita, Yu; Khateb, Ali; Li, Yan; Tinoco, Roberto; Zhang, Tongwu; Bar-Yoseph, Haggai; Tam, Miguel A.; Chowers, Yehuda; Sabo, Edmond; Gerassy-Vainberg, Shiran; Starosvetsky, Elina; James, Brian; Brown, Kevin; Shen-Orr, Shai S.; Bradley, Linda M.; Tessier, Philippe A.; Ronai, Ze'ev A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3296-3311.e6</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inflammatory bowel disease (IBD) is prevalent, but the mechanisms underlying disease development remain elusive.  We identify a role for the E3 ubiquitin ligase RNF5 in IBD.  Intestinal epithelial cells (IECs) express a high level of RNF5, while the colon of Rnf5-/- mice exhibits activated dendritic cells and intrinsic inflammation.  Rnf5-/- mice exhibit severe acute colitis following dextran sodium sulfate (DSS) treatment.  S100A8 is identified as an RNF5 substrate, resulting in S100A8 ubiquitination and proteasomal-dependent degrdn. that is attenuated upon inflammatory stimuli.  Loss of RNF5 from IECs leads to enhanced S100A8 secretion, which induces mucosal CD4+ T cells, resulting in Th1 pro-inflammatory responses.  Administration of S100A8-neutralizing antibodies to DSS-treated Rnf5-/- mice attenuates acute colitis development and increases survival.  An inverse correlation between RNF5 and S100A8 protein expression in IECs of IBD patients coincides with disease severity.  Collectively, RNF5-mediated regulation of S100A8 stability in IECs is required for the maintenance of intestinal homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoduc3XXTfpmbVg90H21EOLACvtfcHk0lgW3gihUnIA-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGnurzP&md5=4844ffd3a3ee82dd88a5760d027a2f34</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.08.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.08.057%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DKhateb%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTinoco%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBar-Yoseph%26aufirst%3DH.%26aulast%3DTam%26aufirst%3DM.%2BA.%26aulast%3DChowers%26aufirst%3DY.%26aulast%3DSabo%26aufirst%3DE.%26aulast%3DGerassy-Vainberg%26aufirst%3DS.%26aulast%3DStarosvetsky%26aufirst%3DE.%26aulast%3DJames%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DShen-Orr%26aufirst%3DS.%2BS.%26aulast%3DBradley%26aufirst%3DL.%2BM.%26aulast%3DTessier%26aufirst%3DP.%2BA.%26aulast%3DRonai%26aufirst%3DZ.%2BA.%26atitle%3DRegulation%2520of%2520S100A8%2520Stability%2520by%2520RNF5%2520in%2520Intestinal%2520Epithelial%2520Cells%2520Determines%2520Intestinal%2520Inflammation%2520and%2520Severity%2520of%2520Colitis%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D24%26spage%3D3296%26epage%3D3311%26doi%3D10.1016%2Fj.celrep.2018.08.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smale, S. T.</span></span> <span> </span><span class="NLM_article-title">Hierarchies of NF-kappaB target-gene regulation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1038/ni.2070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fni.2070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=21772277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptV2ju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=689-694&author=S.+T.+Smale&title=Hierarchies+of+NF-kappaB+target-gene+regulation&doi=10.1038%2Fni.2070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchies of NF-κB target-gene regulation</span></div><div class="casAuthors">Smale, Stephen T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">689-694</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Members of the NF-κB family of transcription factors function as dominant regulators of inducible gene expression in almost all cell types in response to a broad range of stimuli, with particularly important roles in coordinating both innate and adaptive immunity.  This review summarizes the present knowledge and recent progress toward elucidating the numerous regulatory layers that confer target-gene selectivity in response to an NF-κB-inducing stimulus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGdGr_rNMfVbVg90H21EOLACvtfcHk0liaqGKGHUcYTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptV2ju7w%253D&md5=a67b0e438de67f6fbff7e28c07f4c53b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fni.2070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2070%26sid%3Dliteratum%253Aachs%26aulast%3DSmale%26aufirst%3DS.%2BT.%26atitle%3DHierarchies%2520of%2520NF-kappaB%2520target-gene%2520regulation%26jtitle%3DNat.%2520Immunol.%26date%3D2011%26volume%3D12%26spage%3D689%26epage%3D694%26doi%3D10.1038%2Fni.2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Moldes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lastres-Becker, I.</span></span> <span> </span><span class="NLM_article-title">Transcription factors NRF2 and NF-kappaB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">15244</span>– <span class="NLM_lpage">15258</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.540633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1074%2Fjbc.M113.540633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=24759106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVegur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=15244-15258&author=A.+Cuadradoauthor=Z.+Martin-Moldesauthor=J.+Yeauthor=I.+Lastres-Becker&title=Transcription+factors+NRF2+and+NF-kappaB+are+coordinated+effectors+of+the+Rho+family%2C+GTP-binding+protein+RAC1+during+inflammation&doi=10.1074%2Fjbc.M113.540633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation</span></div><div class="casAuthors">Cuadrado, Antonio; Martin-Moldes, Zaira; Ye, Jianping; Lastres-Becker, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">15244-15258</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The small GTPase protein RAC1 participates in innate immunity by activating a complex program that includes cytoskeleton remodeling, chemotaxis, activation of NADPH oxidase, and modulation of gene expression.  However, its role in regulating the transcriptional signatures that in term control the cellular inflammatory profiles are not well defined.  Here we investigated the functional and mechanistic connection between RAC1 and the transcription factor NRF2 (nuclear factor erythroid 2-related factor 2), master regulator of the anti-oxidant response.  Lipopolysaccharide and constitutively active RAC1Q61L mutant induced the anti-oxidant enzyme heme-oxygenase-1 (HO-1) through activation of NRF2.  The use of KEAP1-insensitive NRF2 mutants indicated that RAC1 regulation of NRF2 is KEAP1-independent.  Interestingly, NRF2 overexpression inhibited, whereas a dominant-neg. mutant of NRF2 exacerbated RAC1-dependent activation of nuclear factor-κB (NF-κB), suggesting that NRF2 has an antagonistic effect on the NF-κB pathway.  Moreover, we found that RAC1 acts through NF-κB to induce NRF2 because either expression of a dominant neg. mutant of IκBα that leads to NF-κB degrdn. or the use of p65-NF-κB-deficient cells demonstrated lower NRF2 protein levels and basally impaired NRF2 signature compared with control cells.  In contrast, NRF2-deficient cells showed increased p65-NF-κB protein levels, although the mRNA levels remain unchanged, indicating post-translational alterations.  Our results demonstrate a new mechanism of modulation of RAC1 inflammatory pathway through a cross-talk between NF-κB and NRF2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzn6mVIKjF27Vg90H21EOLACvtfcHk0liaqGKGHUcYTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVegur8%253D&md5=498a5a7e97daffef1cd3c415104c43d5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.540633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.540633%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DMartin-Moldes%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DLastres-Becker%26aufirst%3DI.%26atitle%3DTranscription%2520factors%2520NRF2%2520and%2520NF-kappaB%2520are%2520coordinated%2520effectors%2520of%2520the%2520Rho%2520family%252C%2520GTP-binding%2520protein%2520RAC1%2520during%2520inflammation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D15244%26epage%3D15258%26doi%3D10.1074%2Fjbc.M113.540633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzaei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macmillan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chook, Y. M.</span></span> <span> </span><span class="NLM_article-title">Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1073/pnas.1217203110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1073%2Fpnas.1217203110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23297231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFerur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=1303-1308&author=Q.+Sunauthor=Y.+P.+Carrascoauthor=Y.+Huauthor=X.+Guoauthor=H.+Mirzaeiauthor=J.+Macmillanauthor=Y.+M.+Chook&title=Nuclear+export+inhibition+through+covalent+conjugation+and+hydrolysis+of+Leptomycin+B+by+CRM1&doi=10.1073%2Fpnas.1217203110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1</span></div><div class="casAuthors">Sun, Qingxiang; Carrasco, Yazmin P.; Hu, Youcai; Guo, Xiaofeng; Mirzaei, Hamid; MacMillan, John; Chook, Yuh Min</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1303-1308, S1303/1-S1303/14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The polyketide natural product Leptomycin B (LMB) inhibits nuclear export mediated by the karyopherin protein chromosomal region maintenance 1 (CRM1).  Here, we present 1.8- to 2.0-Å-resoln. crystal structures of CRM1 bound to Leptomycin B and related inhibitors Anguinomycin A (AGA) and Ratjadone A (RJA).  Structural and complementary chem. analyses reveal an unexpected mechanism of inhibition involving covalent conjugation and CRM1-mediated hydrolysis of the natural products' lactone rings.  Furthermore, mutagenesis reveals the mechanism of hydrolysis by CRM1.  The nuclear export signal (NES)-binding groove of CRM1 is able to drive a chem. reaction in addn. to binding protein cargos for transport through the nuclear pore complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB_HH4AmBIkLVg90H21EOLACvtfcHk0liaqGKGHUcYTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFerur8%253D&md5=81c0bfa87142c65788d3229460fd3827</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217203110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217203110%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DCarrasco%26aufirst%3DY.%2BP.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DMirzaei%26aufirst%3DH.%26aulast%3DMacmillan%26aufirst%3DJ.%26aulast%3DChook%26aufirst%3DY.%2BM.%26atitle%3DNuclear%2520export%2520inhibition%2520through%2520covalent%2520conjugation%2520and%2520hydrolysis%2520of%2520Leptomycin%2520B%2520by%2520CRM1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D1303%26epage%3D1308%26doi%3D10.1073%2Fpnas.1217203110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedergran, D. J.</span></span> <span> </span><span class="NLM_article-title">Clinicopathologic study of dextran sulfate sodium experimental murine colitis</span>. <i>Lab Invest</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=8350599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADyaK2cXhs1Smtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1993&pages=238-249&author=H.+S.+Cooperauthor=S.+N.+Murthyauthor=R.+S.+Shahauthor=D.+J.+Sedergran&title=Clinicopathologic+study+of+dextran+sulfate+sodium+experimental+murine+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Clinicopathologic study of dextran sulfate sodium experimental murine colitis</span></div><div class="casAuthors">Cooper, Harry S.; Murthy, S.N.S.; Shah, Rupal S.; Sedergran, Deborah J.</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory Investigation</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-49</span>CODEN:
                <span class="NLM_cas:coden">LAINAW</span>;
        ISSN:<span class="NLM_cas:issn">0023-6837</span>.
    </div><div class="casAbstract">The authors undertook this study in order to fully characterize the clin. and histopathol. features of the dextran sulfate sodium (DSS) model of exptl. murine colitis and to discover the earliest histopathol. changes that lead to colitis.  Acute colitis was induced in Swiss-Webster mice by 7 days of oral DSS with animals sacrificed daily.  Chronic colitis was induced by: (a) 7 days of oral DSS followed by 7 days of H2O (for 1, 2, and 3 cycles) and (b) 7 days of oral DSS followed by 14 and 21 days of H2O.  In each exptl. group, the entire colons were examd. histol. and correlated with clin. symptoms.  Acute clin. symptoms (diarrhea and/or grossly bloody stool) were assocd. with the presence of erosions and inflammation.  More importantly, the earliest histol. changes which predated clin. colitis was loss of the basal one-third of the crypt (day 3), which progressed with time to loss of the entire crypt resulting in erosions on day 5.  The earliest changes were very focal and not assocd. with inflammation.  Inflammation was a secondary phenomena and only became significant after erosions appeared.  Animals treated with only 7 days of DSS followed by 14 and 21 days of H2O developed a chronic colitis with the following histol. features: areas of activity (erosions and inflammation), inactivity, crypt distortion, florid epithelial proliferation and possible dysplasia.  These changes were similar to animals given 3 cycles of DSS.  The clin. disease activity index correlated significantly with pathol. changes in both the acute and chronic phases of the disease.  The mechanism of DSS colitis is presently unknown.  However, the finding of crypt loss without proceeding or accompanying inflammation suggests that the initial insult is at the level of the epithelial cell with inflammation being a secondary phenomena.  This may be a good model to study how early mucosal changes lead to inflammation and the biol. of the colonic enterocyte.  Chronic colitis induced after only 7 days of DSS may serve as a useful model to study the effects of pharmacol. agents in human inflammatory disease and mechanisms of perpetuation of inflammation.  Finally, the authors believe that this model has the potential to study the dysplasia cancer sequence in inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8mi93BIhyJ7Vg90H21EOLACvtfcHk0ljp8vJtpfJCfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhs1Smtr0%253D&md5=e52fe592ea500787eeb7217c5722d3f4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DH.%2BS.%26aulast%3DMurthy%26aufirst%3DS.%2BN.%26aulast%3DShah%26aufirst%3DR.%2BS.%26aulast%3DSedergran%26aufirst%3DD.%2BJ.%26atitle%3DClinicopathologic%2520study%2520of%2520dextran%2520sulfate%2520sodium%2520experimental%2520murine%2520colitis%26jtitle%3DLab%2520Invest%26date%3D1993%26volume%3D69%26spage%3D238%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yuqin Lei, Yuling Li, Yuping Tan, Zhiyong Qian, Qiao Zhou, Da Jia, <span class="NLM_string-name hlFld-ContribAuthor">Qingxiang Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Mechanistic Observations and NES-Binding Groove Features Revealed by the CRM1 Inhibitors Plumbagin and Oridonin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Natural Products</span><span> <strong>2021,</strong> <em>84 </em>
                                    (5)
                                     , 1478-1488. <a href="https://doi.org/10.1021/acs.jnatprod.0c01231" title="DOI URL">https://doi.org/10.1021/acs.jnatprod.0c01231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jnatprod.0c01231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jnatprod.0c01231%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Natural%2520Products%26atitle%3DNovel%252BMechanistic%252BObservations%252Band%252BNES-Binding%252BGroove%252BFeatures%252BRevealed%252Bby%252Bthe%252BCRM1%252BInhibitors%252BPlumbagin%252Band%252BOridonin%26aulast%3DLei%26aufirst%3DYuqin%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30112020%26date%3D23042021%26volume%3D84%26issue%3D5%26spage%3D1478%26epage%3D1488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuqin Lei, Qi An, Xiao-fei Shen, Min Sui, Chungen Li, Da Jia, Youfu Luo, <span class="NLM_string-name hlFld-ContribAuthor">Qingxiang Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Design of the First Noncovalent Small-Molecule Inhibitor of CRM1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6596-6607. <a href="https://doi.org/10.1021/acs.jmedchem.0c01675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDesign%252Bof%252Bthe%252BFirst%252BNoncovalent%252BSmall-Molecule%252BInhibitor%252Bof%252BCRM1%26aulast%3DLei%26aufirst%3DYuqin%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D26102020%26date%3D11052021%26volume%3D64%26issue%3D10%26spage%3D6596%26epage%3D6607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiujiao  Gao</span>, <span class="hlFld-ContribAuthor ">Peng  Chu</span>, <span class="hlFld-ContribAuthor ">Caigang  Liu</span>, <span class="hlFld-ContribAuthor ">Zhaolin  Sun</span>, <span class="hlFld-ContribAuthor ">Quentin  Liu</span>, <span class="hlFld-ContribAuthor ">Yongliang  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and biological evaluation of a small‐molecule inhibitor of
              CRM1
              that suppresses the growth of triple‐negative breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Traffic</span><span> <strong>2021,</strong> <em>22 </em>
                                    (7)
                                     , 221-229. <a href="https://doi.org/10.1111/tra.12802" title="DOI URL">https://doi.org/10.1111/tra.12802</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/tra.12802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ftra.12802%26sid%3Dliteratum%253Aachs%26jtitle%3DTraffic%26atitle%3DDiscovery%252Band%252Bbiological%252Bevaluation%252Bof%252Ba%252Bsmall%2525E2%252580%252590molecule%252Binhibitor%252Bof%252BCRM1%252Bthat%252Bsuppresses%252Bthe%252Bgrowth%252Bof%252Btriple%2525E2%252580%252590negative%252Bbreast%252Bcancer%252Bcells%26aulast%3DGao%26aufirst%3DJiujiao%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D7%26spage%3D221%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alaa  Shaikhqasem</span>, <span class="hlFld-ContribAuthor ">Kerstin  Schmitt</span>, <span class="hlFld-ContribAuthor ">Oliver  Valerius</span>, <span class="hlFld-ContribAuthor ">Ralf  Ficner</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of human CRM1, covalently modified by 2-mercaptoethanol on Cys528, in complex with RanGTP. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section F Structural Biology Communications</span><span> <strong>2021,</strong> <em>77 </em>
                                    (3)
                                     , 70-78. <a href="https://doi.org/10.1107/S2053230X2100203X" title="DOI URL">https://doi.org/10.1107/S2053230X2100203X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2053230X2100203X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2053230X2100203X%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520F%2520Structural%2520Biology%2520Communications%26atitle%3DCrystal%252Bstructure%252Bof%252Bhuman%252BCRM1%25252C%252Bcovalently%252Bmodified%252Bby%252B2-mercaptoethanol%252Bon%252BCys528%25252C%252Bin%252Bcomplex%252Bwith%252BRanGTP%26aulast%3DShaikhqasem%26aufirst%3DAlaa%26date%3D2021%26date%3D2021%26volume%3D77%26issue%3D3%26spage%3D70%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Discovery Scheme of Small-Molecule Antagonist LFS-829</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystallographic structure of compound LFS-829 bound to CRM1. (A) Co-crystallographic structure of compound LFS-829 (green) complexed with CRM1 (cyan) at 2.60 Å resolution (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZPU">5ZPU</a>). (B) A covalent bond between Cys539 and LFS-829 was detected. (C) Electrostatic potential surface display of LFS-829 bound in the nuclear export signal (NES) cleft of CRM1. (D) SDS-PAGE analysis of the GST-NES<sup>MVM</sup> pull-down assay of various CRM1 in the presence or absence of 50 μM compound LFS-829. (E) Schematic representation shows the interaction of LFS-829 with the NES binding cleft of CRM1 (the red dash line indicates the hydrogen bonding, and the dark dash line indicates the hydrophobic pocket).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CRM1 is a major cellular target of LFS-829. (A) The SPR (surface plasmon resonance) binding assay between LFS-829 and CRM1 performed on Biacore T200 with KPT-300 as a positive control (LFS-829, <i>K</i><sub>d</sub> = 26.95 nM; KPT-330, <i>K</i><sub>d</sub> = 18.74 nM). (B) The cellular activities of LFS-829 on siCRM1-HCT-15 and the wild-type HCT-15 cell line with different concentrations of treatment for 24 h. (C) The time course of CRM1-LFS829 complex degradation determined by a cell-based phenotypic nuclear export functional assay. The localization of NES-GFP per hour was monitored by confocal microscopy after cells (293T cell line) were washed with PBS to remove the compounds. Only after two hours, NES-GFP in cells incubated with LFS-829 was almost completely translocated to the cytoplasm, indicating its reverse binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Oral administration of LFS-829 significantly ameliorates DSS-induced colitis mice as compared to 5-ASA. Oral treatment of LFS-829 was assessed by the following. (A) Survival rate. (B) Body weight. (C) Diarrhea. (D) The colon after sacrifice for each group. (E) H&E-stained results for the sections of the mouse colon. (F) The colon length determined for each group after sacrifice. (G) The DAI score for each group. (H) The histopathological score for the H&E-stained sections. Statistical analysis of the quantitative multiple group comparisons was performed using the one-way analysis of variance (ANOVA) followed by Tukeyʼs test, * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. LFS-829 exerts superior efficacy than APD334 in colitis mice in a one-week dosing schedule. (A) The change of body weight during the course of treatment by LFS-829 and APD334. (B) The DAI score during the course of treatment by LFS-829 and APD334. (C) Colon length among different treatment groups. (D) The percentage of diarrhea during the course of treatment. (E) The colon after sacrifice for the LFS-829 treatment group and APD334 treatment group. From left to right: control group, DSS model group, APD334 treatment group (10 mg/kg), and LFS-829 treatment group (10 mg/kg). (F) H&E staining of the colon section for different animal groups. (G) Immunohistochemical analysis for Occuludin expression in the intestinal epithelial layer for different animal groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Proteomics analysis of protein signatures between the DSS-induced animal group and LFS-829-treated group. Comparison of the LFS-829 treatment group signature (right) to the DSS-induced animal group protein signature profile (left) determined by proteomics techniques, showing a generally anticorrelated pattern, with genes at the top- and bottommost ends of the expression pattern, showing generally oppositional expression patterns. Protein signatures that are upregulated are shown in green. Protein signatures that are downregulated are shown in red. An adjusted [Adj] <i>p</i>-value ≤ 0.05 was considered significant. The pathways and functional groups significantly enriched (enrichment <i>P</i> < 0.05) in the top and bottom 25% of genes are shown on the right-hand side.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. LFS-829 treatment causes nuclear accumulation of IkB<sub>α</sub> and Nrf2 observed by confocal microscopy. (A) Nuclear retention of IkB<sub>α</sub> upon treatment with LFS-829. (B) Nuclear retention of Nrf2 upon treatment with LFS-829. (C, D) Quantification of the nuclear IkB<sub>α</sub> and Nrf2 ratio by fluorescence intensity per cell.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. LFS-829 treatment attenuates downstream targets of the NF-κB signaling and Nrf2 cytoprotection pathway. (A) LFS-829 treatment downregulates the expression of p65 and Cox-2. (B) LFS-829 treatment attenuates the expression of HO-1 and NQO1. (C) LFS-829 treatment regulates the expression of MRP8 and MRP14. (D) ELISA detection of cytokine production after treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Oral administration of the encapsulated form of LFS-829 (α-cyclodextrin-LFS-829, also named as CD-LFS-829) ameliorate DSS-induced colitis in model mice. (A) Modeling structure of LFS-829 encapsulated in α-cyclodextrin as a host–guest complex. (B) The scanning electron microscopy (SEM) data for the water-soluble formulation of CD-LFS-829. (C) Survival rate of different animal groups. (D) Percentage of diarrhea among different animal groups. (E) Histopathological score for the H&E-stained sections.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Evaluation of acute toxicity, gastrointestinal tract stability, and cardiotoxicity of compound LFS-829. (A) Stability test of LFS-829 in artificial gastric juice (omeprazole is an FDA-approved drug for GI disorders and routinely used as a control in the pharmacokinetic study). (B) Stability test of LFS-829 in artificial intestinal juice (chlorambucil is an FDA-approved chemotherapy for chronic leukemia and routinely used as a control in the pharmacokinetic study). (C) H&E-stained results for the sections of the mouse colon in the vehicle-treated group and LFS-829-treated group. (D) The concentration dependence curve of the LFS-829 blockade of hERG currents and the inhibition constant IC<sub>50</sub> of LFS-829 is above 30 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/medium/jm9b01663_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. LFS-829 Attenuates Dual NF-κB Signaling and Nrf2 Cytoprotection Pathway</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-8/acs.jmedchem.9b01663/20200416/images/large/jm9b01663_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01663&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i38">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaplan, G. G.</span></span> <span> </span><span class="NLM_article-title">The global burden of IBD: from 2015 to 2025</span>. <i>Nat. Rev. Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">720</span>– <span class="NLM_lpage">727</span>, <span class="refDoi"> DOI: 10.1038/nrgastro.2015.150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnrgastro.2015.150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=26323879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BC287nvFaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=720-727&author=G.+G.+Kaplan&title=The+global+burden+of+IBD%3A+from+2015+to+2025&doi=10.1038%2Fnrgastro.2015.150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of IBD: from 2015 to 2025</span></div><div class="casAuthors">Kaplan Gilaad G</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">720-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD, with substantial costs for health care.  These estimates do not factor in the 'real' price of IBD, which can impede career aspirations, instil social stigma and impair quality of life in patients.  The majority of patients are diagnosed early in life and the incidence continues to rise; therefore, the effect of IBD on health-care systems will rise exponentially.  Moreover, IBD has emerged in newly industrialized countries in Asia, South America and Middle East and has evolved into a global disease with rising prevalence in every continent.  Understanding the worldwide epidemiological patterns of IBD will prepare us to manage the burden of IBD over time.  The goal of this article is to establish the current epidemiology of IBD in the Western world, contrast it with the increase in IBD in newly industrialized countries and forecast the global effects of IBD in 2025.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI7MsrdaYm5d1QT_1O5WBYfW6udTcc2eYfeoklZkZGk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287nvFaktQ%253D%253D&md5=ef578ea867a812e30ecbdcfa52af387c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2015.150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2015.150%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DG.%2BG.%26atitle%3DThe%2520global%2520burden%2520of%2520IBD%253A%2520from%25202015%2520to%25202025%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2015%26volume%3D12%26spage%3D720%26epage%3D727%26doi%3D10.1038%2Fnrgastro.2015.150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ananthakrishnan, A. N.</span></span> <span> </span><span class="NLM_article-title">Epidemiology and risk factors for IBD</span>. <i>Nat. Rev. Gastroenterol. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">217</span>, <span class="refDoi"> DOI: 10.1038/nrgastro.2015.34</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnrgastro.2015.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=25732745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BC2Mngt12ntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=205-217&author=A.+N.+Ananthakrishnan&title=Epidemiology+and+risk+factors+for+IBD&doi=10.1038%2Fnrgastro.2015.34"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology and risk factors for IBD</span></div><div class="casAuthors">Ananthakrishnan Ashwin N</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Gastroenterology & hepatology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">205-17</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">IBD, comprising Crohn's disease and ulcerative colitis, is a chronic immunologically mediated disease at the intersection of complex interactions between genetics, environment and gut microbiota.  Established high-prevalence populations of IBD in North America and Europe experienced the steepest increase in incidence towards the second half of the twentieth century.  Furthermore, populations previously considered 'low risk' (such as in Japan and India) are witnessing an increase in incidence.  Potentially relevant environmental influences span the spectrum of life from mode of childbirth and early-life exposures (including breastfeeding and antibiotic exposure in infancy) to exposures later on in adulthood (including smoking, major life stressors, diet and lifestyle).  Data support an association between smoking and Crohn's disease whereas smoking cessation, but not current smoking, is associated with an increased risk of ulcerative colitis.  Dietary fibre (particularly fruits and vegetables), saturated fats, depression and impaired sleep, and low vitamin D levels have all been associated with incident IBD.  Interventional studies assessing the effects of modifying these risk factors on natural history and patient outcomes are an important unmet need.  In this Review, the changing epidemiology of IBD, mechanisms behind various environmental associations and interventional studies to modify risk factors and disease course are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7OoVPI85pqz0O18WR3iAofW6udTcc2eYfeoklZkZGk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mngt12ntg%253D%253D&md5=ecea9830e7648db864916c2471a37ace</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrgastro.2015.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrgastro.2015.34%26sid%3Dliteratum%253Aachs%26aulast%3DAnanthakrishnan%26aufirst%3DA.%2BN.%26atitle%3DEpidemiology%2520and%2520risk%2520factors%2520for%2520IBD%26jtitle%3DNat.%2520Rev.%2520Gastroenterol.%2520Hepatol.%26date%3D2015%26volume%3D12%26spage%3D205%26epage%3D217%26doi%3D10.1038%2Fnrgastro.2015.34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shenoy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pai, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roedder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarwal, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasricha, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butte, A. J.</span></span> <span> </span><span class="NLM_article-title">Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">96ra76</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3002648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1126%2Fscitranslmed.3002648" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=21849664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOisL3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=96ra76&author=J.+T.+Dudleyauthor=M.+Sirotaauthor=M.+Shenoyauthor=R.+K.+Paiauthor=S.+Roedderauthor=A.+P.+Chiangauthor=A.+A.+Morganauthor=M.+M.+Sarwalauthor=P.+J.+Pasrichaauthor=A.+J.+Butte&title=Computational+repositioning+of+the+anticonvulsant+topiramate+for+inflammatory+bowel+disease&doi=10.1126%2Fscitranslmed.3002648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease</span></div><div class="casAuthors">Dudley, Joel T.; Sirota, Marina; Shenoy, Mohan; Pai, Reetesh K.; Roedder, Silke; Chiang, Annie P.; Morgan, Alex A.; Sarwal, Minnie M.; Pasricha, Pankaj Jay; Butte, Atul J.</div><div class="citationInfo"><span class="NLM_cas:title">Science Translational Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">96</span>),
    <span class="NLM_cas:pages">96ra76</span>CODEN:
                <span class="NLM_cas:coden">STMCBQ</span>;
        ISSN:<span class="NLM_cas:issn">1946-6242</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract for which there are few safe and effective therapeutic options for long-term treatment and disease maintenance.  Here, we applied a computational approach to discover new drug therapies for IBD in silico, using publicly available mol. data reporting gene expression in IBD samples and 164 small-mol. drug compds.  Among the top compds. predicted to be therapeutic for IBD by our approach were prednisolone, a corticosteroid used to treat IBD, and topiramate, an anticonvulsant drug not previously described to have efficacy for IBD or any related disorders of inflammation or the gastrointestinal tract.  Using a trinitrobenzenesulfonic acid (TNBS)-induced rodent model of IBD, we exptl. validated our topiramate prediction in vivo.  Oral administration of topiramate significantly reduced gross pathol. signs and microscopic damage in primary affected colon tissue in the TNBS-induced rodent model of IBD.  These findings suggest that topiramate might serve as a therapeutic option for IBD in humans and support the use of public mol. data and computational approaches to discover new therapeutic options for disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmF-DmOnq3dLVg90H21EOLACvtfcHk0lj7kt3VCuWDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOisL3J&md5=42dd418de306427e93735180e40288a9</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3002648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3002648%26sid%3Dliteratum%253Aachs%26aulast%3DDudley%26aufirst%3DJ.%2BT.%26aulast%3DSirota%26aufirst%3DM.%26aulast%3DShenoy%26aufirst%3DM.%26aulast%3DPai%26aufirst%3DR.%2BK.%26aulast%3DRoedder%26aufirst%3DS.%26aulast%3DChiang%26aufirst%3DA.%2BP.%26aulast%3DMorgan%26aufirst%3DA.%2BA.%26aulast%3DSarwal%26aufirst%3DM.%2BM.%26aulast%3DPasricha%26aufirst%3DP.%2BJ.%26aulast%3DButte%26aufirst%3DA.%2BJ.%26atitle%3DComputational%2520repositioning%2520of%2520the%2520anticonvulsant%2520topiramate%2520for%2520inflammatory%2520bowel%2520disease%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D96ra76%26doi%3D10.1126%2Fscitranslmed.3002648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Targeting the nuclear transport machinery by rational drug design</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2318</span>– <span class="NLM_lpage">2325</span>, <span class="refDoi"> DOI: 10.2174/1381612811319120018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.2174%2F1381612811319120018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23082981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVKqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=2318-2325&author=L.+Maoauthor=Y.+Yang&title=Targeting+the+nuclear+transport+machinery+by+rational+drug+design&doi=10.2174%2F1381612811319120018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the nuclear transport machinery by rational drug design</span></div><div class="casAuthors">Mao, Lei; Yang, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2318-2325</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  CRM1 (also referred as exportin1 or Xpo1) is a key member of the importin β superfamily of nuclear transport receptors.  Its potential as therapeutic target has attracted significant attention in recent years.  CRM1 controls the transport of a no. of growth regulatory proteins and tumor suppressor proteins including p53, p21, FOXO, PI3K/AKT, Wnt/β-catenin, AP-1 and NF-kB etc.  The overexpression of CRM1 has been found to correlate with a variety of neoplastic conditions such as pancreatic and liver cancer.  In addn., CRM1 could mediate the transport of viral proteins such as Rev, an essential factor protein for HIV replication.  Moreover, CRM1 has been implicated in key steps of mitosis during cell cycles.  Over the past years, the in-depth biol. studies have rendered CRM1 as a promising clin. target.  The interference of CRM1-mediated transport machinery could lead to the effective treatment of a variety of human disease related to cell proliferation.  The aim of this paper is to summarize the research progress of CRM1 inhibitors in the late 30 years.  More importantly, we want to provide new insights for the CRM1 drug design from the perspective of mol. simulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3z4u5peS1EbVg90H21EOLACvtfcHk0lj7kt3VCuWDFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVKqtbY%253D&md5=03afff8f1fea66b329e0b7b6cb931d44</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F1381612811319120018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612811319120018%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DTargeting%2520the%2520nuclear%2520transport%2520machinery%2520by%2520rational%2520drug%2520design%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26spage%3D2318%26epage%3D2325%26doi%3D10.2174%2F1381612811319120018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.cbi.2017.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1016%2Fj.cbi.2017.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=29247643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWmu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2018&pages=11-23&author=H.+Wangauthor=F.+Wangauthor=S.+Wuauthor=Z.+Liuauthor=T.+Liauthor=L.+Maoauthor=J.+Zhangauthor=C.+Liauthor=C.+Liuauthor=Y.+Yang&title=Traditional+herbal+medicine-derived+sulforaphene+promotes+mitophagic+cell+death+in+lymphoma+cells+through+CRM1-mediated+p62%2FSQSTM1+accumulation+and+AMPK+activation&doi=10.1016%2Fj.cbi.2017.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activation</span></div><div class="casAuthors">Wang, Haina; Wang, Fuqiang; Wu, Sijin; Liu, Zhiheng; Li, Tingting; Mao, Lei; Zhang, Jie; Li, Cheng; Liu, Caigang; Yang, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-23</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Sulforaphene (LFS-01) is the major chem. constituent of Raphanus sativus, a medicinal herb used for over a thousand years in traditional Chinese medicine.  Here we identified that LFS-01 can selectively eradicate lymphoma cells while sparing normal lymphocytes by triggering concomitant mitophagy and apoptosis.  We demonstrated that LFS-01 can retain Nrf2 in the nucleus by covalently modulating CRM1 and consequently upregulate p62/SQSTM1, an essential structural component of the autophagosomes during mitophagic process.  We found that LFS-01 treatment also stimulated AMPK and thereby inhibited the mTOR pathway.  On the contrary, we revealed that AMPK inhibition can severely impair the LFS-01-mediated mitophagy.  Transcriptomic studies confirmed that 15 autophagy-assocd. genes such as p62/SQSTM1, VCP and BCL2 were differentially expressed after LFS-01 treatment.  Furthermore, protein interactome network anal. revealed that the events of apoptosis and the assembly of autophagy vacuole were significant upon LFS-01 exposure.  Lastly, we found that LFS-01 exhibited strong efficacy in xenograft mouse model yet with the lack of apparent toxicity to animals.  We concluded that LFS-01 triggered mitophagic cell death via CRM1-mediated p62 overexpression and AMPK activation.  Our findings provide new insights into the mechanism of action for LFS-01 and highlight its potential applications in treating major human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqk3O6Yv3HUKbVg90H21EOLACvtfcHk0lizbKniKIvjgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWmu7bP&md5=2838e0a8f41c316557d28aa2963a4319</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2017.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2017.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DTraditional%2520herbal%2520medicine-derived%2520sulforaphene%2520promotes%2520mitophagic%2520cell%2520death%2520in%2520lymphoma%2520cells%2520through%2520CRM1-mediated%2520p62%252FSQSTM1%2520accumulation%2520and%2520AMPK%2520activation%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2018%26volume%3D281%26spage%3D11%26epage%3D23%26doi%3D10.1016%2Fj.cbi.2017.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">655</span>– <span class="NLM_lpage">662</span>, <span class="refDoi"> DOI: 10.1111/cbdd.12905</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1111%2Fcbdd.12905" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=27863053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvVOqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=655-662&author=S.+Wuauthor=K.+Zhangauthor=H.+Qinauthor=M.+Niuauthor=W.+Zhaoauthor=M.+Yeauthor=H.+Zouauthor=Y.+Yang&title=Caffeic+acid+phenethyl+ester+%28CAPE%29+revisited%3A+Covalent+modulation+of+XPO1%2FCRM1+activities+and+implication+for+its+mechanism+of+action&doi=10.1111%2Fcbdd.12905"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Caffeic acid phenethyl ester (CAPE) revisited: Covalent modulation of XPO1/CRM1 activities and implication for its mechanism of action</span></div><div class="casAuthors">Wu, Sijin; Zhang, Keren; Qin, Hongqiang; Niu, Mingshan; Zhao, Weijie; Ye, Mingliang; Zou, Hanfa; Yang, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">655-662</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Caffeic acid phenethyl ester (CAPE) is the bioactive constituent of propolis from honeybee hives and is well known for its anti-inflammatory, anticarcinogenic, antioxidant, and immunomodulatory properties.  Here, we revisited the cellular mechanism underlying the diverse biol. effects of CAPE.  We demonstrated that exportin 1 (XPO1/CRM1), a major nuclear export receptor, is a cellular target of CAPE.  Through nuclear export functional assay, we obsd. a clear shift of XPO1 cargo proteins from a cytoplasmic localization to the nucleus when treated with CAPE.  In particular, we showed that CAPE could specifically target the non-catalytic and conserved Cys-528 residue of XPO1 through the means of mass spectrometric anal.  In addn., we demonstrated that the mutation of Cys-528 in XPO1 could rescue the nuclear export defects caused by CAPE.  Furthermore, we performed position-restraint mol. dynamics simulations to show that the Michael acceptor moiety of CAPE is the warhead to enable covalent binding with the Cys-528 residue of XPO1.  The covalent modulation of nuclear export by CAPE may explain its diverse biol. effects.  These findings may have general implications for further investigation of CAPE and its structural analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc3emljCcYzLVg90H21EOLACvtfcHk0lhTXko5T1AMiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvVOqsrg%253D&md5=ea49ace7c429483108936fbf45e505ae</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12905%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DQin%26aufirst%3DH.%26aulast%3DNiu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DCaffeic%2520acid%2520phenethyl%2520ester%2520%2528CAPE%2529%2520revisited%253A%2520Covalent%2520modulation%2520of%2520XPO1%252FCRM1%2520activities%2520and%2520implication%2520for%2520its%2520mechanism%2520of%2520action%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2017%26volume%3D89%26spage%3D655%26epage%3D662%26doi%3D10.1111%2Fcbdd.12905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice</span>. <i>Traffic</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1042</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1111/tra.12090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1111%2Ftra.12090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23829533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2lurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1042-1052&author=M.+Niuauthor=S.+Wuauthor=L.+Maoauthor=Y.+Yang&title=CRM1+is+a+cellular+target+of+curcumin%3A+new+insights+for+the+myriad+of+biological+effects+of+an+ancient+spice&doi=10.1111%2Ftra.12090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">CRM1 is a cellular target of curcumin: New insights for the myriad of biological effects of an ancient spice</span></div><div class="casAuthors">Niu, Mingshan; Wu, Sijin; Mao, Lei; Yang, Yongliang</div><div class="citationInfo"><span class="NLM_cas:title">Traffic (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1042-1052</span>CODEN:
                <span class="NLM_cas:coden">TRAFFA</span>;
        ISSN:<span class="NLM_cas:issn">1398-9219</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Curcumin is the major constituent of turmeric plant, an ancient spice widely used in Indian cuisine and traditional herbal medicine.  Recently, the potential medical use of curcumin as anti-cancer and anti-inflammatory agent has set off an upsurge in research into the mechanism for its broad biol. effects.  We showed that CRM1, an important nuclear exportin, is a cellular target of curcumin by serious exptl. and theor. investigation.  Using a nuclear export functional assay, we obsd. a clear and rapid shift of cargo proteins from a cytoplasmic localization to the nucleus when treated with curcumin or its structural analog dibenzylideneacetone (DBA).  We demonstrated that curcumin could specifically target the conserved Cys528 of CRM1 through mass spectrometric anal. and in vivo expts.  Furthermore, computational modeling has revealed that curcumin could be correctly docked into the hydrophobic pocket of CRM1 judged from shape complementarity and putative mol. interactions.  The Michael acceptor moiety on curcumin is within the appropriate distance to enable Michael reaction with Cys residue of CRM1.  More importantly, we showed that nuclear retention of FOXO1 could be obsd. in the presence of Leptomycin B (LMB) or curcumin whereas in cells expressing the CRM1-Cys528 mutant, only a cytoplasmic localization was obsd.  The inhibition of nuclear traffic by curcumin may account for its myriad of biol. effects, particularly for its therapeutic properties in cancer and inflammatory diseases.  Our findings may have important implications for further clin. investigation of curcumin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeyZF80XFocLVg90H21EOLACvtfcHk0lhTXko5T1AMiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2lurfK&md5=e01ce73d75ce025035005fca1de975d3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Ftra.12090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ftra.12090%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DCRM1%2520is%2520a%2520cellular%2520target%2520of%2520curcumin%253A%2520new%2520insights%2520for%2520the%2520myriad%2520of%2520biological%2520effects%2520of%2520an%2520ancient%2520spice%26jtitle%3DTraffic%26date%3D2013%26volume%3D14%26spage%3D1042%26epage%3D1052%26doi%3D10.1111%2Ftra.12090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landesman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calle, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cea, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tannenbaum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnetta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reagan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senapedis, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saint-Martin, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghobrial, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schey, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. C.</span></span> <span> </span><span class="NLM_article-title">CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1038/leu.2013.115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fleu.2013.115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23588715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVWktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=155-165&author=Y.+T.+Taiauthor=Y.+Landesmanauthor=C.+Acharyaauthor=Y.+Calleauthor=M.+Y.+Zhongauthor=M.+Ceaauthor=D.+Tannenbaumauthor=A.+Cagnettaauthor=M.+Reaganauthor=A.+A.+Munshiauthor=W.+Senapedisauthor=J.+R.+Saint-Martinauthor=T.+Kashyapauthor=S.+Shachamauthor=M.+Kauffmanauthor=Y.+Guauthor=L.+Wuauthor=I.+Ghobrialauthor=F.+Zhanauthor=A.+L.+Kungauthor=S.+A.+Scheyauthor=P.+Richardsonauthor=N.+C.+Munshiauthor=K.+C.+Anderson&title=CRM1+inhibition+induces+tumor+cell+cytotoxicity+and+impairs+osteoclastogenesis+in+multiple+myeloma%3A+molecular+mechanisms+and+therapeutic+implications&doi=10.1038%2Fleu.2013.115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications</span></div><div class="casAuthors">Tai, Y-T.; Landesman, Y.; Acharya, C.; Calle, Y.; Zhong, M. Y.; Cea, M.; Tannenbaum, D.; Cagnetta, A.; Reagan, M.; Munshi, A. A.; Senapedis, W.; Saint-Martin, J-R.; Kashyap, T.; Shacham, S.; Kauffman, M.; Gu, Y.; Wu, L.; Ghobrial, I.; Zhan, F.; Kung, A. L.; Schey, S. A.; Richardson, P.; Munshi, N. C.; Anderson, K. C.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-165</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The key nuclear export protein CRM1/XPO1 may represent a promising novel therapeutic target in human multiple myeloma (MM).  Here we showed that chromosome region maintenance 1 (CRM1) is highly expressed in patients with MM, plasma cell leukemia cells and increased in patient cells resistant to bortezomib treatment.  CRM1 expression also correlates with increased lytic bone and shorter survival.  Importantly, CRM1 knockdown inhibits MM cell viability.  Novel, oral, irreversible selective inhibitors of nuclear export (SINEs) targeting CRM1 (KPT-185, KPT-330) induce cytotoxicity against MM cells (ED50<200 nM), alone and cocultured with bone marrow stromal cells (BMSCs) or osteoclasts (OC).  SINEs trigger nuclear accumulation of multiple CRM1 cargo tumor suppressor proteins followed by growth arrest and apoptosis in MM cells.  They further block c-myc, Mcl-1, and nuclear factor κB (NF-κB) activity.  SINEs induce proteasome-dependent CRM1 protein degrdn.; concurrently, they upregulate CRM1, p53-targeted, apoptosis-related, anti-inflammatory and stress-related gene transcripts in MM cells.  In SCID mice with diffuse human MM bone lesions, SINEs show strong anti-MM activity, inhibit MM-induced bone lysis and prolong survival.  Moreover, SINEs directly impair osteoclastogenesis and bone resorption via blockade of RANKL-induced NF-κB and NFATc1, with minimal impact on osteoblasts and BMSCs.  These results support clin. development of SINE CRM1 antagonists to improve patient outcome in MM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYqp9GPUaiEbVg90H21EOLACvtfcHk0lhOif1eg0kTsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVWktA%253D%253D&md5=aa7f3a69285c3c5157267ef781c3b472</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fleu.2013.115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2013.115%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DY.%2BT.%26aulast%3DLandesman%26aufirst%3DY.%26aulast%3DAcharya%26aufirst%3DC.%26aulast%3DCalle%26aufirst%3DY.%26aulast%3DZhong%26aufirst%3DM.%2BY.%26aulast%3DCea%26aufirst%3DM.%26aulast%3DTannenbaum%26aufirst%3DD.%26aulast%3DCagnetta%26aufirst%3DA.%26aulast%3DReagan%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DA.%2BA.%26aulast%3DSenapedis%26aufirst%3DW.%26aulast%3DSaint-Martin%26aufirst%3DJ.%2BR.%26aulast%3DKashyap%26aufirst%3DT.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DKauffman%26aufirst%3DM.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGhobrial%26aufirst%3DI.%26aulast%3DZhan%26aufirst%3DF.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DSchey%26aufirst%3DS.%2BA.%26aulast%3DRichardson%26aufirst%3DP.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26atitle%3DCRM1%2520inhibition%2520induces%2520tumor%2520cell%2520cytotoxicity%2520and%2520impairs%2520osteoclastogenesis%2520in%2520multiple%2520myeloma%253A%2520molecular%2520mechanisms%2520and%2520therapeutic%2520implications%26jtitle%3DLeukemia%26date%3D2014%26volume%3D28%26spage%3D155%26epage%3D165%26doi%3D10.1038%2Fleu.2013.115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span> <span> </span><span class="NLM_article-title">Chromosome region maintenance-1 (CRM1) regulates apoptosis of intestinal epithelial cells via p27kip1 in Crohn’s disease</span>. <i>Clin. Res. Hepatol. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1016/j.clinre.2017.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1016%2Fj.clinre.2017.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=28286054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjt1Kgsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2017&pages=445-458&author=L.+Yanauthor=L.+Wangauthor=J.+Baiauthor=X.+Miaoauthor=W.+Zengauthor=X.+Huaauthor=R.+Niauthor=D.+Zhangauthor=Q.+Tang&title=Chromosome+region+maintenance-1+%28CRM1%29+regulates+apoptosis+of+intestinal+epithelial+cells+via+p27kip1+in+Crohn%E2%80%99s+disease&doi=10.1016%2Fj.clinre.2017.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Chromosome region maintenance-1 (CRM1) regulates apoptosis of intestinal epithelial cells via p27kip1 in Crohn's disease</span></div><div class="casAuthors">Yan, Lijun; Wang, Liang; Bai, Jian'an; Miao, Xianjing; Zeng, Weiwen; Hua, Xiumei; Ni, Runzhou; Zhang, Dongmei; Tang, Qiyun</div><div class="citationInfo"><span class="NLM_cas:title">Clinics and Research in Hepatology and Gastroenterology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">445-458</span>CODEN:
                <span class="NLM_cas:coden">CRHGAQ</span>;
        ISSN:<span class="NLM_cas:issn">2210-7401</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">To investigate the role of chromosome region maintenance-1 (CRM1) in Crohn's disease (CD) and its potential pathol. mechanisms.The expression and distribution of CRM1 in mucosal biopsies from patients with active CD and normal controls were detected by immunohistochem. (IHC).  We established a murine model of acute colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS).  Western blot was performed to investigate the expression levels of CRM1, apoptotic markers (active caspase-3 and cleaved PARP), p27kip1 and p-p27ser10.  IHC was performed to evaluate the distribution of CRM1, and double immunofluorescence (IF) was performed to evaluate the co-localization of CRM1 and active capase-3.  Cells of the human intestinal epithelial cell line HT-29 were incubated with tumor necrosis factor-α (TNF-α) to establish an apoptotic in vitro model.  Western blot was performed to det. the expression levels of CRM1, active caspase-3, cleaved PARP and p-p27ser10.  Cytoplasmic and nuclear exts. were assessed to examine the translocation of CRM1.  The interaction between CRM1 and p27kip1 was assessed by co-immunopptn. (co-IP) assays.  Furthermore, we used small interfering RNA (siRNA) to knock down the protein expression of CRM1 in HT-29 cells and then measured the expression of active caspase-3, cleaved PARP and p-p27ser10.  Flow cytometry was used to det. the effect of CRM1 on intestinal epithelial cell (IEC) apoptosis.We obsd. up-regulation of CRM1 accompanied by elevated levels of IEC apoptotic markers (active caspase-3 and cleaved PARP) and p-p27ser10 in IECs of patients with active CD and in TNBS-induced colitis model cells.  However, the expression of p27kip1 was neg. correlated with the expression patterns of CRM1, p-p27ser10 and apoptotic biochem. markers.  Co-localization of CRM1 and active caspase-3 in IECs of the TNBS group further indicated the possible involvement of CRM1 in IEC apoptosis.  By employing TNF-α-treated HT-29 cells as an in vitro IEC apoptosis model, we found that the expression levels of CRM1 and p-p27ser10 were in accordance with active caspase-3 and cleaved PARP.  In addn., immunopptn. confirmed the phys. interaction between CRM1 and p27kip1. siRNA knockdown of CRM1 significantly inhibited the phosphorylation of p27kip1 and the expression of active caspase-3 and cleaved PARP.  In addn., flow cytometry anal. also showed that silencing CRM1 by siRNA inhibited TNF-α-induced cellular apoptosis in HT-29 cells.Up-regulated CRM1 may facilitate IEC apoptosis possibly through p27kip1 in CD, indicating an important role of CRM1 in the pathophysiol. of CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8nkcXnqCB4bVg90H21EOLACvtfcHk0lhn8ZWwWD5syg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjt1Kgsb8%253D&md5=55f1e936eda2b74c2415f3087d56ab71</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.clinre.2017.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clinre.2017.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DW.%26aulast%3DHua%26aufirst%3DX.%26aulast%3DNi%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DTang%26aufirst%3DQ.%26atitle%3DChromosome%2520region%2520maintenance-1%2520%2528CRM1%2529%2520regulates%2520apoptosis%2520of%2520intestinal%2520epithelial%2520cells%2520via%2520p27kip1%2520in%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Res.%2520Hepatol.%2520Gastroenterol.%26date%3D2017%26volume%3D41%26spage%3D445%26epage%3D458%26doi%3D10.1016%2Fj.clinre.2017.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">Traditional Herbal Medicine-Derived Sulforaphene LFS-01 Reverses Colitis in Mice by Selectively Altering the Gut Microbiota and Promoting Intestinal Gamma-Delta T Cells</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">959</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.3389%2Ffphar.2017.00959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=29375374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=959&author=M.+Liauthor=J.+Gaoauthor=Y.+Tangauthor=M.+Liuauthor=S.+Wuauthor=K.+Quauthor=X.+Longauthor=H.+Liauthor=M.+Liuauthor=Y.+Liuauthor=J.+Yuanauthor=L.+Maoauthor=Y.+Liuauthor=X.+Zhengauthor=E.+Wangauthor=J.+Wangauthor=Y.+Yang&title=Traditional+Herbal+Medicine-Derived+Sulforaphene+LFS-01+Reverses+Colitis+in+Mice+by+Selectively+Altering+the+Gut+Microbiota+and+Promoting+Intestinal+Gamma-Delta+T+Cells&doi=10.3389%2Ffphar.2017.00959"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00959%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DQu%26aufirst%3DK.%26aulast%3DLong%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DTraditional%2520Herbal%2520Medicine-Derived%2520Sulforaphene%2520LFS-01%2520Reverses%2520Colitis%2520in%2520Mice%2520by%2520Selectively%2520Altering%2520the%2520Gut%2520Microbiota%2520and%2520Promoting%2520Intestinal%2520Gamma-Delta%2520T%2520Cells%26jtitle%3DFront.%2520Pharmacol.%26date%3D2018%26volume%3D8%26spage%3D959%26doi%3D10.3389%2Ffphar.2017.00959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Etchin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezovskaya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kentsis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodig, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galinsky, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klebanov, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landesman, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shacham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Look, A. T.</span></span> <span> </span><span class="NLM_article-title">Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1038/leu.2015.194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fleu.2015.194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=26202935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Fls1KrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=190-199&author=J.+Etchinauthor=J.+Monteroauthor=A.+Berezovskayaauthor=B.+T.+Leauthor=A.+Kentsisauthor=A.+L.+Christieauthor=A.+S.+Conwayauthor=W.+C.+Chenauthor=C.+Reedauthor=M.+R.+Mansourauthor=C.+E.+Ngauthor=S.+Adamiaauthor=S.+J.+Rodigauthor=I.+A.+Galinskyauthor=R.+M.+Stoneauthor=B.+Klebanovauthor=Y.+Landesmanauthor=M.+Kauffmanauthor=S.+Shachamauthor=A.+L.+Kungauthor=J.+C.+Wangauthor=A.+Letaiauthor=A.+T.+Look&title=Activity+of+a+selective+inhibitor+of+nuclear+export%2C+selinexor+%28KPT-330%29%2C+against+AML-initiating+cells+engrafted+into+immunosuppressed+NSG+mice&doi=10.1038%2Fleu.2015.194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice</span></div><div class="casAuthors">Etchin J; Berezovskaya A; Le B T; Christie A L; Conway A S; Reed C; Mansour M R; Ng C E L; Look A T; Etchin J; Look A T; Montero J; Adamia S; Galinsky I A; Stone R M; Letai A; Kentsis A; Chen W C; Wang J C Y; Chen W C; Wang J C Y; Mansour M R; Rodig S J; Klebanov B; Landesman Y; Kauffman M; Shacham S; Kung A L</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">190-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Currently available combination chemotherapy for acute myeloid leukemia (AML) often fails to result in long-term remissions, emphasizing the need for novel therapeutic strategies.  We reasoned that targeted inhibition of a prominent nuclear exporter, XPO1/CRM1, could eradicate self-renewing leukemia-initiating cells (LICs) whose survival depends on timely XPO1-mediated transport of specific protein and RNA cargoes.  Using an immunosuppressed mouse model bearing primary patient-derived AML cells, we demonstrate that selinexor (KPT-330), an oral antagonist of XPO1 that is currently in clinical trials, has strong activity against primary AML cells while sparing normal stem and progenitor cells.  Importantly, limiting dilution transplantation assays showed that this cytotoxic activity is not limited to the rapidly proliferating bulk population of leukemic cells but extends to the LICs, whose inherent drug resistance and unrestricted self-renewal capacity has been implicated in the difficulty of curing AML patients with conventional chemotherapy alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfx-eGkpq8PFUIs6wFK5xJfW6udTcc2eZr4oFzdEy8fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Fls1KrsA%253D%253D&md5=956ccb6e88e07e314a1494c1261e9f1b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fleu.2015.194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fleu.2015.194%26sid%3Dliteratum%253Aachs%26aulast%3DEtchin%26aufirst%3DJ.%26aulast%3DMontero%26aufirst%3DJ.%26aulast%3DBerezovskaya%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DB.%2BT.%26aulast%3DKentsis%26aufirst%3DA.%26aulast%3DChristie%26aufirst%3DA.%2BL.%26aulast%3DConway%26aufirst%3DA.%2BS.%26aulast%3DChen%26aufirst%3DW.%2BC.%26aulast%3DReed%26aufirst%3DC.%26aulast%3DMansour%26aufirst%3DM.%2BR.%26aulast%3DNg%26aufirst%3DC.%2BE.%26aulast%3DAdamia%26aufirst%3DS.%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DGalinsky%26aufirst%3DI.%2BA.%26aulast%3DStone%26aufirst%3DR.%2BM.%26aulast%3DKlebanov%26aufirst%3DB.%26aulast%3DLandesman%26aufirst%3DY.%26aulast%3DKauffman%26aufirst%3DM.%26aulast%3DShacham%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DWang%26aufirst%3DJ.%2BC.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DActivity%2520of%2520a%2520selective%2520inhibitor%2520of%2520nuclear%2520export%252C%2520selinexor%2520%2528KPT-330%2529%252C%2520against%2520AML-initiating%2520cells%2520engrafted%2520into%2520immunosuppressed%2520NSG%2520mice%26jtitle%3DLeukemia%26date%3D2016%26volume%3D30%26spage%3D190%26epage%3D199%26doi%3D10.1038%2Fleu.2015.194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirtz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichtner-Feigl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span> <span> </span><span class="NLM_article-title">Chemically induced mouse models of acute and chronic intestinal inflammation</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1295</span>– <span class="NLM_lpage">1309</span>, <span class="refDoi"> DOI: 10.1038/nprot.2017.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnprot.2017.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=28569761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2sXovFCqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1295-1309&author=S.+Wirtzauthor=V.+Poppauthor=M.+Kindermannauthor=K.+Gerlachauthor=B.+Weigmannauthor=S.+Fichtner-Feiglauthor=M.+F.+Neurath&title=Chemically+induced+mouse+models+of+acute+and+chronic+intestinal+inflammation&doi=10.1038%2Fnprot.2017.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically induced mouse models of acute and chronic intestinal inflammation</span></div><div class="casAuthors">Wirtz, Stefan; Popp, Vanessa; Kindermann, Markus; Gerlach, Katharina; Weigmann, Benno; Fichtner-Feigl, Stefan; Neurath, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1295-1309</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammatory bowel diseases (IBDs) result in diarrhea and abdominal pain with further potential complications such as tissue fibrosis and stenosis.  Animal models help in understanding the immunopathogenesis of IBDs and in the design of novel therapeutic concepts.  Here we present an updated version of a protocol we published in 2007 for key models of acute and chronic forms of colitis induced by 2,4,6-trinitro-benzene sulfonic acid (TNBS), oxazolone and dextran sulfate sodium (DSS).  This protocol update describes an adaptation of the existing protocol that modifies the technique.  This protocol has been used to generate improved mouse models that better reflect the nature of IBDs in humans.  In TNBS and oxazolone colitis models, topical administration of hapten reagents results in T-cell-mediated immunity against haptenized proteins and luminal antigens.  By contrast, to generate DSS colitis models, mice orally receive DSS, causing death of epithelial cells, compromising barrier function and causing subsequent inflammation.  The anal. of the acute colitis models can be performed within 1-2 wk, whereas that of the chronic models may take 2-4 mo.  The strengths of the acute models are that they are based on the anal. of short-lasting barrier alterations, innate immune effects and flares.  The advantages of the chronic models are that they may offer better insight into adaptive immunity and complications such as neoplasia and tissue fibrosis.  The protocol requires basic skills in lab. animal research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMwK4B3_nXsbVg90H21EOLACvtfcHk0lgPHRAlEqKr5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXovFCqu7o%253D&md5=f1eea8dd2b9540214ae1731453748353</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2017.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2017.044%26sid%3Dliteratum%253Aachs%26aulast%3DWirtz%26aufirst%3DS.%26aulast%3DPopp%26aufirst%3DV.%26aulast%3DKindermann%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DK.%26aulast%3DWeigmann%26aufirst%3DB.%26aulast%3DFichtner-Feigl%26aufirst%3DS.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26atitle%3DChemically%2520induced%2520mouse%2520models%2520of%2520acute%2520and%2520chronic%2520intestinal%2520inflammation%26jtitle%3DNat.%2520Protoc.%26date%3D2017%26volume%3D12%26spage%3D1295%26epage%3D1309%26doi%3D10.1038%2Fnprot.2017.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirtz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span> <span> </span><span class="NLM_article-title">Chemically induced mouse models of intestinal inflammation</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnprot.2007.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=17406617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=541-546&author=S.+Wirtzauthor=C.+Neufertauthor=B.+Weigmannauthor=M.+F.+Neurath&title=Chemically+induced+mouse+models+of+intestinal+inflammation&doi=10.1038%2Fnprot.2007.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically induced mouse models of intestinal inflammation</span></div><div class="casAuthors">Wirtz, Stefan; Neufert, Clemens; Weigmann, Benno; Neurath, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-546</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Animal models of intestinal inflammation are indispensable for our understanding of the pathogenesis of Crohn disease and ulcerative colitis, the two major forms of inflammatory bowel disease in humans.  Here, we provide protocols for establishing murine 2,4,6-trinitro benzene sulfonic acid (TNBS)-, oxazolone- and both acute and chronic dextran sodium sulfate (DSS) colitis, the most widely used chem. induced models of intestinal inflammation.  In the former two models, colitis is induced by intrarectal administration of the covalently reactive reagents TNBS/oxazolone, which are believed to induce a T-cell-mediated response against hapten-modified autologous proteins/luminal antigens.  In the DSS model, mice are subjected several days to drinking water supplemented with DSS, which seems to be directly toxic to colonic epithelial cells of the basal crypts.  The procedures for the hapten models of colitis and acute DSS colitis can be accomplished in about 2 wk but the protocol for chronic DSS colitis takes about 2 mo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-D9fB-7WMbVg90H21EOLACvtfcHk0lgPHRAlEqKr5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbnL&md5=7a3c29eaca8be756e3d866e23e151fdf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.41%26sid%3Dliteratum%253Aachs%26aulast%3DWirtz%26aufirst%3DS.%26aulast%3DNeufert%26aufirst%3DC.%26aulast%3DWeigmann%26aufirst%3DB.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26atitle%3DChemically%2520induced%2520mouse%2520models%2520of%2520intestinal%2520inflammation%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26spage%3D541%26epage%3D546%26doi%3D10.1038%2Fnprot.2007.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buzard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thoresen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ullman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbaoui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montalban, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sage, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semple, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barden, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usmani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopher, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thatte, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whelan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shamma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gatlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidarov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behan, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1313</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/ml500389m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500389m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLnE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1313-1317&author=D.+J.+Buzardauthor=S.+H.+Kimauthor=L.+Lopezauthor=A.+Kawasakiauthor=X.+Zhuauthor=J.+Moodyauthor=L.+Thoresenauthor=I.+Calderonauthor=B.+Ullmanauthor=S.+Hanauthor=J.+Lehmannauthor=T.+Gharbaouiauthor=D.+Senguptaauthor=L.+Calvanoauthor=A.+G.+Montalbanauthor=Y.+A.+Maauthor=C.+Sageauthor=Y.+Gaoauthor=G.+Sempleauthor=J.+Edwardsauthor=J.+Bardenauthor=M.+Morganauthor=W.+Chenauthor=K.+Usmaniauthor=C.+Chenauthor=A.+Sadequeauthor=R.+J.+Christopherauthor=J.+Thatteauthor=L.+Fuauthor=M.+Solomonauthor=D.+Millsauthor=K.+Whelanauthor=H.+Al-Shammaauthor=J.+Gatlinauthor=M.+Leauthor=I.+Gaidarovauthor=T.+Anthonyauthor=D.+J.+Unettauthor=A.+Blackburnauthor=J.+Rueterauthor=S.+Stirnauthor=D.+P.+Behanauthor=R.+M.+Jones&title=Discovery+of+APD334%3A+Design+of+a+Clinical+Stage+Functional+Antagonist+of+the+Sphingosine-1-phosphate-1+Receptor&doi=10.1021%2Fml500389m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor</span></div><div class="casAuthors">Buzard, Daniel J.; Kim, Sun Hee; Lopez, Luis; Kawasaki, Andrew; Zhu, Xiuwen; Moody, Jeanne; Thoresen, Lars; Calderon, Imelda; Ullman, Brett; Han, Sangdon; Lehmann, Juerg; Gharbaoui, Tawfik; Sengupta, Dipanjan; Calvano, Lorene; Montalban, Antonio Garrido; Ma, You-An; Sage, Carleton; Gao, Yinghong; Semple, Graeme; Edwards, Jeff; Barden, Jeremy; Morgan, Michael; Chen, Weichao; Usmani, Khawja; Chen, Chuan; Sadeque, Abu; Christopher, Ronald J.; Thatte, Jayant; Fu, Lixia; Solomon, Michelle; Mills, David; Whelan, Kevin; Al-Shamma, Hussien; Gatlin, Joel; Le, Minh; Gaidarov, Ibragim; Anthony, Todd; Unett, David J.; Blackburn, Anthony; Rueter, Jaimie; Stirn, Scott; Behan, Dominic P.; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1313-1317</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">APD334 I was discovered as part of the internal effort to identify potent, centrally available, functional antagonists of the S1P1 receptor for use as next generation therapeutics for treating multiple sclerosis (MS) and other autoimmune diseases.  I is a potent functional antagonist of S1P1 and has a favorable PK/PD profile, producing robust lymphocyte lowering at relatively low plasma concns. in several preclin. species.  This new agent was efficacious in a mouse exptl. autoimmune encephalomyelitis model of MS and a rat collagen induced arthritis model and was found to have appreciable central exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_ikF-8Xd3ibVg90H21EOLACvtfcHk0lifFWI9PQMpFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGlsLnE&md5=1e44d556d856ea6f87883b3a535e554c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml500389m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500389m%26sid%3Dliteratum%253Aachs%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLopez%26aufirst%3DL.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DMoody%26aufirst%3DJ.%26aulast%3DThoresen%26aufirst%3DL.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DUllman%26aufirst%3DB.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DSengupta%26aufirst%3DD.%26aulast%3DCalvano%26aufirst%3DL.%26aulast%3DMontalban%26aufirst%3DA.%2BG.%26aulast%3DMa%26aufirst%3DY.%2BA.%26aulast%3DSage%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DBarden%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DUsmani%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChristopher%26aufirst%3DR.%2BJ.%26aulast%3DThatte%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DL.%26aulast%3DSolomon%26aufirst%3DM.%26aulast%3DMills%26aufirst%3DD.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DGatlin%26aufirst%3DJ.%26aulast%3DLe%26aufirst%3DM.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DAnthony%26aufirst%3DT.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DRueter%26aufirst%3DJ.%26aulast%3DStirn%26aufirst%3DS.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520APD334%253A%2520Design%2520of%2520a%2520Clinical%2520Stage%2520Functional%2520Antagonist%2520of%2520the%2520Sphingosine-1-phosphate-1%2520Receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D1313%26epage%3D1317%26doi%3D10.1021%2Fml500389m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dassopoulos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cope, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brant, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayless, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmigiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarti, S.</span></span> <span> </span><span class="NLM_article-title">Genome-wide gene expression differences in Crohn’s disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis</span>. <i>Inflamm Bowel Dis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">807</span>– <span class="NLM_lpage">821</span>, <span class="refDoi"> DOI: 10.1002/ibd.20110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1002%2Fibd.20110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=17262812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BD2szitFCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=807-821&author=F.+Wuauthor=T.+Dassopoulosauthor=L.+Copeauthor=A.+Maitraauthor=S.+R.+Brantauthor=M.+L.+Harrisauthor=T.+M.+Baylessauthor=G.+Parmigianiauthor=S.+Chakravarti&title=Genome-wide+gene+expression+differences+in+Crohn%E2%80%99s+disease+and+ulcerative+colitis+from+endoscopic+pinch+biopsies%3A+insights+into+distinctive+pathogenesis&doi=10.1002%2Fibd.20110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis</span></div><div class="casAuthors">Wu Feng; Dassopoulos Themistocles; Cope Leslie; Maitra Anirban; Brant Steven R; Harris Mary L; Bayless Theodore M; Parmigiani Giovanni; Chakravarti Shukti</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">807-21</span>
        ISSN:<span class="NLM_cas:issn">1078-0998</span>.
    </div><div class="casAbstract">BACKGROUND:  Ulcerative colitis (UC) and Crohn's disease (CD) are inflammatory bowel diseases (IBD) with variable, overlapping clinical features and complex pathophysiologies.  METHODS:  To identify pathogenic processes underlying these disease subtypes, we used single endoscopic pinch biopsies to elucidate patterns of gene expression in active and inactive areas of UC and CD and compared these to infectious colitis and healthy control samples.  RESULTS:  Unsupervised classification of a total of 36 samples yielded promising separation between the affected IBD, unaffected IBD, non-IBD colitis, and normal control samples, suggesting each sample type had a distinctive gene expression pattern.  Genes differentially expressed in the CD samples compared to in the controls were related to IFNgamma-inducible TH1 processes (IFITM1, IFITM3, STAT1, and STAT3) and antigen presentation (TAP1, PSME2, PSMB8).  The most noticeable change in the UC samples was reduced expression of genes regulating biosynthesis, metabolism, and electrolyte transport (HNF4G, KLF5, AQP8, ATP2B1, and SLC16A).  Twenty-five percent of genes down-regulated in the UC samples were also down-regulated in the infectious colitis samples.  Unaffected biopsy samples of IBD patients also registered differences expression of genes compared to in the normal controls.  Of these differentially expressed genes, only 2 were up-regulated, PSKH1, a regulator of mRNA processing, and PPID, a suppressor of apoptosis.  CONCLUSIONS:  The study shows that the gene expression patterns of IBD, CD in particular, are quite different from those of infectious colitis, highlighting distinctive expression of genes and pathways in UC and CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReNUVw0kIPZjMsgLhIoICsfW6udTcc2ea03ots0dePJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szitFCqtg%253D%253D&md5=7623b44f78750fbf1c64f030e2a371c2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fibd.20110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fibd.20110%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DF.%26aulast%3DDassopoulos%26aufirst%3DT.%26aulast%3DCope%26aufirst%3DL.%26aulast%3DMaitra%26aufirst%3DA.%26aulast%3DBrant%26aufirst%3DS.%2BR.%26aulast%3DHarris%26aufirst%3DM.%2BL.%26aulast%3DBayless%26aufirst%3DT.%2BM.%26aulast%3DParmigiani%26aufirst%3DG.%26aulast%3DChakravarti%26aufirst%3DS.%26atitle%3DGenome-wide%2520gene%2520expression%2520differences%2520in%2520Crohn%25E2%2580%2599s%2520disease%2520and%2520ulcerative%2520colitis%2520from%2520endoscopic%2520pinch%2520biopsies%253A%2520insights%2520into%2520distinctive%2520pathogenesis%26jtitle%3DInflamm%2520Bowel%2520Dis%26date%3D2007%26volume%3D13%26spage%3D807%26epage%3D821%26doi%3D10.1002%2Fibd.20110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holgersen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutlu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serikawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holm, T. L.</span></span> <span> </span><span class="NLM_article-title">High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis</span>. <i>J. Crohns Colitis</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">492</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1093/ecco-jcc/jjv050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1093%2Fecco-jcc%2Fjjv050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=25795566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmsFaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=492-506&author=K.+Holgersenauthor=B.+Kutluauthor=B.+Foxauthor=K.+Serikawaauthor=J.+Lordauthor=A.+K.+Hansenauthor=T.+L.+Holm&title=High-resolution+gene+expression+profiling+using+RNA+sequencing+in+patients+with+inflammatory+bowel+disease+and+in+mouse+models+of+colitis&doi=10.1093%2Fecco-jcc%2Fjjv050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis</span></div><div class="casAuthors">Holgersen Kristine; Kutlu Burak; Fox Brian; Serikawa Kyle; Lord James; Hansen Axel Kornerup; Holm Thomas Lindebo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Crohn's & colitis</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">492-506</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND AIMS:  Proper interpretation of data from preclinical animal studies requires thorough knowledge of the pathophysiology of both the human disease and animal models.  In this study, the expression of inflammatory bowel disease [IBD]-associated genes was characterised in mouse models of colitis to examine the underlying molecular pathways and assess the similarity between the experimental models and human disease.  METHODS:  RNA sequencing was performed on colon biopsies from Crohn's disease [CD] patients, ulcerative colitis [UC] patients and non-IBD controls.  Genes shown to be significantly dysregulated in human IBD were used to study gene expression in colons from a piroxicam-accelerated colitis interleukin-10 knockout [PAC IL-10 k.o.], an adoptive transfer [AdTr] and a dextran sulfate sodium [DSS] colitis mouse model.  RESULTS:  Of 115 literature-defined genes linked to IBD, 92 were significantly differentially expressed in inflamed mucosa of CD and/or UC patients compared with non-IBD controls.  The most upregulated genes were shared by both diseases, including REG1A, LCN2, NOS2, CXCL1-2, and S100A9.  Of those 92 IBD-associated genes, 71 [77%] were significantly dysregulated in PAC IL-10 k.o. mice, whereas 59 [64%] were significantly dysregulated in AdTr mice compared with wild-type controls.  Some of the most upregulated genes, including S100a8-9, Nos2, and Lcn2, were shared by the colitis models and correlated with disease activity.  CONCLUSIONS:  IBD and experimental murine colitis have a high degree of similarity in the colonic transcriptional profile, probably secondary to non-specific inflammatory processes.  However, differences do exist between models, emphasising the need for careful selection and interpretation of qualified animal models in preclinical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTY-92jPa75bmgRQsDqrjW_fW6udTcc2eZ8C3rLyN3gN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmsFaktQ%253D%253D&md5=2bddec9f8e9c76b76720517aa1abc02e</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Fecco-jcc%2Fjjv050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fecco-jcc%252Fjjv050%26sid%3Dliteratum%253Aachs%26aulast%3DHolgersen%26aufirst%3DK.%26aulast%3DKutlu%26aufirst%3DB.%26aulast%3DFox%26aufirst%3DB.%26aulast%3DSerikawa%26aufirst%3DK.%26aulast%3DLord%26aufirst%3DJ.%26aulast%3DHansen%26aufirst%3DA.%2BK.%26aulast%3DHolm%26aufirst%3DT.%2BL.%26atitle%3DHigh-resolution%2520gene%2520expression%2520profiling%2520using%2520RNA%2520sequencing%2520in%2520patients%2520with%2520inflammatory%2520bowel%2520disease%2520and%2520in%2520mouse%2520models%2520of%2520colitis%26jtitle%3DJ.%2520Crohns%2520Colitis%26date%3D2015%26volume%3D9%26spage%3D492%26epage%3D506%26doi%3D10.1093%2Fecco-jcc%2Fjjv050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khor, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1485</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2008.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1016%2Fj.bcp.2008.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=18694732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2qtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2008&pages=1485-1489&author=W.+Liauthor=T.+O.+Khorauthor=C.+Xuauthor=G.+Shenauthor=W.+S.+Jeongauthor=S.+Yuauthor=A.+N.+Kong&title=Activation+of+Nrf2-antioxidant+signaling+attenuates+NFkappaB-inflammatory+response+and+elicits+apoptosis&doi=10.1016%2Fj.bcp.2008.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosis</span></div><div class="casAuthors">Li, Wenge; Khor, Tin Oo; Xu, Changjiang; Shen, Guoxiang; Jeong, Woo-Sik; Yu, Siwang; Kong, Ah-Ng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1485-1489</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress has been implicated in the etiol. of neurodegenerative disease, cancer and aging.  Indeed, accumulation of reactive oxygen and nitrogen species generated by inflammatory cells that created oxidative stress is thought to be one of the major factor by which chronic inflammation contributes to neoplastic transformation as well as many other diseases.  We have recently reported that mice lacking nuclear factor-erythroid 2-related factor 2 (Nrf2) are more susceptible to dextran sulfate sodium (DSS)-induced colitis and colorectal carcinogenesis.  Nrf2 is a basic leucine zipper redox-sensitive transcriptional factor that plays a center role in ARE (antioxidant response element)-mediated induction of phase II detoxifying and antioxidant enzymes.  We found that increased susceptibility of Nrf2 deficient mice to DSS-induced colitis and colorectal cancer was assocd. with decreased expression of antioxidant/phase II detoxifying enzymes in parallel with upregulation of pro-inflammatory cytokines/biomarkers.  These findings suggest that Nrf2 may play an important role in defense against oxidative stress possibly by activation of cellular antioxidant machinery as well as suppression of pro-inflammatory signaling pathways.  In addn., in vivo and in vitro data generated from our lab. suggest that many dietary compds. can differentially regulate Nrf2-mediated antioxidant/anti-inflammatory signaling pathways as the first line defense or induce apoptosis once the cells have been damaged.  In this review, we will summarize our thoughts on the potential cross-talks between Nrf2 and NFκB pathways.  Although the mechanisms involved in the cross-talk between these signaling pathways are still illusive, targeting Nrf2-antioxidative stress signaling is an ideal strategy to prevent or treat oxidative stress-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqacAYKm_OYALVg90H21EOLACvtfcHk0lg-amPnoBxTBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2qtLfI&md5=c441c1224ecf7885104ffe7a8cf806d6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2008.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2008.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DKhor%26aufirst%3DT.%2BO.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DShen%26aufirst%3DG.%26aulast%3DJeong%26aufirst%3DW.%2BS.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DActivation%2520of%2520Nrf2-antioxidant%2520signaling%2520attenuates%2520NFkappaB-inflammatory%2520response%2520and%2520elicits%2520apoptosis%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2008%26volume%3D76%26spage%3D1485%26epage%3D1489%26doi%3D10.1016%2Fj.bcp.2008.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khor, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer</span>. <i>Cancer Prev. Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1158/1940-6207.CAPR-08-0028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1158%2F1940-6207.CAPR-08-0028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=19138955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVyruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=187-191&author=T.+O.+Khorauthor=M.+T.+Huangauthor=A.+Prawanauthor=Y.+Liuauthor=X.+Haoauthor=S.+Yuauthor=W.+K.+Cheungauthor=J.+Y.+Chanauthor=B.+S.+Reddyauthor=C.+S.+Yangauthor=A.+N.+Kong&title=Increased+susceptibility+of+Nrf2+knockout+mice+to+colitis-associated+colorectal+cancer&doi=10.1158%2F1940-6207.CAPR-08-0028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer</span></div><div class="casAuthors">Khor, Tin Oo; Huang, Mou-Tuan; Prawan, Auemduan; Liu, Yue; Hao, Xingpei; Yu, Siwang; Cheung, William Ka Lung; Chan, Jefferson Y.; Reddy, Bandaru S.; Yang, Chung S.; Kong, Ah-Ng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Prevention Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-191</span>CODEN:
                <span class="NLM_cas:coden">CPRACC</span>;
        ISSN:<span class="NLM_cas:issn">1940-6207</span>.
    
            (<span class="NLM_cas:orgname">American Association of Cancer Research</span>)
        </div><div class="casAbstract">The nuclear factor-erythroid 2-related factor 2 (Nrf2) plays a crit. role in protecting various tissues against inflammation, which is a potential risk factor for colorectal and other cancers.  Our previously published mouse model work showed that Nrf2 helps protect against dextran sulfate sodium (DSS)-induced colitis/inflammation, and others have shown that Nrf2 helps protect against inflammation-assocd. colorectal carcinogenesis (aberrant crypt foci).  The present study extended these important earlier findings by exploring the role of Nrf2 in colitis-assocd. colorectal cancer in a mouse model involving azoxymethane/DSS-induced colorectal carcinogenesis in Nrf2 knockout mice.  Azoxymethane/DSS-treated Nrf2 knockout mice had increased incidence, multiplicity, and size of all colorectal tumors, including adenomas, vs. treated wild-type (WT) mice, and the proportion of tumors that were adenocarcinoma was much higher in knockout (80%) vs. WT (29%) mice.  Compared with WT mice, knockout mice also had increased markers of inflammation in tumor tissue (cyclooxygenase-2 and 5-lipoxygenase expressions and prostaglandin E2 and leukotriene B4 levels) and in inflamed colonic mucosa (nitrotyrosine expression), supporting the assocn. of knockout mouse tumor formation with inflammation.  The phase II detoxifying/antioxidant enzymes NAD(P)H-quinone reductase 1 and UDP-glucurosyltransferase 1A1 were elevated in the normal mucosa of WT, but not Nrf 2 knockout, mice treated with azoxymethane/DSS.  Our findings show that Nrf2 plays a crit. role in protecting against inflammation-assocd. colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl9iv4xHJX_LVg90H21EOLACvtfcHk0lg-amPnoBxTBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVyruro%253D&md5=8d5e102c6226f0e71bb73cad8aacf451</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1940-6207.CAPR-08-0028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1940-6207.CAPR-08-0028%26sid%3Dliteratum%253Aachs%26aulast%3DKhor%26aufirst%3DT.%2BO.%26aulast%3DHuang%26aufirst%3DM.%2BT.%26aulast%3DPrawan%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DW.%2BK.%26aulast%3DChan%26aufirst%3DJ.%2BY.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DYang%26aufirst%3DC.%2BS.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DIncreased%2520susceptibility%2520of%2520Nrf2%2520knockout%2520mice%2520to%2520colitis-associated%2520colorectal%2520cancer%26jtitle%3DCancer%2520Prev.%2520Res.%26date%3D2008%26volume%3D1%26spage%3D187%26epage%3D191%26doi%3D10.1158%2F1940-6207.CAPR-08-0028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sands, B. E.</span></span> <span> </span><span class="NLM_article-title">Biomarkers of Inflammation in Inflammatory Bowel Disease</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>149</i></span>,  <span class="NLM_fpage">1275</span>– <span class="NLM_lpage">1285</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2015.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1053%2Fj.gastro.2015.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=26166315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFygsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2015&pages=1275-1285&author=B.+E.+Sands&title=Biomarkers+of+Inflammation+in+Inflammatory+Bowel+Disease&doi=10.1053%2Fj.gastro.2015.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">biomarkers of inflammation in inflammatory bowel disease</span></div><div class="casAuthors">Sands, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1275-1285.e2</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Recent observations suggest that subjective measures of disease activity in inflammatory bowel disease (IBD) are often misleading.  Objective measures of inflammation are more closely assocd. with important long-term outcomes, but often depend upon invasive and costly procedures such as ileocolonoscopy and cross-sectional imaging by computed tomog. or magnetic resonance imaging.  Noninvasive, accurate, and inexpensive measures of intestinal inflammation would allow clinicians to adopt widely the paradigm of adjusting therapies with a goal of controlling inflammation.  Blood, stool, and urine markers have all been explored as indicators of intestinal inflammation in IBD, and although none has been universally adopted, some have been well-characterized, and others hold great promise.  Serum C-reactive protein and fecal calprotectin are among the best-studied noninvasive biomarkers of inflammation in IBD, and their test characteristics have been described in the setting of differentiating IBD from irritable bowel syndrome, for grading inflammation, to describe the response to therapy, and in demonstrating recurrent inflammation after medical or surgically induced remission.  High-throughput research platforms, including gene expression arrays, metabolomics and proteomics, are also being applied to the discovery of novel biomarkers of inflammation.  It is certain that biomarkers of inflammation will attain growing importance in the clinic as we strive for more effective and cost-effective strategies to treat patients with IBD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKm5-GLEf6XbVg90H21EOLACvtfcHk0lgt5m4SbiqxEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFygsr3J&md5=c83cd9c17316a67748b940ded53f4f3a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2015.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2015.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DSands%26aufirst%3DB.%2BE.%26atitle%3DBiomarkers%2520of%2520Inflammation%2520in%2520Inflammatory%2520Bowel%2520Disease%26jtitle%3DGastroenterology%26date%3D2015%26volume%3D149%26spage%3D1275%26epage%3D1285%26doi%3D10.1053%2Fj.gastro.2015.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, D.</span></span> <span> </span><span class="NLM_article-title">Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1393</span>– <span class="NLM_lpage">1407</span>, <span class="refDoi"> DOI: 10.1517/17425247.2012.730517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1517%2F17425247.2012.730517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23036075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFCgsbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=1393-1407&author=B.+Xiaoauthor=D.+Merlin&title=Oral+colon-specific+therapeutic+approaches+toward+treatment+of+inflammatory+bowel+disease&doi=10.1517%2F17425247.2012.730517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease</span></div><div class="casAuthors">Xiao, Bo; Merlin, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1393-1407</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Inflammatory bowel disease (IBD) is a chronic relapsing idiopathic disease.  In clin. terms, most patients require lifelong medication assocd. with possible unpleasant adverse effects.  Oral colon-specific drug delivery systems are designed to deliver therapeutic drugs to the inflamed colon to target pathophysiol. manifestations of IBD.  The aim is to maintain the drug with proper concn. in the inflamed colon, to enhance drug residence time and to minimize drug absorption by healthy tissues.  Areas covered: This review addresses the main barriers for colon-specific drug delivery from organism, tissue and cell levels, resp.  It also summarizes novel colon-specific therapeutic strategies using microparticles and nanoparticles.  Expert opinion: Oral colon-specific drug delivery represents a possible approach toward efficient treatment of IBD.  As the environment of the gastrointestinal tract is harsh and intricate, this approach requires that drug carriers can respond to specific environmental factors of the inflamed colon, permitting stimulus-responsive release of loaded drugs to specific cells or even into specific organelles within cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB-fbULoB6WbVg90H21EOLACvtfcHk0lgt5m4SbiqxEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFCgsbfM&md5=f5c53683fb88ac93711ac2373c503b0a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1517%2F17425247.2012.730517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425247.2012.730517%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DB.%26aulast%3DMerlin%26aufirst%3DD.%26atitle%3DOral%2520colon-specific%2520therapeutic%2520approaches%2520toward%2520treatment%2520of%2520inflammatory%2520bowel%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2012%26volume%3D9%26spage%3D1393%26epage%3D1407%26doi%3D10.1517%2F17425247.2012.730517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mladenka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Applova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patocka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remiao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mladenka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlickova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahodar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voprsalova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varner, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterba, M.</span></span> <span> </span><span class="NLM_article-title">Comprehensive review of cardiovascular toxicity of drugs and related agents</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1332</span>– <span class="NLM_lpage">1403</span>, <span class="refDoi"> DOI: 10.1002/med.21476</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1002%2Fmed.21476" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=29315692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1SmsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=1332-1403&author=P.+Mladenkaauthor=L.+Applovaauthor=J.+Patockaauthor=V.+M.+Costaauthor=F.+Remiaoauthor=J.+Pourovaauthor=A.+Mladenkaauthor=J.+Karlickovaauthor=L.+Jahodarauthor=M.+Voprsalovaauthor=K.+J.+Varnerauthor=M.+Sterba&title=Comprehensive+review+of+cardiovascular+toxicity+of+drugs+and+related+agents&doi=10.1002%2Fmed.21476"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive review of cardiovascular toxicity of drugs and related agents</span></div><div class="casAuthors">Mladenka, Premysl; Applova, Lenka; Patocka, Jiri; Costa, Vera Marisa; Remiao, Fernando; Pourova, Jana; Mladenka, Ales; Karlickova, Jana; Jahodar, Ludek; Voprsalova, Marie; Varner, Kurt J.; Sterba, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1332-1403</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Cardiovascular diseases are a leading cause of morbidity and mortality in most developed countries of the world.  Pharmaceuticals, illicit drugs, and toxins can significantly contribute to the overall cardiovascular burden and thus deserve attention.  The present article is a systematic overview of drugs that may induce distinct cardiovascular toxicity.  The compds. are classified into agents that have significant effects on the heart, blood vessels, or both.  The mechanism(s) of toxic action are discussed and treatment modalities are briefly mentioned in relevant cases.  Due to the large no. of clin. relevant compds. discussed, this article could be of interest to a broad audience including pharmacologists and toxicologists, pharmacists, physicians, and medicinal chemists.  Particular emphasis is given to clin. relevant topics including the cardiovascular toxicity of illicit sympathomimetic drugs (e.g., cocaine, amphetamines, cathinones), drugs that prolong the QT interval, antidysrhythmic drugs, digoxin and other cardioactive steroids, beta-blockers, calcium channel blockers, female hormones, nonsteroidal anti-inflammatory, and anticancer compds. encompassing anthracyclines and novel targeted therapy interfering with the HER2 or the vascular endothelial growth factor pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8r0vImKjog7Vg90H21EOLACvtfcHk0lgt5m4SbiqxEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1SmsrnK&md5=f35f6341f689366c0c810b9f30c2c7ad</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fmed.21476&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21476%26sid%3Dliteratum%253Aachs%26aulast%3DMladenka%26aufirst%3DP.%26aulast%3DApplova%26aufirst%3DL.%26aulast%3DPatocka%26aufirst%3DJ.%26aulast%3DCosta%26aufirst%3DV.%2BM.%26aulast%3DRemiao%26aufirst%3DF.%26aulast%3DPourova%26aufirst%3DJ.%26aulast%3DMladenka%26aufirst%3DA.%26aulast%3DKarlickova%26aufirst%3DJ.%26aulast%3DJahodar%26aufirst%3DL.%26aulast%3DVoprsalova%26aufirst%3DM.%26aulast%3DVarner%26aufirst%3DK.%2BJ.%26aulast%3DSterba%26aufirst%3DM.%26atitle%3DComprehensive%2520review%2520of%2520cardiovascular%2520toxicity%2520of%2520drugs%2520and%2520related%2520agents%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2018%26volume%3D38%26spage%3D1332%26epage%3D1403%26doi%3D10.1002%2Fmed.21476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hueber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sands, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewitzky, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandemeulebroecke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinisch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehkamp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feagan, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karczewski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karczewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pezous, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellgard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertolino, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tougas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travis, S. P.</span></span> <span> </span><span class="NLM_article-title">Secukinumab in Crohn’s Disease Study, G. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: unexpected results of a randomised, double-blind placebo-controlled trial</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1700</span>, <span class="refDoi"> DOI: 10.1136/gutjnl-2011-301668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1136%2Fgutjnl-2011-301668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=22595313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFOitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=1693-1700&author=W.+Hueberauthor=B.+E.+Sandsauthor=S.+Lewitzkyauthor=M.+Vandemeulebroeckeauthor=W.+Reinischauthor=P.+D.+Higginsauthor=J.+Wehkampauthor=B.+G.+Feaganauthor=M.+D.+Yaoauthor=M.+Karczewskiauthor=J.+Karczewskiauthor=N.+Pezousauthor=S.+Bekauthor=G.+Bruinauthor=B.+Mellgardauthor=C.+Bergerauthor=M.+Londeiauthor=A.+P.+Bertolinoauthor=G.+Tougasauthor=S.+P.+Travis&title=Secukinumab+in+Crohn%E2%80%99s+Disease+Study%2C+G.+Secukinumab%2C+a+human+anti-IL-17A+monoclonal+antibody%2C+for+moderate+to+severe+Crohn%E2%80%99s+disease%3A+unexpected+results+of+a+randomised%2C+double-blind+placebo-controlled+trial&doi=10.1136%2Fgutjnl-2011-301668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial</span></div><div class="casAuthors">Hueber, Wolfgang; Sands, Bruce E.; Lewitzky, Steve; Vandemeulebroecke, Marc; Reinisch, Walter; Higgins, Peter D. R.; Wehkamp, Jan; Feagan, Brian G.; Yao, Michael D.; Karczewski, Marek; Karczewski, Jacek; Pezous, Nicole; Bek, Stephan; Bruin, Gerard; Mellgard, Bjoern; Berger, Claudia; Londei, Marco; Bertolino, Arthur P.; Tougas, Gervais; Travis, Simon P. L.</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1693-1700</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objective The authors tested whether the anti-interleukin (IL)-17A monoclonal antibody secukinumab was safe and effective for the treatment of active Crohn's disease.  Design In a double-blind, randomized, placebo-controlled proof-of-concept study, 59 patients with moderate to severe Crohn's disease (Crohn's Disease Activity Index (CDAI) ≥220 to ≤450) were assigned in a 2:1 ratio to 2×10 mg/kg i.v. secukinumab or placebo.  The primary end point, addressed by Bayesian statistics augmented with historical placebo information, was the probability that secukinumab reduces the CDAI by ≥50 points more than placebo at week 6.  Ancillary analyses explored assocns. of 35 candidate genetic polymorphisms and fecal calprotectin response.  Results 59 patients (39 secukinumab, 20 placebo, mean baseline CDAI 307 and 301, resp.) were recruited.  18/59 (31%) Patients discontinued prematurely (12/39 (31%) secukinumab, 6/20 (30%) placebo), 10/59 (17%) due to insufficient therapeutic effect (8/39 (21%) secukinumab, 2/20 (10%) placebo).  Fourteen serious adverse events occurred in 10 patients (seven secukinumab, three placebo); 20 infections, including four local fungal infections, were seen on secukinumab vs. -none on placebo.  Primary end point anal. estd. <0.1% probability (ΔCDAI (SD) =33.9 (19.7), 95% credible interval -4.9 to 72.9) that secukinumab reduces CDAI by ≥50 points more than placebo.  Secondary area under the curve anal. (weeks 4-10) showed a significant difference (mean ΔCDAI=49; 95% CI (2 to 96), p=0.043) in favor of placebo.  Post hoc subgroup anal. showed that unfavorable responses on secukinumab were driven by patients with elevated inflammatory markers (CRP≥10 mg/l and/or fecal calprotectin≥200 ng/mL; mean ΔCDAI=62; 95% CI (-1 to 125), p=0.054 in favor of placebo).  Absence of the minor allele of tumor necrosis factor-like ligand 1A was strongly assocd. with lack of response measured by baseline-adjusted changes in calprotectin at week 6 (p=0.00035 Bonferroni-cor.).  Conclusions. Blockade of IL-17A was ineffective and higher rates of adverse events were noted compared with placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZQta3YJouL7Vg90H21EOLACvtfcHk0lhnRdoIICYpLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFOitg%253D%253D&md5=efa8d726701168a26949ba174059db97</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1136%2Fgutjnl-2011-301668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgutjnl-2011-301668%26sid%3Dliteratum%253Aachs%26aulast%3DHueber%26aufirst%3DW.%26aulast%3DSands%26aufirst%3DB.%2BE.%26aulast%3DLewitzky%26aufirst%3DS.%26aulast%3DVandemeulebroecke%26aufirst%3DM.%26aulast%3DReinisch%26aufirst%3DW.%26aulast%3DHiggins%26aufirst%3DP.%2BD.%26aulast%3DWehkamp%26aufirst%3DJ.%26aulast%3DFeagan%26aufirst%3DB.%2BG.%26aulast%3DYao%26aufirst%3DM.%2BD.%26aulast%3DKarczewski%26aufirst%3DM.%26aulast%3DKarczewski%26aufirst%3DJ.%26aulast%3DPezous%26aufirst%3DN.%26aulast%3DBek%26aufirst%3DS.%26aulast%3DBruin%26aufirst%3DG.%26aulast%3DMellgard%26aufirst%3DB.%26aulast%3DBerger%26aufirst%3DC.%26aulast%3DLondei%26aufirst%3DM.%26aulast%3DBertolino%26aufirst%3DA.%2BP.%26aulast%3DTougas%26aufirst%3DG.%26aulast%3DTravis%26aufirst%3DS.%2BP.%26atitle%3DSecukinumab%2520in%2520Crohn%25E2%2580%2599s%2520Disease%2520Study%252C%2520G.%2520Secukinumab%252C%2520a%2520human%2520anti-IL-17A%2520monoclonal%2520antibody%252C%2520for%2520moderate%2520to%2520severe%2520Crohn%25E2%2580%2599s%2520disease%253A%2520unexpected%2520results%2520of%2520a%2520randomised%252C%2520double-blind%2520placebo-controlled%2520trial%26jtitle%3DGut%26date%3D2012%26volume%3D61%26spage%3D1693%26epage%3D1700%26doi%3D10.1136%2Fgutjnl-2011-301668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaffen, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garg, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cua, D. J.</span></span> <span> </span><span class="NLM_article-title">The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">600</span>, <span class="refDoi"> DOI: 10.1038/nri3707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnri3707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=25145755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSit7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=585-600&author=S.+L.+Gaffenauthor=R.+Jainauthor=A.+V.+Gargauthor=D.+J.+Cua&title=The+IL-23-IL-17+immune+axis%3A+from+mechanisms+to+therapeutic+testing&doi=10.1038%2Fnri3707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing</span></div><div class="casAuthors">Gaffen, Sarah L.; Jain, Renu; Garg, Abhishek V.; Cua, Daniel J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">585-600</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Following the discovery of T helper 17 (TH17) cells, the past decade has witnessed a major revision of the TH subset paradigm and substantial progress has been made in deciphering the mol. mechanisms of T cell lineage commitment and function.  In this Review, we focus on the recent advances that have been made regarding the transcriptional control of TH17 cell plasticity and stability, as well as the effector functions of TH17 cells, and we highlight the mechanisms of IL-17 signalling in mesenchymal and barrier epithelial tissues.  We also discuss the emerging clin. data showing that IL-17-specific and IL-23-specific antibody treatments are remarkably effective for treating many immune-mediated inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsrf-chGl_n7Vg90H21EOLACvtfcHk0lhnRdoIICYpLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSit7%252FL&md5=3b78e054323aae062527ce32ec8e05e2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnri3707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3707%26sid%3Dliteratum%253Aachs%26aulast%3DGaffen%26aufirst%3DS.%2BL.%26aulast%3DJain%26aufirst%3DR.%26aulast%3DGarg%26aufirst%3DA.%2BV.%26aulast%3DCua%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520IL-23-IL-17%2520immune%2520axis%253A%2520from%2520mechanisms%2520to%2520therapeutic%2520testing%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D585%26epage%3D600%26doi%3D10.1038%2Fnri3707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer zum Buschenfelde, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strober, W.</span></span> <span> </span><span class="NLM_article-title">Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">998</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1038/nm0996-998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnm0996-998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=8782457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADyaK28XlsFenurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1996&pages=998-1004&author=M.+F.+Neurathauthor=S.+Petterssonauthor=K.+H.+Meyer+zum+Buschenfeldeauthor=W.+Strober&title=Local+administration+of+antisense+phosphorothioate+oligonucleotides+to+the+p65+subunit+of+NF-kappa+B+abrogates+established+experimental+colitis+in+mice&doi=10.1038%2Fnm0996-998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice</span></div><div class="casAuthors">Neurath, Markus F.; Pettersson, Sven; Meyer zum Bueschenfelde, Karl-Hermann; Strober, Warren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">998-1004</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Chronic intestinal inflammation induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS) is characterized by a transmural granulomatous colitis that mimics some characteristics of human Crohn's disease.  Here, we show that the transcription factor NF-κB p65 was strongly activated in TNBS-induced colitis and in colitis of interleukin-10-deficient mice.  Local administration of p65 antisense phosphorothioate oligonucleotides abrogated clin. and histol. signs of colitis and was more effective in treating TNBS-induced colitis than single or daily administration of glucocorticoids.  The data provide direct evidence for the central importance of p65 in chronic intestinal inflammation and suggest a potential therapeutic utility of p65 antisense oligonucleotides as a novel mol. approach for the treatment of patients with Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqJYS7uBMXJLVg90H21EOLACvtfcHk0lhssv-nSKn9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFenurg%253D&md5=dc5699b3b9e6e4160baf0ab917ca8e37</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnm0996-998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0996-998%26sid%3Dliteratum%253Aachs%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26aulast%3DPettersson%26aufirst%3DS.%26aulast%3DMeyer%2Bzum%2BBuschenfelde%26aufirst%3DK.%2BH.%26aulast%3DStrober%26aufirst%3DW.%26atitle%3DLocal%2520administration%2520of%2520antisense%2520phosphorothioate%2520oligonucleotides%2520to%2520the%2520p65%2520subunit%2520of%2520NF-kappa%2520B%2520abrogates%2520established%2520experimental%2520colitis%2520in%2520mice%26jtitle%3DNat.%2520Med.%26date%3D1996%26volume%3D2%26spage%3D998%26epage%3D1004%26doi%3D10.1038%2Fnm0996-998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nenci, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wullaert, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danese, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumucio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasparakis, M.</span></span> <span> </span><span class="NLM_article-title">Epithelial NEMO links innate immunity to chronic intestinal inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>446</i></span>,  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1038/nature05698</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fnature05698" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=17361131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsV2iur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=557-561&author=A.+Nenciauthor=C.+Beckerauthor=A.+Wullaertauthor=R.+Gareusauthor=G.+van+Looauthor=S.+Daneseauthor=M.+Huthauthor=A.+Nikolaevauthor=C.+Neufertauthor=B.+Madisonauthor=D.+Gumucioauthor=M.+F.+Neurathauthor=M.+Pasparakis&title=Epithelial+NEMO+links+innate+immunity+to+chronic+intestinal+inflammation&doi=10.1038%2Fnature05698"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Epithelial NEMO links innate immunity to chronic intestinal inflammation</span></div><div class="casAuthors">Nenci, Arianna; Becker, Christoph; Wullaert, Andy; Gareus, Ralph; van Loo, Geert; Danese, Silvio; Huth, Marion; Nikolaev, Alexei; Neufert, Clemens; Madison, Blair; Gumucio, Deborah; Neurath, Markus F.; Pasparakis, Manolis</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">446</span>
        (<span class="NLM_cas:issue">7135</span>),
    <span class="NLM_cas:pages">557-561</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Deregulation of intestinal immune responses seems to have a principal function in the pathogenesis of inflammatory bowel disease.  The gut epithelium is critically involved in the maintenance of intestinal immune homeostasis-acting as a phys. barrier sepg. luminal bacteria and immune cells, and also expressing antimicrobial peptides.  However, the mol. mechanisms that control this function of gut epithelial cells are poorly understood.  Here we show that the transcription factor NF-κB, a master regulator of pro-inflammatory responses, functions in gut epithelial cells to control epithelial integrity and the interaction between the mucosal immune system and gut microflora.  Intestinal epithelial-cell-specific inhibition of NF-κB through conditional ablation of NEMO (also called IκB kinase-γ (IKKγ)) or both IKK1 (IKKα) and IKK2 (IKKβ)-IKK subunits essential for NF-κB activation-spontaneously caused severe chronic intestinal inflammation in mice.  NF-κB deficiency led to apoptosis of colonic epithelial cells, impaired expression of antimicrobial peptides and translocation of bacteria into the mucosa.  Concurrently, this epithelial defect triggered a chronic inflammatory response in the colon, initially dominated by innate immune cells but later also involving T lymphocytes.  Deficiency of the gene encoding the adaptor protein MyD88 prevented the development of intestinal inflammation, demonstrating that Toll-like receptor activation by intestinal bacteria is essential for disease pathogenesis in this mouse model.  Furthermore, NEMO deficiency sensitized epithelial cells to tumor-necrosis factor (TNF)-induced apoptosis, whereas TNF receptor-1 inactivation inhibited intestinal inflammation, demonstrating that TNF receptor-1 signalling is crucial for disease induction.  These findings demonstrate that a primary NF-κB signalling defect in intestinal epithelial cells disrupts immune homeostasis in the gastrointestinal tract, causing an inflammatory-bowel-disease-like phenotype.  Our results identify NF-κB signalling in the gut epithelium as a crit. regulator of epithelial integrity and intestinal immune homeostasis, and have important implications for understanding the mechanisms controlling the pathogenesis of human inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomI2IJJWF2krVg90H21EOLACvtfcHk0lhssv-nSKn9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsV2iur4%253D&md5=d2364862e0d4b2c08489fb56d758956a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnature05698&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05698%26sid%3Dliteratum%253Aachs%26aulast%3DNenci%26aufirst%3DA.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DWullaert%26aufirst%3DA.%26aulast%3DGareus%26aufirst%3DR.%26aulast%3Dvan%2BLoo%26aufirst%3DG.%26aulast%3DDanese%26aufirst%3DS.%26aulast%3DHuth%26aufirst%3DM.%26aulast%3DNikolaev%26aufirst%3DA.%26aulast%3DNeufert%26aufirst%3DC.%26aulast%3DMadison%26aufirst%3DB.%26aulast%3DGumucio%26aufirst%3DD.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26aulast%3DPasparakis%26aufirst%3DM.%26atitle%3DEpithelial%2520NEMO%2520links%2520innate%2520immunity%2520to%2520chronic%2520intestinal%2520inflammation%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D557%26epage%3D561%26doi%3D10.1038%2Fnature05698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbulescu, K.</span></span> <span> </span><span class="NLM_article-title">Role of NF-kappaB in immune and inflammatory responses in the gut</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">856</span>– <span class="NLM_lpage">860</span>, <span class="refDoi"> DOI: 10.1136/gut.43.6.856</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1136%2Fgut.43.6.856" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=9824616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADyaK1cXotVagt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=856-860&author=M.+F.+Neurathauthor=C.+Beckerauthor=K.+Barbulescu&title=Role+of+NF-kappaB+in+immune+and+inflammatory+responses+in+the+gut&doi=10.1136%2Fgut.43.6.856"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Role of NF-κB in immune and inflammatory responses in the gut</span></div><div class="casAuthors">Neurath, M. F.; Becker, C.; Barbulescu, K.</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">856-860</span>CODEN:
                <span class="NLM_cas:coden">GUTTAK</span>;
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review with 76 refs.  NF-κB is a pleiotropic transcription factor with key functions in the intestinal immune system.  NF-κB family members control transcriptional activity of various promoters of proinflammatory cytokines, cell surface receptors, transcription factors, and adhesion mols. that are involved in intestinal inflammation.  The perpetuated activation of NF-κB in patients with active inflammatory bowel disease suggests that regulation of NF-κB activity is a very attractive target for therapeutic intervention.  Such strategies include antioxidants, proteasome inhibitors, inhibition of NF-κB by adenoviral IκBα expression vectors, and antisense DNA targeting of NF-κB.  These approaches will hopefully permit the design of new treatment strategies for chronic intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnZJU348S7orVg90H21EOLACvtfcHk0lhssv-nSKn9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVagt7o%253D&md5=57bb48c513e76e3d93e91125fbb4bce0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1136%2Fgut.43.6.856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.43.6.856%26sid%3Dliteratum%253Aachs%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DBarbulescu%26aufirst%3DK.%26atitle%3DRole%2520of%2520NF-kappaB%2520in%2520immune%2520and%2520inflammatory%2520responses%2520in%2520the%2520gut%26jtitle%3DGut%26date%3D1998%26volume%3D43%26spage%3D856%26epage%3D860%26doi%3D10.1136%2Fgut.43.6.856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khor, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, A. N.</span></span> <span> </span><span class="NLM_article-title">Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">11580</span>– <span class="NLM_lpage">11584</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-06-3562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1158%2F0008-5472.CAN-06-3562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=17178849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlagurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=11580-11584&author=T.+O.+Khorauthor=M.+T.+Huangauthor=K.+H.+Kwonauthor=J.+Y.+Chanauthor=B.+S.+Reddyauthor=A.+N.+Kong&title=Nrf2-deficient+mice+have+an+increased+susceptibility+to+dextran+sulfate+sodium-induced+colitis&doi=10.1158%2F0008-5472.CAN-06-3562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium-Induced Colitis</span></div><div class="casAuthors">Khor, Tin Oo; Huang, Mou-Tuan; Kwon, Ki Han; Chan, Jefferson Y.; Reddy, Bandaru S.; Kong, Ah-Ng</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11580-11584</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inflammatory bowel diseases, chronic inflammatory disorders, have been strongly linked with an increased risk of the development of colorectal cancer.  Understanding the etiol. of these diseases is pivotal for the improvement of currently available strategies to fight against inflammatory bowel disease, and more importantly, to prevent colorectal cancer.  Nuclear factor-erythroid 2-related factor 2 (Nrf2) has been known to be a transcriptional factor which plays a crucial role in cytoprotection against inflammation, as well as oxidative and electrophilic stresses.  The aim of this study is to investigate the role of Nrf2 in the regulation of dextran sulfate sodium (DSS)-induced exptl. colitis in mice.  Nrf2-deficient mice were found to be more susceptible to DSS-induced colitis as shown by the increased severity of colitis following 1 wk of oral administration of 1% DSS.  The increased severity of colitis in Nrf2(-/-) mice was found to be assocd. with decreased expression of antioxidant/phase II detoxifying enzymes including heme-oxygenase-1, NAD(P)H-quinone reductase-1, UDP-glucurosyltransferase 1A1, and glutathione S-transferase Mu-1.  In addn., proinflammatory mediators/cytokines such as COX-2, inducible nitric oxide synthase, interleukin 1β, interleukin 6, and tumor necrosis factor α were significantly increased in the colonic tissues of Nrf2(-/-) mice compared with their wild-type (Nrf2+/+) counterparts.  In summary, we show for the first time that mice lacking Nrf2 are more susceptible to DSS-induced colitis.  Our data suggests that Nrf2 could play an important role in protecting intestinal integrity, through regulation of proinflammatory cytokines and induction of phase II detoxifying enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiYnmui9KH6rVg90H21EOLACvtfcHk0lhssv-nSKn9Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlagurjI&md5=b40e65af2cdb7dcc412f7eece187d875</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-3562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-3562%26sid%3Dliteratum%253Aachs%26aulast%3DKhor%26aufirst%3DT.%2BO.%26aulast%3DHuang%26aufirst%3DM.%2BT.%26aulast%3DKwon%26aufirst%3DK.%2BH.%26aulast%3DChan%26aufirst%3DJ.%2BY.%26aulast%3DReddy%26aufirst%3DB.%2BS.%26aulast%3DKong%26aufirst%3DA.%2BN.%26atitle%3DNrf2-deficient%2520mice%2520have%2520an%2520increased%2520susceptibility%2520to%2520dextran%2520sulfate%2520sodium-induced%2520colitis%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D11580%26epage%3D11584%26doi%3D10.1158%2F0008-5472.CAN-06-3562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khateb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinoco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bar-Yoseph, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowers, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerassy-Vainberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starosvetsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen-Orr, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tessier, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronai, Z. A.</span></span> <span> </span><span class="NLM_article-title">Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3296</span>– <span class="NLM_lpage">3311</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2018.08.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1016%2Fj.celrep.2018.08.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=30232010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslGnurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=3296-3311&author=Y.+Fujitaauthor=A.+Khatebauthor=Y.+Liauthor=R.+Tinocoauthor=T.+Zhangauthor=H.+Bar-Yosephauthor=M.+A.+Tamauthor=Y.+Chowersauthor=E.+Saboauthor=S.+Gerassy-Vainbergauthor=E.+Starosvetskyauthor=B.+Jamesauthor=K.+Brownauthor=S.+S.+Shen-Orrauthor=L.+M.+Bradleyauthor=P.+A.+Tessierauthor=Z.+A.+Ronai&title=Regulation+of+S100A8+Stability+by+RNF5+in+Intestinal+Epithelial+Cells+Determines+Intestinal+Inflammation+and+Severity+of+Colitis&doi=10.1016%2Fj.celrep.2018.08.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis</span></div><div class="casAuthors">Fujita, Yu; Khateb, Ali; Li, Yan; Tinoco, Roberto; Zhang, Tongwu; Bar-Yoseph, Haggai; Tam, Miguel A.; Chowers, Yehuda; Sabo, Edmond; Gerassy-Vainberg, Shiran; Starosvetsky, Elina; James, Brian; Brown, Kevin; Shen-Orr, Shai S.; Bradley, Linda M.; Tessier, Philippe A.; Ronai, Ze'ev A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3296-3311.e6</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inflammatory bowel disease (IBD) is prevalent, but the mechanisms underlying disease development remain elusive.  We identify a role for the E3 ubiquitin ligase RNF5 in IBD.  Intestinal epithelial cells (IECs) express a high level of RNF5, while the colon of Rnf5-/- mice exhibits activated dendritic cells and intrinsic inflammation.  Rnf5-/- mice exhibit severe acute colitis following dextran sodium sulfate (DSS) treatment.  S100A8 is identified as an RNF5 substrate, resulting in S100A8 ubiquitination and proteasomal-dependent degrdn. that is attenuated upon inflammatory stimuli.  Loss of RNF5 from IECs leads to enhanced S100A8 secretion, which induces mucosal CD4+ T cells, resulting in Th1 pro-inflammatory responses.  Administration of S100A8-neutralizing antibodies to DSS-treated Rnf5-/- mice attenuates acute colitis development and increases survival.  An inverse correlation between RNF5 and S100A8 protein expression in IECs of IBD patients coincides with disease severity.  Collectively, RNF5-mediated regulation of S100A8 stability in IECs is required for the maintenance of intestinal homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoduc3XXTfpmbVg90H21EOLACvtfcHk0lgYawzTM4dZwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslGnurzP&md5=4844ffd3a3ee82dd88a5760d027a2f34</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.08.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.08.057%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DY.%26aulast%3DKhateb%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DTinoco%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DBar-Yoseph%26aufirst%3DH.%26aulast%3DTam%26aufirst%3DM.%2BA.%26aulast%3DChowers%26aufirst%3DY.%26aulast%3DSabo%26aufirst%3DE.%26aulast%3DGerassy-Vainberg%26aufirst%3DS.%26aulast%3DStarosvetsky%26aufirst%3DE.%26aulast%3DJames%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DShen-Orr%26aufirst%3DS.%2BS.%26aulast%3DBradley%26aufirst%3DL.%2BM.%26aulast%3DTessier%26aufirst%3DP.%2BA.%26aulast%3DRonai%26aufirst%3DZ.%2BA.%26atitle%3DRegulation%2520of%2520S100A8%2520Stability%2520by%2520RNF5%2520in%2520Intestinal%2520Epithelial%2520Cells%2520Determines%2520Intestinal%2520Inflammation%2520and%2520Severity%2520of%2520Colitis%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D24%26spage%3D3296%26epage%3D3311%26doi%3D10.1016%2Fj.celrep.2018.08.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smale, S. T.</span></span> <span> </span><span class="NLM_article-title">Hierarchies of NF-kappaB target-gene regulation</span>. <i>Nat. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">689</span>– <span class="NLM_lpage">694</span>, <span class="refDoi"> DOI: 10.1038/ni.2070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1038%2Fni.2070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=21772277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptV2ju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=689-694&author=S.+T.+Smale&title=Hierarchies+of+NF-kappaB+target-gene+regulation&doi=10.1038%2Fni.2070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Hierarchies of NF-κB target-gene regulation</span></div><div class="casAuthors">Smale, Stephen T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">689-694</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Members of the NF-κB family of transcription factors function as dominant regulators of inducible gene expression in almost all cell types in response to a broad range of stimuli, with particularly important roles in coordinating both innate and adaptive immunity.  This review summarizes the present knowledge and recent progress toward elucidating the numerous regulatory layers that confer target-gene selectivity in response to an NF-κB-inducing stimulus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGdGr_rNMfVbVg90H21EOLACvtfcHk0lgYawzTM4dZwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptV2ju7w%253D&md5=a67b0e438de67f6fbff7e28c07f4c53b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fni.2070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2070%26sid%3Dliteratum%253Aachs%26aulast%3DSmale%26aufirst%3DS.%2BT.%26atitle%3DHierarchies%2520of%2520NF-kappaB%2520target-gene%2520regulation%26jtitle%3DNat.%2520Immunol.%26date%3D2011%26volume%3D12%26spage%3D689%26epage%3D694%26doi%3D10.1038%2Fni.2070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Moldes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lastres-Becker, I.</span></span> <span> </span><span class="NLM_article-title">Transcription factors NRF2 and NF-kappaB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">15244</span>– <span class="NLM_lpage">15258</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.540633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1074%2Fjbc.M113.540633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=24759106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVegur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=15244-15258&author=A.+Cuadradoauthor=Z.+Martin-Moldesauthor=J.+Yeauthor=I.+Lastres-Becker&title=Transcription+factors+NRF2+and+NF-kappaB+are+coordinated+effectors+of+the+Rho+family%2C+GTP-binding+protein+RAC1+during+inflammation&doi=10.1074%2Fjbc.M113.540633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation</span></div><div class="casAuthors">Cuadrado, Antonio; Martin-Moldes, Zaira; Ye, Jianping; Lastres-Becker, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">15244-15258</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The small GTPase protein RAC1 participates in innate immunity by activating a complex program that includes cytoskeleton remodeling, chemotaxis, activation of NADPH oxidase, and modulation of gene expression.  However, its role in regulating the transcriptional signatures that in term control the cellular inflammatory profiles are not well defined.  Here we investigated the functional and mechanistic connection between RAC1 and the transcription factor NRF2 (nuclear factor erythroid 2-related factor 2), master regulator of the anti-oxidant response.  Lipopolysaccharide and constitutively active RAC1Q61L mutant induced the anti-oxidant enzyme heme-oxygenase-1 (HO-1) through activation of NRF2.  The use of KEAP1-insensitive NRF2 mutants indicated that RAC1 regulation of NRF2 is KEAP1-independent.  Interestingly, NRF2 overexpression inhibited, whereas a dominant-neg. mutant of NRF2 exacerbated RAC1-dependent activation of nuclear factor-κB (NF-κB), suggesting that NRF2 has an antagonistic effect on the NF-κB pathway.  Moreover, we found that RAC1 acts through NF-κB to induce NRF2 because either expression of a dominant neg. mutant of IκBα that leads to NF-κB degrdn. or the use of p65-NF-κB-deficient cells demonstrated lower NRF2 protein levels and basally impaired NRF2 signature compared with control cells.  In contrast, NRF2-deficient cells showed increased p65-NF-κB protein levels, although the mRNA levels remain unchanged, indicating post-translational alterations.  Our results demonstrate a new mechanism of modulation of RAC1 inflammatory pathway through a cross-talk between NF-κB and NRF2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzn6mVIKjF27Vg90H21EOLACvtfcHk0lgYawzTM4dZwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVegur8%253D&md5=498a5a7e97daffef1cd3c415104c43d5</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.540633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.540633%26sid%3Dliteratum%253Aachs%26aulast%3DCuadrado%26aufirst%3DA.%26aulast%3DMartin-Moldes%26aufirst%3DZ.%26aulast%3DYe%26aufirst%3DJ.%26aulast%3DLastres-Becker%26aufirst%3DI.%26atitle%3DTranscription%2520factors%2520NRF2%2520and%2520NF-kappaB%2520are%2520coordinated%2520effectors%2520of%2520the%2520Rho%2520family%252C%2520GTP-binding%2520protein%2520RAC1%2520during%2520inflammation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D15244%26epage%3D15258%26doi%3D10.1074%2Fjbc.M113.540633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrasco, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzaei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macmillan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chook, Y. M.</span></span> <span> </span><span class="NLM_article-title">Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1073/pnas.1217203110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=10.1073%2Fpnas.1217203110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=23297231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFerur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=1303-1308&author=Q.+Sunauthor=Y.+P.+Carrascoauthor=Y.+Huauthor=X.+Guoauthor=H.+Mirzaeiauthor=J.+Macmillanauthor=Y.+M.+Chook&title=Nuclear+export+inhibition+through+covalent+conjugation+and+hydrolysis+of+Leptomycin+B+by+CRM1&doi=10.1073%2Fpnas.1217203110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nuclear export inhibition through covalent conjugation and hydrolysis of Leptomycin B by CRM1</span></div><div class="casAuthors">Sun, Qingxiang; Carrasco, Yazmin P.; Hu, Youcai; Guo, Xiaofeng; Mirzaei, Hamid; MacMillan, John; Chook, Yuh Min</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1303-1308, S1303/1-S1303/14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The polyketide natural product Leptomycin B (LMB) inhibits nuclear export mediated by the karyopherin protein chromosomal region maintenance 1 (CRM1).  Here, we present 1.8- to 2.0-Å-resoln. crystal structures of CRM1 bound to Leptomycin B and related inhibitors Anguinomycin A (AGA) and Ratjadone A (RJA).  Structural and complementary chem. analyses reveal an unexpected mechanism of inhibition involving covalent conjugation and CRM1-mediated hydrolysis of the natural products' lactone rings.  Furthermore, mutagenesis reveals the mechanism of hydrolysis by CRM1.  The nuclear export signal (NES)-binding groove of CRM1 is able to drive a chem. reaction in addn. to binding protein cargos for transport through the nuclear pore complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB_HH4AmBIkLVg90H21EOLACvtfcHk0lg0gUyMIopxXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFerur8%253D&md5=81c0bfa87142c65788d3229460fd3827</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1217203110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1217203110%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DCarrasco%26aufirst%3DY.%2BP.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DMirzaei%26aufirst%3DH.%26aulast%3DMacmillan%26aufirst%3DJ.%26aulast%3DChook%26aufirst%3DY.%2BM.%26atitle%3DNuclear%2520export%2520inhibition%2520through%2520covalent%2520conjugation%2520and%2520hydrolysis%2520of%2520Leptomycin%2520B%2520by%2520CRM1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D1303%26epage%3D1308%26doi%3D10.1073%2Fpnas.1217203110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedergran, D. J.</span></span> <span> </span><span class="NLM_article-title">Clinicopathologic study of dextran sulfate sodium experimental murine colitis</span>. <i>Lab Invest</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">249</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=8350599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;key=1%3ACAS%3A528%3ADyaK2cXhs1Smtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1993&pages=238-249&author=H.+S.+Cooperauthor=S.+N.+Murthyauthor=R.+S.+Shahauthor=D.+J.+Sedergran&title=Clinicopathologic+study+of+dextran+sulfate+sodium+experimental+murine+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Clinicopathologic study of dextran sulfate sodium experimental murine colitis</span></div><div class="casAuthors">Cooper, Harry S.; Murthy, S.N.S.; Shah, Rupal S.; Sedergran, Deborah J.</div><div class="citationInfo"><span class="NLM_cas:title">Laboratory Investigation</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-49</span>CODEN:
                <span class="NLM_cas:coden">LAINAW</span>;
        ISSN:<span class="NLM_cas:issn">0023-6837</span>.
    </div><div class="casAbstract">The authors undertook this study in order to fully characterize the clin. and histopathol. features of the dextran sulfate sodium (DSS) model of exptl. murine colitis and to discover the earliest histopathol. changes that lead to colitis.  Acute colitis was induced in Swiss-Webster mice by 7 days of oral DSS with animals sacrificed daily.  Chronic colitis was induced by: (a) 7 days of oral DSS followed by 7 days of H2O (for 1, 2, and 3 cycles) and (b) 7 days of oral DSS followed by 14 and 21 days of H2O.  In each exptl. group, the entire colons were examd. histol. and correlated with clin. symptoms.  Acute clin. symptoms (diarrhea and/or grossly bloody stool) were assocd. with the presence of erosions and inflammation.  More importantly, the earliest histol. changes which predated clin. colitis was loss of the basal one-third of the crypt (day 3), which progressed with time to loss of the entire crypt resulting in erosions on day 5.  The earliest changes were very focal and not assocd. with inflammation.  Inflammation was a secondary phenomena and only became significant after erosions appeared.  Animals treated with only 7 days of DSS followed by 14 and 21 days of H2O developed a chronic colitis with the following histol. features: areas of activity (erosions and inflammation), inactivity, crypt distortion, florid epithelial proliferation and possible dysplasia.  These changes were similar to animals given 3 cycles of DSS.  The clin. disease activity index correlated significantly with pathol. changes in both the acute and chronic phases of the disease.  The mechanism of DSS colitis is presently unknown.  However, the finding of crypt loss without proceeding or accompanying inflammation suggests that the initial insult is at the level of the epithelial cell with inflammation being a secondary phenomena.  This may be a good model to study how early mucosal changes lead to inflammation and the biol. of the colonic enterocyte.  Chronic colitis induced after only 7 days of DSS may serve as a useful model to study the effects of pharmacol. agents in human inflammatory disease and mechanisms of perpetuation of inflammation.  Finally, the authors believe that this model has the potential to study the dysplasia cancer sequence in inflammatory disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8mi93BIhyJ7Vg90H21EOLACvtfcHk0lg0gUyMIopxXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhs1Smtr0%253D&md5=e52fe592ea500787eeb7217c5722d3f4</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DH.%2BS.%26aulast%3DMurthy%26aufirst%3DS.%2BN.%26aulast%3DShah%26aufirst%3DR.%2BS.%26aulast%3DSedergran%26aufirst%3DD.%2BJ.%26atitle%3DClinicopathologic%2520study%2520of%2520dextran%2520sulfate%2520sodium%2520experimental%2520murine%2520colitis%26jtitle%3DLab%2520Invest%26date%3D1993%26volume%3D69%26spage%3D238%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZPU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5ZPU','PDB','5ZPU'); return false;">PDB: 5ZPU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HAT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HAT','PDB','4HAT'); return false;">PDB: 4HAT</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-NOTES-d7e1081-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i34"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01663">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27818"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01663?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01663</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Organic synthesis; the expression of CRM1 in intestinal tissues of UC patients; co-crystallographic structure; mass spectrometric analysis; MS data analysis; cell-based phenotypic assay; pull-down assay; GSH/GSSG ratio detection assay; si-RNA knockdown efficiency; acute toxicity; cardiotoxicity; PK/liver microsome stability; putative metabolic products; permeability properties; <sup>1</sup>H and <sup>13</sup>C NMR spectra; evaluation of different linkers; SPR results of control proteins (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_001.pdf">jm9b01663_si_001.pdf (1.34 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01663/suppl_file/jm9b01663_si_002.csv">jm9b01663_si_002.csv (0.21 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01663&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-8%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01663%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01663" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                14MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667987d7fed42428","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
